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“Let food be thy medicine and medicine be thy food.” 
Hippocrates 
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AI: adequate intake 
AICR: American Institute for Cancer Research 
AMDR: acceptable macronutrient distribution ranges 
APC: adenomatous polyposis coli 
ASRi: age-estandarized incidence rate 
ASRm: age-estandarized mortality rate 
BMI: body mass index 
C: cytosine 
CI: confidence interval 
CRC: colorectal cancer 
CRCSP: colorectal cancer screening programme 
CUP: Continuous Update Project 
DHA: docosahexaenoic acid 
DI: deprivation index 
DUSP10: dual specificity protein phosphatase 10 
EAR: estimated average requirements 
EER: estimated energy requirement 
EPA: eicosapentaenoic acid 
ERK: extracellular regulated mitogen-activated protein kinase 
FOBT: faecal occult blood test 
FS: flexible sigmoidoscopy 
G: guanine 
gFOBT: guaiac-based faecal occult blood test 
GH1: growth hormone 1 
GQ: general questionnaire 
GWAS: genome-wide association study 
HEISD: Healthy Eating Index for Spanish Diet 
HRT: hormonal replacement therapy 
HWE: Hardy-Weinberg equilibrum 
IBD: inflammatory bowel disease 
IGF-I: insulin like growth factor 1 
iFOBT: immunochemical faecal occult blood test 
JNK: c-Jun amino terminal kinase 
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KOM: Kolon-ondesteko minbizia 
L: level 
MAPK: mitogen-activated protein kinase 
MD: Mediterranean diet 
MDS: MedDietScore 
MEKK1: MAPK/ERK kinase kinase 1 
mRNA: messenger RNA 
MTHFR: methylenetetrahydrofolate reductase 
MUFA: monounsaturated fatty acids 
NA: not available data 
NOSP: nutritional objectives for the Spanish population 
NSAID: non-steroidal anti-inflammatory drug 
OR: odds ratio 
PA: physical activity 
PE: physical exercise 
PI: physical inactivity 
PRM: predictive risk modelling 
PKG: cGMP-dependent protein kinase 
PUFA: polyunsaturated fatty acids 
Q: quintile 
QoL: quality of life 
RCT: randomized controlled trial 
RR: relative risk 
rs: reference single nucleotide polymorphism 
SEK1: dual specificity mitogen-activated protein kinase kinase sek-1 
SFFQ: short food frequency questionnaire 
SFA: saturated fatty acids 
SNP: single nucleotide polymorphism 
T: thymine 
TEI: total energy intake 
WCR: World Cancer Research Fund 
WHO: World Health Organization 





To date, case-control studies have revealed inconsistent evidence on the influence of 
dietary and genetic factors on colorectal cancer (CRC) risk. In order to better elucidate 
the role of some of these factors in the aetiology of CRC, the main objective of this study 
was to analyse dietary and genetic factors in a sample of cases and controls from the 
population-based CRC screening programme of the Osakidetza/Basque Health Service. 
In addition, taking into account that an unhealthy diet is associated with the risk of tumour 
recurrence, metastasis and death, the other aim of this thesis was to assess the 
adequacy of nutrients consumed and diet quality in a group of CRC patients postsurgery. 
The results showed that the diet of the studied CRC patients postsurgery is inadequate 
in many respects, including nutrients and food intakes. In fact, this inadequacy is 
associated with certain health determinants. On the other hand, there are direct 
associations between CRC risk and high-fat cheese, and inverse associations with fibre-
containing foods and fatty fish, as well as adherence to a Mediterranean Diet pattern, in 
the case-control sample analysed. With respect to genetic factors, it was confirmed a 
CRC susceptibility locus and the existence of associations between modifiable factors 
and the rs6687758 SNP; moreover, the Genetic Risk Score was associated with CRC. 
However, further studies are needed to better understand the influence of the dietary 
habits on CRC prevention and to establish the role of the genetic factors, as well as the 
contribution of the gene-diet interactions to the risk of CRC in this population.   
  





Hasta la fecha, los estudios de casos y controles han mostrado contradicciones en las 
evidencias sobre la influencia de factores dietéticos y genéticos en el aumento del riesgo 
de cáncer colorrectal (CCR). Con el fin de conocer mejor el papel de algunos de estos 
factores en la etiología del CCR, planteamos el presente estudio con el objetivo principal 
de analizar factores dietéticos y genéticos en una muestra de casos y controles 
procedente del programa de cribado de CCR de Osakidetza/Servicio Vasco de Salud. 
Además, teniendo en cuenta que una dieta poco saludable se asocia con mayor riesgo 
de recurrencia del tumor, metástasis y mayor mortalidad, otro objetivo de esta tesis fue 
evaluar la adecuación de la ingesta de nutrientes y la calidad de la dieta en un grupo de 
pacientes diagnosticados de CCR, después del tratamiento quirúrgico. Los resultados 
mostraron que la dieta de los pacientes con CRC estudiados tras la cirugía, era 
inadecuada en varios aspectos, incluida la ingesta de nutrientes y alimentos, y que esta 
inadecuación estaba asociada a ciertos determinantes de salud. Por otro lado, en la 
muestra de casos y controles, se observó asociación directa entre el riesgo de CCR y el 
consumo de quesos con un alto contenido en grasa, y asociaciones inversas con la 
ingesta de alimentos ricos en fibra y de pescado azul, así como con la adherencia a un 
patrón de Dieta Mediterránea. Con respecto a los factores genéticos, se confirmó un 
locus de susceptibilidad para el CCR y la asociación entre ciertos factores modificables 
y el SNP rs6687758. También se asoció una mayor puntuación en el riesgo genético 
con el CCR. En cualquier caso, son necesarios más estudios para comprender mejor la 
influencia de los hábitos dietéticos sobre el CCR y para establecer el papel de los 
factores genéticos, así como la contribución de las interacciones gen-dieta al riesgo de 
CCR en esta población.  





Orain arte, kasuen eta kontrolen azterketek agerian utzi dute faktore dietetikoek eta 
genetikoek kolon-ondesteko minbizirako (KOM) arriskua areagotzean duten eraginari 
buruzko ebidentziak kontraesankorrak direla. Faktore horietako batzuek KOM etiologian 
duten zeregina hobeto argitu nahiean, azterlan honen helburu nagusia faktore 
dietetikoak eta genetikoak aztertzea izan zen, Osakidetza-Euskal osasun zerbitzuaren 
KOM detekzio goiztiarreko programaren kasuen eta kontrolen lagin batean. Gainera, 
kontuan hartuta dieta ez oso osasungarria tumorearen errepikatze-arriskuarekin, 
metastasiarekin eta hilkortasunarekin lotuta dagoela, tesi honen beste helburua izan zen 
ebaluatzea ea egokia zen mantenugaien kontsumoa eta dietaren kalitatea KOM zuten 
pazienteen talde batean, kirurgia-tratamendua jaso ondoren. Emaitzek erakutsi zuten 
kirurgiaren ondoren aztertutako KOM zuten pazienteen dieta desegokia zela alderdi 
batzuetan, mantenugaien eta elikagaien kontsumoan barne, eta gutxiegitasun hori 
osasun-determinatzaile jakin batzuekin lotuta zegoela. Bestalde, kasuen eta kontrolen 
laginean, lotura zuzenak zeuden KOM arriskuaren eta gantz eduki handiko gazta 
kontsumoaren artean, eta alderantzizko asoziazioak zuntza eta arrain koipetsua duten 
elikagai-kontsumoarekin, baita Dieta Mediterraneoko patroi  batekiko atxikidura ere. 
Faktore genetikoei dagokienez, baieztatu zen KOM izateko arriskua zegoela, eta faktore 
aldagarrien eta SNP rs687758 delakoaren arteko loturak zeudela. Gainera, arrisku 
genetikoan puntuazio handiagoa lortu izana gaixotasunarekin lotu zen. Dena den, 
azterlan gehiago behar dira elikadura-ohituren eragina KOM arriskuan, faktore 
genetikoen zeregina, eta geneen eta dietaren arteko elkarrekintzak hobeto ulertzeko. 
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Motivation of the present study 
 
CRC is both one of the most common and one of the most preventable cancers. Its 
incidence is steadily rising in western countries and it is already the second most deadly 
cancer worldwide. The increased incidence of CRC has been attributed to environmental 
changes, such as a high consumption of processed foods, meat, meat derivatives and 
alcohol, more frequent sedentary behaviours, greater obesity and longevity. Many risk 
and protective factors, very common and potentially modifiable lifestyle behaviours, and 
specifically diet and nutrition have been studied to date. However, many of the results 
are inconsistent and vary considerably depending on the population and the 
methodology used. In order to better elucidate the role of some of these factors in the 
aetiology of CRC, the present work aimed to analyse dietary and genetic factors in a 
sample, not studied to date in this regard, from the population-based CRCSP of the 
Osakidetza/Basque Health Service. In addition, taking into account the potential of 
tertiary prevention measures to improve the prognosis and quality of life of CRC patients, 
the other aim of this work was to assess the adequacy of the diet of CRC patients 
postsurgery to the nutritional recommendations. Given the complexity of the subject that 
we will tackle, the results will be confirmed in subsequent studies with bigger sample 
sizes. In this sense, the population of the Autonomous Region of Basque Country opens 
up new opportunities, due to the relatively high incidence of this kind of cancer and the 
fact of having a public health system that allows us access to clinical histories, pathology 
reports and tissue samples, all of which are necessary for this study. 
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1. COLORECTAL CANCER  
 
1.1.  DEFINITION AND EPIDEMIOLOGY  
Colorectal cancer (CRC) is a malignant neoplasm arising from epithelium anywhere in 
the large bowel (caecum, ascending, transverse, descending or sigmoid colon, rectum), 
excluding the appendix and the anus [1]. More than 90% of colorectal carcinomas are 
adenocarcinomas originating from the glandular epithelial of the large intestine [2]. CRC 
is already the second most deadly cancer worldwide, with about 881,000 deaths 
estimated for 2018 [3], and its incidence is steadily rising in western countries [4]. 
According to GLOBOCAN 2018 data, CRCs are the third most commonly diagnosed 
form of cancer globally, consisting of 11% of all cancer diagnoses [4]. This type of cancer 
has a higher incidence in men than women and an increasing age-standardized 
incidence rate, (ASRi) per 100,000 of CRC in both sexes is 19.7, in males it is 23.6, and 
in females 16.3 [5].  
Incidence and mortality varies geographically, more-developed regions have a higher 
incidence and mortality than less-developed ones [5]. Europe is among the seven world 
regions ranked according to ASRi, with an ASRi of 30.0 per 100,000 [6]. In particular, in 
Spain, the ASRi for CRC is 33.4 per 100,000 (21.1 per 100,000 in males and 12.4 per 
100,000 in females) [7]. In the Basque Country, one of the autonomous regions of the 
North of Spain, this pathology is the most frequent type of cancer (taking into account 
the incidence rates of both sexes combined) [8]. The main factors that contribute to 
incidence variation between countries and even within a nation are disparities in access 
to screenings and in lifestyle behaviours [4,9,10].  
Regarding the mortality in CRC in countries with a high human development index, the 
age-standardized mortality rate (ASRm) is 12.8 per 100,000 among males and 8.5 per 
100,000 among females [4]. The CRC is the deadliest cancer among males in Saudi 
Arabia, Oman and United Arab Emirates, and the most deadly among females in Algeria, 
Belarus, Japan, Spain, and Portugal [4]. During recent years, mortality rates by CRC 
have been decreasing due to early screening programs [10,11] and better treatment 
options [12]. However, by the year 2030, the global burden of CRC is expected to 
increase by 60% to over 2.2 million new cases. This growth would be probably related 
to environmental changes, such as a high consumption of processed foods, meat, meat 
derivatives and alcohol, more frequent sedentary behaviours, greater obesity and 
longevity [13]. 
3
Dietary and genetic factors in colorectal cancer  Introduction 
 
1.2. AETIOLOGY 
The aetiology of CRC is complex and still not fully understood. Historically, CRCs have 
been hypothesized to arise via the gradual stepwise accumulation of mutations [14,15]. 
The progression from normal tissue to dysplastic epithelium to carcinoma would be 
accompanied by the accumulation of mutations that perturb specific genetic pathways at 
each phase of the tumorigenic process. However, several studies demonstrated that 
80%–90% of CRC are initiated following the loss of activity of the adenomatous polyposis 
coli (APC) gene [16,17].  
New evolutionary models, for their part, explain better the vast amount of heterogeneity 
observed within and across colorectal tumours [18]. Good examples of this are the “Big 
Bang” theory of tumorigenesis [19] and the cancer “punctuated equilibrium” model. This 
latter model describes the development of tumours as a process characterized by long 
periods of stasis, punctuated by rapid periods of transformation and molecular changes 
[20]. In these rapid periods, mutations, epigenetic and transcriptional alterations take 
place, producing changes in the phenotype and contributing to the development of 
adenoma.  
Notwithstanding these advances, many aspects related to the aetiology of this type of 
cancer such as the adenoma-to-carcinoma sequence, the timing of mechanisms 
involved and the dynamics between multiple clones remain unknown. Authors such as 
Sievers et al. [18] have speculated that there are previously unidentified factors, such 
genetic, epigenetic, or signalling related factors, that make certain cells more susceptible 
to neoplastic transformation. Understanding better the causes and mechanisms of this 
disease is critical for long-term prevention, detection and treatment.  
1.3. RISK FACTORS  
Unlike other cancers, no single risk factor accounts for most cases of CRC. Although 
inherited susceptibility results in the most striking increases in risk, the majority of CRCs 
are sporadic rather than familial. Moreover, both genetic and environmental factors play 
an important role in its aetiology [21]. Males have about a 1.5-fold higher chance than 
females of developing CRC, taking into account all ages and nations [4]. However, 
women are more susceptible to suffer from right-sided colon cancer, which is 
characterised by a greater aggressive growth compared to the left-sided one [22]. In 
addition, people over 65 years old are about three times more likely to suffer from CRC 
than those between 50-64 years of age, and about 30 times more likely to suffer from 
CRC than those who are 25-49 years old [3].  
4
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Besides age and male sex, other risk factors identified in epidemiological studies are the 
following: family history of CRC [23], inflammatory bowel disease (IBD), smoking, 
excessive alcohol consumption, high consumption of red and processed meat, physical 
inactivity (PI), obesity, and diabetes. The risk increase is strongest for people with CRC 
history in first-degree and people with IBD, for both factors the estimated relative risks 
(RRs) are greater than 2. More than 30% of CRC patients have a family history of this 
type of cancer. Those with a relative with CRC history in first-degree suffer a 2-4 times 
higher risk. The most common hereditary syndrome, the Lynch syndrome, accounts for 
2%-4% all cases. The second one is the familial adenomatous polyposis, which is less 
than 1% of all cases [3]. 
Patients with IBD have a two-fold risk of developing CRC. The primary causes behind 
IBD are ulcerative colitis and Crohn´s disease [24,25]. Both IBDs are auto-immunes and 
characterised by inflammation that results in the abnormal release of growth cytokines, 
metabolic free radicals, excess blood flow and other factors that have an influence on 
carcinogenesis. There are other, more common and potentially modifiable, risk factors, 
such as lifestyle and certain diseases that contribute greatly to CRC process at the 
population level, even if their RR is low (between 1.2 and 2.0) [26]. Thus toxic habits 
such as tobacco and alcohol have been associated with CRC risk. The relative CRC risk 
of regular smoking is 1.18 [27] and this risk has been associated with mutagens of 
tobacco [28]. A meta-analysis [29] and more recent studies [30] have also found that 
associations between alcohol consumption and CRC risk is dose-dependent. Although 
the mechanisms underlying alcohol-induced CRC are still not well defined, plausible 
events include: genotoxic effect of acetaldehyde, increased estrogen concentration, 
cellular stress, altered folate metabolism, and inflammation [31,32]. 
With regard to diet, red meat and meat derivatives are known to increase the risk of CRC 
[33]. Prospective studies found a RR of 1.22 among those who consumed the most red 
meat and meat derivatives [34]. In fact, the International Agency for Research on Cancer 
(IARC) designated processed meat as “carcinogenic” and red meat as “probably 
carcinogenic”, due to its impact on CRC risk [35]. This effect has been related to the high 
fat and inflammatory substances content [36,37] and the high-temperature cooking of 
meat [37,38].  
On the other hand, both obesity and PI constitute the most significant behavioural 
contributors to CRC development, especially in countries with a high human 
development index, Studies found that sedentary people can have up to a 50% risk of 
CRC. It has been estimated that obesity is associated with a 50% greater risk of colon 
5
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cancer in men and 20% in women, and 20% greater risk of rectal cancer in men and 
10% in women [3]. The changes that occur in the obese state and that connect obesity 
with increased CRC risk are the following: altered levels of insulin, insulin-like growth 
factor-1, leptin, adiponectin, steroid hormones, and cytokines [39]. In the same way, 
Diabetes mellitus is linked to a predisposition to suffer from CRC [40], due to shared risk 
factors between diabetes, obesity and sedentary behaviours. Finally, emerging evidence 
suggests that infection with Helicobacter pylori, Fusobacterium spp, and other potential 
infectious agents might be associated with an increase of CRC [41-43].  
1.4. PREVENTIVE FACTORS  
Established preventive factors against CRC include physical activity (PA) and use of 
certain medications with risk reduction in the order of 20%-30% [22,44-46]. Many studies 
have emphasized the effect of PA in reducing the risk of susceptibility to CRC [47,48]. 
Authors such Golshiri et al. [49] found that CRC risk in people that practice PA in leisure-
time is 27% less than people who do not. Possible events related to the mechanisms 
underlying PA-mediated CRC include: changes in the material in gastrointestinal 
transmit time, immune function as well as changes in prostaglandin levels, insulin, 
insulin-like growth factors, bile acid secretion, serum cholesterol as well as pancreatic 
and gastrointestinal hormone profiles [50,51]. 
Certain medications that are commonly used for other diseases, such as non-steroidal 
anti-inflammatory drugs (NSAIDs) and hormonal replacement therapy (HRT) in 
postmenopausal women have also been shown to protect against CRC. For the first of 
these drugs, the benefit has not been quantified, and due to the side effects that these 
drugs can cause they are not used in primary prevention of CRC [3]. And with regard to 
the latter, the protective effects remain controversial: although observational studies 
found a long-term decreased risk of CRC, randomized trials did not replicate these 
results [3]. Although not as consistent as PA and certain medications, several data 
suggest a protective effect of a diet especially rich in fruits and vegetables, fibre, resistant 
starch, dairy products, as well as calcium supplements [33,52,53]. This protective effect 
of diet and nutrition against the development of CRC is independent of obesity and is 
estimated to explain 30%-50% of the CRC incidences.  
Fibre found commonly in vegetables, fruits, and whole grains are protective because 
they increase transit time and consequently reduce the carcinogens exposition. In 
addition, bacterial fermentation of fibre produces short-chain fatty acids with 
anticarcinogenic properties [54,55]. The Continuous Update Project (CUP) on CRC of 
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2011, led by the World Cancer Research Fund and American Institute of Cancer 
Research (WCRF/AICR), concluded that there was now “convincing” evidence that 
increased fibre intake was protective against the risk of colorectal cancer [56]. Regarding 
dairy product consumption, two meta-analyses [57,58] reported a significant inverse 
association when comparing the highest and lowest levels of intake. Observed inverse 
associations between intake of dairy products and CRC development have been largely 
attributed to their content of calcium, as well as lactic acid-producing bacteria and other 
constituents or bio-active compounds [59,60].  
The last CUP on CRC, led by WCRF/AICR, determined that there is strong evidence that 
the consumption of dairy products may help to protect against CRC [33]. However, the 
CRC risk associated with the consumption of different types of dairy products (e.g., 
yogurt or hard cheese), as well as the consumption of dairy product subtypes according 
to their fat composition (e.g., skimmed/semi-skimmed or full milk), remains unclear [61-
63].  The WCRF/AICR, in the last CUP on CRC, concluded that calcium supplement 
diets probably decrease CRC risk [33]. This mineral may reduce CRC risk via stimulating 
differentiation, reducing proliferation, and inducing apoptosis [64]. In addition, a few large 
randomized controlled trials (RCTs), have reported that this supplementation can reduce 
recurrence of adenomas, precursors of most sporadic CRCs [65-66]. Nevertheless, 
some issues on the association between calcium and CRC risk are still not well 
understood, as is the case of differences according to the anatomic subsite of the tumour, 
the dose-response or when exposure to this mineral may play the most significant role.  
Other nutrients supplements apart from calcium, such as folate seem to inhibit 
carcinogenesis but promote the growth of existent tumours. Therefore, its use is not 
recommended, except in case of pregnancy or MTHFR mutation, which have a 
predisposition to high homocysteine levels [3]. In any case, foods and nutrients are not 
consumed in isolation but as part of a dietary pattern; therefore, the actual effect of diet 
on disease risk may be observed only when all components are considered jointly [67]. 
For this purpose, several diet quality indexes have been developed using point systems 
to measure whole diet quality based on the alignment of food choices with dietary 
recommendations. Some of these indices have been used to begin assessing the 
relationships between overall diet quality and CRC risk, and the results show that high 
scores in these indices are associated with a lower CRC risk [68-71]. In particular, the 
association between Mediterranean Diet (MD) and CRC has been examined by many 
case-control [72-74] and cohort studies [75].  
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This dietary pattern is characterised by high intakes of vegetables, fruits, whole grains, 
nuts, and olive oil; moderate intakes of fish, poultry, and low-fat dairy foods; and low 
intakes of red meat, processed meat, and sugar-sweetened drinks. Although most of 
studies showed an inverse association between the use of MD and the risk for CRC, 
some inconsistencies have been observed, firstly relating to the different scoring indexes 
utilized to determine MD adherence. In spite of these inconsistencies, results of 
observational studies and three meta-analyses showed a decreased risk of CRC 
associated with adherence to a MD [76]. The health benefits of the MD have been 
extensively documented in the literature about protection against various diseases, 
including cancers. This is also reflected in its inclusion as a recommended dietary 
pattern, among others in the 2015 Dietary Guidelines for Americans [77]. 
Lastly, it should be noted that protective and risk factors are not present in isolation, but 
coexist and interact with each other and with other factors, for example, both dietary and 
genetic factors affect CRC risk, through an interactive manner [78]. The recognition of 
these interactions as a driver in CRC may open up new areas of research in disease 
epidemiology, risk assessment, and treatments.  
1.5. GENETIC SUSCEPTIBILITY 
Although environmental factors are undoubtedly major risk factors for this type of cancer, 
early onset and familial clustering suggest that CRC has a substantial heritable 
component [79]. In a study carried out in a large twin sample [80], researchers noted that 
35% of CRC risk might be attributable to heritable factors. While rare genetic variants 
with high penetrance do confer a predisposition for inherited forms of CRC, as is also 
the case in familial adenomatous polyposis and Lynch syndrome, which account for 5% 
of CRC cases [81], the remaining genetic heritability appears to be a consequence of 
joint inheritance of multiple common low‐penetrance genetic variants [82,83]. It seems 
that susceptibility single-nucleotide polymorphisms (SNPs) confer weak but cumulative 
and increasing effects on CRC development [84].  
To investigate common low‐penetrance genetic variants for CRC, genome‐wide 
screening using high‐throughput DNA sequencing has been tried. A previous genome‐
wide association study (GWAS) had identified several CRC‐susceptibility SNPs that 
confer a modest increased risk of CRC in populations of European ancestry [85-91]. 
Despite many candidate gene [92] and genome-wide association studies (GWAS) [93] 
evaluating common genetic risk factors for CRC, only a few of these have been 
replicated in subsequent studies [94]. 
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1.6. PREVENTION 
Colorectal cancer (CRC) is both one of the most common and one of the most 
preventable cancers globally, with an important potential for primary, secondary and 
tertiary prevention. Epidemiological evidence suggests that a significant proportion of 
CRCs could be avoided by changing lifestyle-related factors [96]. Several of the 
aforementioned risk factors, especially maintenance of a reasonable level of PA and a 
healthy weight, should be included in comprehensive primary prevention strategies. 
Regarding diet and nutrition, since foods and nutrients are not consumed in isolation and 
there is controversy about the role of specific foods groups and nutrients, consideration 
of dietary pattern as a whole appears useful for establishing recommendations.  
The role of many nutritional supplements, including, folate, vitamin B6 and omega-3, 
remains unknown. Apparently, only calcium and vitamin D supplementation appear to 
add a modest benefit, particularly in those with a low daily intake [97]. On the other hand, 
the role of medications such as aspirin and NSAIDs drugs, and postmenopausal HRT 
might be associated with substantial reductions in CRC risk. However, due to lack of 
data and possible side-effects, these medications are not recommended in primary 
prevention of CRC [98]. Since most cases of CRC develop slowly over more than 10 
years and early detection allows efficient treatment, perspectives for secondary 
prevention by screening are much better for this cancer than for most other cancers. 
Faecal occult blood testing (FOBT) (that can either be guaiac-based (gFOBT) or 
immunochemical (iFOBT)), flexible sigmoidoscopy (FS) and colonoscopy are recognized 
as being cost-efficient [100] and the majority of guidelines suggest 1-2 year intervals for 
FOBT screening [99].  
National and international screening guidelines also recommended starting at 50 years 
of age for average-risk individuals, with use of gFOBT or iFOBT. A positive gFOBT or 
iFOBT has to be followed up by colonoscopy. Population-based CRC screening 
programmes (CRCSPs) have been implemented from 2013 nationally or regionally in 20 
of the EU Member States, in the 50+ year age group. Modelling studies [101] suggest 
that the cost-effectiveness ratio of theses CRCSPs is dependent on several factors such 
as background risk, screening method and organization of the programme, resources in 
health care and on the targeted age range, among others. iFOBT has been the most 
common screening test because of its higher sensitivity and the logistic advantages it 
has over gFOBT [102,103].  
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The Spanish Society of Medical Oncology, for its part, recommends screening for 
average-risk individuals aged >= 50, without any other added risk factors, with use of 
biennial iFOBT. As an alternative to iFOBT, annual or biennial high-sensitivity gFOBT, 
FS repeated every 5 years or colonoscopy repeated every 10 years can be used. 
Population-based CRCSP is covered in all the Autonomous Communities, and it was 
estimated that the entire population would be included in organized population-based 
programmes by the year 2024 [104]. In particular, in 2008, in the Autonomous 
Community of the Basque Country the implementation of a regional population-based 
screening programme for CRC was approved. The programme was aimed at men and 
women between 50 and 69 years old, using one sample of iFOBT biennially and a 
colonoscopy under sedation as a diagnostic confirmation in positive cases. The 
programme started in 2009, reaching almost the whole target population (approximately 
586,700 people) at the beginning of 2014. The main results found in the first period 
showed a high participation rate, as well as high adenoma and CRC detection rates 
[105,106]. 
Increasing evidence shows also that the prognosis and quality of life (QoL) of CRC 
patients can be substantially improved by tertiary prevention measures [107]. In 
particular, the use of aspirin, increasing PA level and cessation of smoking could improve 
the survival and the quality of life of CRC patients. In observational studies there is 
increasing evidence that use of low-dose aspirin could enhance survival after CRC 
diagnosis [108-110], through mechanisms related to cyclooxygenase (COX) inhibition 
and non-COX mechanisms [111]. Some randomized controlled trials have begun to 
study the potential role of this medication in tertiary prevention [112]. A smoking habit 
and excessive alcohol consumption, in addition to being risk factors for CRC, are 
associated with lower survival rates in CRC patients [113]. Although the mechanism of 
these associations remain unclear, it is known that these unhealthy lifestyle habits 
increase surgical complications and decrease response to radiotherapy and 
chemotherapy, among other effects [114-116].  
Moreover, there is evidence that PA appears to have a favourable influence on cancer 
outcomes, including common cancer symptoms, quality of life and survival [117,118]. In 
this sense, some of the most studied mechanisms include changes in whole-body and 
visceral fatness, metabolic dysregulation, adipokines, and sex hormones; chronic, low-
grade inflammation; oxidative stress causing DNA damage and gene mutations; and 
impaired immune surveillance/function [119-121]. Finally, there is no convincing 
evidence about the association with improved survival in CRC patients that follow 
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guidelines [122]. However, having a healthy body weight, being physically active and 
following a healthy diet after diagnosis were all associated with a longer survival of colon 
cancer patients in stage III in a chemotherapy trial [123]. Taking into account that after 
the “teachable moment” of a cancer diagnosis patients are more likely to change their 
habits, then it seems likely that the promotion of healthy lifestyle in CRC patients could 
improve prognoses considerably.  
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2. HYPOTHESES AND OBJECTIVES 
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The hypotheses of this doctoral thesis, concerning participants in the CRCSP of the 
Osakidetza/Basque Health Service, are as follows: 
1. The diet of CRC patients postsurgery is inadequate in many respects, including 
nutrients and food intakes, and this dietetic and nutritional inadequacy is 
associated with certain health determinants such as age, weight status, lifestyles 
and socioeconomic conditions.  
2. There are significant differences between cases and controls with regard to 
lifestyles (including diet), weight status, use of drugs related to decreasing CRC 
risk, socioeconomic level, health status, quality of life and stress level. These 
factors are more favourable in controls than in cases, that is, cases have healthy 
lifestyles, a healthy weight, a better health status, higher socioeconomic level, 
better life quality and lower stress level and use drugs related to decreasing CRC 
risk.  
3. The consumption of certain foods (such as red meat, processed meat and alcoholic 
drinks, among others) are associated with an increased risk of CRC. Whereas 
other foods (for example, fibre-containing foods) and dietary patterns such as the 
MD pattern are associated with decreasing risk of CRC. These associations vary 
depending on tumour location.  
4. Some of the previously reported CRC-related SNPs are associated with CRC 
susceptibility in the case-control sample under study. 
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To date, case-control studies have revealed inconsistent evidence on the influence of 
dietary and genetic factors on CRC risk. In order to better elucidate the role of some of 
these factors in the aetiology of CRC, the main objective of this study was to analyse 
dietary and genetic factors in a sample of cases and controls from the population-based 
CRCSP of the Osakidetza/Basque Health Service. In addition, taking into account that 
an unhealthy diet is associated with the risk of tumour recurrence, metastasis and death, 
the other aim of this thesis was to assess the adequacy of nutrients consumed and diet 
quality in a group of CRC patients postsurgery. This doctoral thesis is part of a line of 
research on the impact of gene-diet interactions on the risk of CRC in the Basque 
Country.  
Specific objectives 
To achieve this general objective, the following specific objectives were set: 
1. To assess the adequacy of nutrients consumed and diet quality, and to identify 
possible associations between nutritional adequacy and diet quality and certain 
health determinants (such as age, weight status, lifestyles and socioeconomic 
conditions), in a group of postsurgery CRC patients who participated in the CRCSP 
of the Osakidetza/Basque Health Service. Study 1.  
2. To analyse lifestyle (including diet from the nutritional perspective), weight status, 
health status, socioeconomic level, quality of life, stress level and use of drugs 
related to decreasing CRC risk, in a sample of cases and controls from the 
population-based CRCSP of the Osakidetza/Basque Health Service. Study 2. 
3. To assess the relationships between food group consumption, diet quality and CRC 
risk, and identify possible differences in consumption depending on tumour 
location, in the sample of cases and controls mentioned in objective 2. Study 3. 
4. To investigate possible associations between susceptibility SNPs and development 

























3. PARTICIPANTS, METHODS AND RESULTS  
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3.1. STUDY 1: “Nutritional Adequacy and Diet Quality in 
Colorectal Cancer Patients Post-Surgery: A Pilot Study” 
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ABSTRACT 
Recent evidence has shown that an unhealthy diet is associated with a higher risk of 
tumor recurrence, metastasis and death among patients with colorectal cancer (CRC). 
The aims of this study were to assess nutritional adequacy and diet quality in a group of 
CRC patients post-surgery and to identify possible associations between dietary and 
nutritional aspects and environmental factors and weight status. This was an 
observational study conducted on a random sample of 74 patients, aged 50-69 years. 
Dietary intake was evaluated utilizing a validated frequency questionnaire, and diet 
quality was evaluated utilizing the Healthy Eating Index for Spanish diet and the 
MedDietScore. Data regarding socio-economic, demographic, lifestyles, dietary 
supplements use and body mass index were collected. Participants followed a diet 
characterized by a low carbohydrate intake (94% of the cases), excessive protein (48%) 
and high fat intake (67%), and some micronutrient deficiencies. The inadequacy of some 
nutrients was associated with male gender, overweight/obesity, smoking and low 
educational level, and low adherence to the MedDiet was identified in those with a low 
educational level (adjusted OR=4.16, P<0.05). Therefore, such patients should be an 
important target group when applying educational programs and giving individualized 
nutritional advice to improve their life quality. 
 
Keywords: Colorectal cancer, Diet, Body mass/BMI, Micronutrients 
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Colorectal cancer (CRC) is a major public health challenge worldwide. In Europe, it is 
the leading malignancy in terms of incidence and the second in terms of mortality in both 
genders (1). Diet contributes to 50-90% of colon cancer cases (2). Epidemiological 
studies have established a strong link between some dietary factors, such as fiber 
(inversely) and red/processed meat (increased risk), and the risk of developing CRC (3). 
Furthermore, an overall assessment of diet is an important alternative to traditional 
methods that have focused only on single nutrients or foods (4) given that people 
consume a variety of foods with complex combinations of micro- and macronutrients 
rather than single nutrients or foods. Because foods and nutrients act synergistically 
rather than in isolation (5-6), recent research has investigated the role of diet quality in 
cancer incidence (7-8) and survival (9).  
 
Some dietary patterns, such as the Mediterranean Diet (MD), have been widely 
associated with human health. Specifically, several studies have associated adherence 
to the MD with a reduction in the risk of some types of cancer, specifically colorectal 
cancer as well as other neoplasms (16,17). The MD is characterized by a nutritional 
model consisting mainly of olive oil, cereals, fresh or dried fruits and vegetables as well 
as a moderate amount of fish, dairy and meat, accompanied by wine or infusions. 
However, it should be noted that the MD varies from country to country, even from region 
to region, throughout the Mediterranean basin due to the influence of various cultural 
and environmental factors (12).  
 
There is scientific evidence of the relationship between the MD pattern and CRC risk 
(13-15); however, little is known about dietary intake, nutrient intake as well as diet 
quality, in CRC patients post-surgery, especially in the medium term post-operatively 
(16,17). In a recent study with respect to CRC recurrence and survival, an unhealthy diet 
(the processed meat dietary pattern) was associated with the risk of tumor recurrence, 
metastasis and death (16). The consumption of an adequate diet, supplying energy and 
nutrients in amounts sufficient to meet needs, should improve nutritional status and may 
enhance disease resistance, thereby prolonging lifespan.  
 
Thus, the aim of this work was to assess the adequacy of nutrients consumed and diet 
quality in a group of CRC patients post-surgery. In addition, the study identified possible 
associations between nutritional adequacy and diet quality and environmental factors 
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and weight status. To the best of our knowledge, this nutritional study is the first one 





This study is part of a project that aims to analyze diet/genetic interactions on the risk of 
CRC in a population group in the Basque Country. Recruitment and data collection for 
the present pilot study were conducted between 2013 and 2014. A sample size of 142 
participants was randomly selected from the list of confirmed CRC diagnosis and 
subjected to a surgical resection between January 1, 2009 and December 31, 2012 at 
some hospitals that participate in the CRC screening program in the Basque Country 
(Osakidetza/The Basque Health Service) (n=191). Participants were randomized using 
computer generated random numbers by SPSS version 22.0. (SPSS Inc., Chicago, IL). 
The sample size for this pilot study represents the 10% of the sample required for the full 
research, such as it is recommended for pilot studies (18), and was estimated taking into 
account the expected participation rate (50%). 
 
The sample was stratified according to the age and gender distribution of the target 
population. The participation rate was 55.6%, and the low number of participants (n=5) 
excluded due to missing information supports the high quality of the data. Finally, 74 
subjects (66.2% males) consented to participate in the survey and complete all 
questionnaires. CRC stage at diagnosis was stage 1 (62.2%), stage 2a (14.9%), stage 
3a (4.1%) and stage 3b (18.9%). 
 
This research was approved by the Clinical Research Ethics Committee of the Basque 
Country (Reference number PI2011006 and PI2014042). To be eligible for this CRC 
screening program, patients had to be between the ages of 50 and 69 years, 
asymptomatic with respect to colorectal symptoms, and registered with the services of 
the Osakidetza/The Basque Health Service. Subjects with symptoms suggestive of CRC 
or known risk groups for CRC such as familial adenomatous polyposis or hereditary 
nonpolyposis colorectal cancer are managed outside this program and are not included 
in this analysis. The CRC screening program in the Basque Country employed the 
immunochemical fecal occult blood test (FOBT), and patients with a positive result were 
invited to undergo colonoscopy with sedation (19). 
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Participants in the present study who had tested positive in their FOBT results and had 
positive colonoscopy results had undergone surgical resection of CRC, and some of 
them had undergone adjuvant treatments, radiotherapy and/or chemotherapy. The 
percentages of participants according to the type of surgery procedure were the 
following: 50% sigmoidectomy, 18.9% right hemicolectomy resection, 13.5% left 
hemicolectomy resection, 9.5% right hemicolectomy resection + rectal anterior resection, 
4.1% low anterior resection and 4.1% rectum amputation. The percentage who received 
chemotherapy was 33.8%, and chemotherapy and radiation 14.9%. Subjects were 
invited to take part in this survey at least 1 year after their operation (median, 2.0 years; 
range, 1.0-2.8 years). Written informed consent to assess their medical records was 
required from study participants. Consenting participants completed and returned a 
detailed Food Frequency Questionnaire (FFQ) and one General Questionnaire (GQ). All 
questionnaires were self-completed. Assistance from study staff was available to help 
with understanding items on the questionnaires.  
 
Dietary intake and adequacy of nutrients intake 
Diet was assessed using a FFQ that is a modified version of the Rodríguez et al. 
questionnaire (20). This adaptation was validated utilizing multiple 24-h recalls in a 
subsample of participants. It consists of 67 items and requires participants to recall the 
number of times each food item was consumed either per week or per month. The 
respondents might also record consumption of other foods not included on the food list. 
Moreover, data regarding dietary supplements and foods with added dietary ingredients 
were recorded.  
 
Average portion sizes were employed to convert FFQ consumptions (21). For items that 
included several foods, each food’s contribution was estimated with weighting 
coefficients obtained from usual consumption data (22). All food items consumed were 
entered into DIAL 2.12 (2011 ALCE INGENIERIA), a dietary assessment program. Initial 
energy and nutrient intakes were reported as mean and standard deviation (SD). The 
macronutrients were expressed as a percentage of total energy intake (TEI) and were 
compared to acceptable macronutrient distribution ranges (AMDR), ranges of intakes 
associated with reduced risk of chronic disease and which provide adequate intakes of 
essential nutrients (23). The approach employed to evaluate nutrient adequacy was the 
estimated average requirements (EARs) (24). Results of micronutrient and protein 
intakes were expressed as a percentage of the EARs. The EAR is the mean daily intake 
value which is estimated to meet the requirement of half the healthy individuals in a life-
stage and gender group for that nutrient (25). Nutrient data were also compared with 
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tolerable upper intake levels (ULs) (26). Caffeine consumption was compared to 
reference values without any adverse effects (27). 
 
Diet quality assessment 
Adherence to the dietary guidelines was evaluated utilizing the Healthy Eating Index for 
Spanish Diet (HEISD) (28) and the MedDietScore (MDS) (29). The first one is a rapid 
and cheap method to estimate the quality of the diet in the population because it utilizes 
secondary data taken from the National Health Questionnaire and from feeding 
guidelines. The HEISD included 10 items: cereals and derivatives, vegetables, fruits, 
milk and dairy products, meats, legumes, cold meats, sweets, soft-drinks with added 
sugar, and diet variety. The items are equally weighted; thus, each item can contribute 
10 points to the total score, and the theoretical range is 0-100.  
 
MDS is an index that estimates the adherence level to the MD and is associated with 
biomarkers of cardiovascular disease risk (30). This diet score has 11 main components: 
non-refined cereals, fruits, vegetables, potatoes, legumes, olive oil, fish, red meat and 
products, poultry, full fat dairy products and alcohol beverages. Each component was 
scored separately. For the consumption of items presumed to be close to the MD pattern, 
scores 0, 1, 2, 3, 4, and 5 were assigned when a participant reported no consumption, 
rare, frequent, very frequent, weekly and daily, respectively. For the consumption of 
foods presumed to be away from this diet pattern, the scores were assigned on a reverse 
scale (scores 5 to 0). Reverse scale was applied to four components of the MDS (red 
meat and products, poultry, full fat dairy products and alcohol beverages). Especially for 
alcohol, score 5 was assigned for the consumption of less 300 ml per day, score 0 for 
consumption of more than 700 ml per day or no consumption, and scores 4 to 1 for 
consumption of 300-400, 400-500, 500-600, and 600-700 ml per day, respectively (100 
ml = 12 g ethanol). The total score (sum) is between 0 and 55. Higher values of this 
score indicate greater adherence to the MD pattern. A score equal to 55 represents 
100% adherence to the MD pattern; then, a score equal to k represents (k/55) x 100% 
agreement to this pattern. 
 
Covariates 
The GQ measured weight status (self-reported weight and height) and environmental 
factors (socioeconomic status: educational attainment, economic activity and last work 
activity; demographic factors: age and gender; and lifestyle information: physical activity 
in free time, smoking and alcohol consumption). These questions were taken from the 
Spanish Health Questionnaire (31). Body mass index (BMI) estimated from self-reported 
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height and weight was classified according to the WHO criteria (32). Additionally, life 
quality in general and stress level during the last month were analyzed utilizing a 
continuous scale with a range from 0 to 100, with higher scores indicating a better life 
quality and a higher stress level. 
 
Statistical analysis 
Data were analyzed utilizing SPSS version 22.0. (SPSS Inc., Chicago, IL) and reported 
as mean (standard deviation, SD), 95% confidence interval (CI) and frequencies. 
Symmetry in the distribution of continuous variables was determined by Kolmogorov–
Smirnov–Lilliefors test for sample sizes greater than 30 and by Shapiro-Wilk test for 
sample size fewer than 30.  
 
Differences between variables were calculated employing the Student´s t test and 
ANOVA one way (in the case of normally distributed data) or Mann-Whitney U test and 
Wilcoxon W test (if the variables were not normally distributed). In addition, the effect 
size was performed employing the statistical Cohen's d and f for mean comparisons and 
g for proportions (G-power 3.1.7 software) to estimate the magnitude and significance of 
the result. Cohen´s guidelines for the interpretation of effect size were employed (33). 
The categorical variables were analyzed using the Chi-square test (or the Fisher test 
when applicable), and the relationships between these categories were analyzed utilizing 
adjusted residuals.  
 
Logistic regression analysis was performed for adjusted odds ratio (OR) based on weight 
status (BMI) and environmental factors to identify possible associations between these 
variables and inadequate intake of nutrients and inadequate diet quality. For simplicity 
and descriptive purposes, the variables educational attainment, economic activity and 
last work were regrouped according to the criteria of the Spanish Health Questionnaire 
(31). Continuous variable age was split at the sample median, thereby defining high and 
low groups of this variable in question. In the same sense, the dependent variable, 
adherence to the MD pattern, was dichotomized into less than or equal to 67.3%, and 
higher than 67.3%, utilizing the median split to define low and high adherence to the MD. 
All reported P values are two tailed (P<0.05; P<0.01; P<0.001). Analyses were 
conducted separately for men and women, because of the differences in dietary intake 
(34). In addition, differences in dietary intake were analyzed by cancer stage and type of 
surgery. These variables were regrouped to simplify the analyses of results: cancer stage 
(stage 1; stage 2 or greater) and type of surgery (hemicolectomy; sigmoidectomy or 
rectal resection). Those participants who have undergone two types of surgery, that it is 
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mean, hemicolectomy and rectal resection, were excluded for these comparisons, since 




General characteristics of the studied sample 
General characteristics of the sample are shown in Table 1. BMI of the total sample was 
27.2(3.5) kg/m2 (95% CI 26.3-28.0). For men, BMI was 27.2(3.5) kg/m2 (95% CI 26.2-
28.2) and for women, was 27.1(3.5) kg/m2 (95% CI 25.6-28.6). There was no difference 
in BMI between genders (P=0.912; d=0.03). Moreover, 69.4% of men and 60.0% of 
women had excess weight (overweight/obesity), and none of the sample reported 
underweight.  
 
In the total sample, the score for life quality was 71.3(14.8) to 100 and for the stress level 
41.2(28.1) to 100. There were no differences in these variables by gender (P=0.474 for 
life quality and P=0.248 for stress level), being the effect size for mean comparisons 
between low and moderate (d=0.21 for quality life and d=0.35 for stress level). 
 
Dietary intake and adequacy of nutrients intake 
The average daily intakes of energy, macro- and micronutrients are shown in Table 2. 
Significant gender differences were found only in polyunsaturated fatty acids (PUFA) and 
alcohol consumption (P<0.05). The effect sizes of the gender differences were between 
low and moderate for lipids (d=0.41), saturated fatty acids (SFA) (d=0.20) and fiber 
(d=0.37). Without allowing for gender, more than 94% participants had an inadequate 
carbohydrate intake by default; over 48% of them had excessive protein intake; and more 
than 67% of the sample had an excessive fat intake.  
 
Dietary nutrient density is presented in Table 3. Over one half of the participants had 
intakes below EARs for folic acid (66.2%), vitamins A (56.8%), D (100%) and E (85.1%), 
calcium (66.2%), magnesium (75.7%) and iodine (59.5%). Although gender differences 
were not found in the dietary nutrient density, the effect sizes of some micronutrients 
were between small and moderate: riboflavin (d=0.39), vitamins B6 (d=0.33), B12 
(d=0.23), C (d=0.31) and E (d=0.38), folic acid (d=0.21), Ca (d=0.44) and Fe (d=0.24). 
And males were more likely to have inadequate intakes of thiamine (55.1% of men had 
intakes below EARs vs. 24.0% of women, P=0.011), vitamin A (69.4% of men vs. 32.0% 
of women, P=0.002), magnesium (95.9% of men vs. 76.0% of women, P<0.001) and 
zinc (59.2% of men vs. 8.0% of women, P<0.001). Some of these results were also 
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observed in logistic regression analysis, which revealed the following adjusted ORs, 
95%CIs and significance level for men: inadequate intake of thiamine (OR=4.16, 1.06-
16.40, P=0.041) and vitamin A (OR=5.37, 1.44-20.12, P=0.013), compared with women.  
 
According to the cancer stage and type of surgery, no significant differences were found 
for energy and nutrients intake, nor for %EARs. However, the effect size for α-linolenic 
acid (g/d) was large (d=0.89), being higher the intake in stage 1 (12.7(5.5)) than in the 
other ones (8.9(2.5)). And according to the type of surgery, the effect size for thiamine 
was large (d=1.26), those who had undergone hemicolectomy had lower %EARs 
(96.3(21.3)) than who had undergone sigmoidectomy or rectal resection (147.2(52.9)). 
Participants who had undergone hemicolectomy were more likely to have inadequate 
intakes of thiamine (60.0% had intakes below EARs) than those who had undergone 
sigmoidectomy or rectal resection (15.4% had intakes below EARs) (Chi-square=3.58; 
P=0.058; effect size g=0.45). 
 
Furthermore, participants who were overweight/obese had a higher inadequate intake of 
folic acid (OR=4.99, 1.37-18.22, P=0.015), vitamin A (OR=4.95, 1.34-18.30, P=0.016) 
and zinc (OR=7.05, 1.66-29.87, P=0.008) than those of normal weight. Smokers had a 
high inadequacy of folic acid intake (OR=4.40, 1.08-17.88, P=0.038), and those without 
studies or primary education had a higher inadequacy of thiamine (OR=5.42, 1.31-22.40, 
P=0.020). Logistic regression was not estimated for all nutrients because of their not 
meeting the criteria for this analysis (minimum ratio of valid cases to independent 
variables: 10 to 1). 
 
However, there was a large proportion of participants with sodium intake exceeding the 
tolerable upper intake level (UL: 2300 mg/day), 57.1% of males and 48.0% of females 
(P=0.011). Furthermore, the median intake of caffeine was 63.0 mg/day; there were no 




Table 4 presents the scores for components of the HEISD and the percentage of 
participants who did not meet the recommendations. No significant differences by gender 
were found, either for total score or for the components scores. Nevertheless, the effect 
sizes were small to medium for vegetables (d=0.35), fruits (d=0.37), legumes (d=0.21) 
and soft-drinks (d=0.22). According to the classification of HEISD, 14.9% had a "healthy 
diet" and 85.1% were in the category of "not healthy/need changes" (P<0.001). The 
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HEISD components with higher cases of non-compliance of HEISD recommendations 
were meats (100%), cold meats (89.2%), sweets (87.8%) and diet variety (100%); no 
differences were found by gender (P>0.05). 
 
The scores of adequacies for components of the MDS for the total sample and by gender 
are presented in Table 5. Significant gender differences were found for non-refined 
cereals, the highest score for this component being found in women rather than in men 
(P<0.01). And the effect sizes for gender differences were small to medium for fruits 
(d=0.44), legumes (d=0.31), poultry (d=0.33), olive oil (d=0.20) and MDS total (d=0.35). 
The percentage of adherence to the MD was 66.6% (5.5) and there were no gender 
differences (P>0.05). No statistically significant correlation was found between HEISD 
and MDS (P>0.05). 
 
No significant differences were found in HEISD and MDS, neither in components´ scores, 
nor in the total scores, by cancer stage or by type of surgery.  However, the effect size 
for potatoes group was large (d=0.88), being higher the score for participants who had 
undergone hemicolectomy (2.5(1.5)) than sigmoidectomy or rectal resection (3.7(1.2)). 
Table 6 presents the HEISD score and the adherence to the MD pattern by lifestyle and 
socio-economic and demographic factors. Participants who were 61 years or older 
obtained higher HEISD scores than subjects younger than 61 (P<0.05). None of the other 
variables considered in this study (weight status and environmental factors) were 
significantly associated with HEISD score. Nevertheless, the following data had the most 
significance for the HEISD: schooling (f=0.44), smoking status (f =1.12), physical activity 
during free time (d=0.80) and most recent job (f =1.41). Subjects who registered higher 
HEISD scores were those that had secondary educational level, were ex-smokers or had 
never smoked, had engaged in physical activity, and had worked as a 
businessman/women in the past. Logistic regression analyses did not show significant 
associations between HEISD and environmental factors and weight status. 
 
Regarding MDS, although no significant differences were found for the adherence to the 
MD pattern between the categories according the socio-economic, demographic and 
lifestyle characteristics, the greatest size effect occurred in the variables schooling 
(f=0.62) and smoking status (f=0.68); subjects having secondary education and who are 
non-smokers exhibited a higher adherence to the MD (Table 6). According to results of 
logistic regression analysis, educational level, without studies or primary education, was 
associated with a low adherence to the MD (adherence  67.3%) (adjusted OR= 4.16, 
1.15-15.03, P=0.029). In addition, the association between health behavior (alcohol, 
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tobacco use and physical activity) and adherence to the MD was analyzed; however, 
there was no relationship. 
 
Table 1. General characteristics of the studied sample: colorectal patients post-surgery 
 Total sample (n= 74) 
Gender, male, % 
Age, Mean(SD)   
Schooling, % 
   Without studies 
   Primary education 
   Secondary education 
   University degree 
Smoking status, % 
   Never 
   Past 
   Current 
BMI classification, overweight /obesity, % 
Physical activity during free time, yes, % 
Economic activity (multiple answer), % 
   Working 
   Unemployed 
   Retired  
   Housework 
Last work, % 
   Employer  
   Businessman/women 
   Family help 
   Steady salaried employee 
   Temporary salaried employee 
   Member of a cooperative 
66.2 
60.2(5.5)    
 












  6.8 
62.2 
  9.5 
 
  5.4 
  8.1 
  6.8 
70.3 
  4.1 
  5.4 
SD, standard deviation 
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Table 2. Intakes of energy, macronutrients, cholesterol, fiber, water and alcohol in the 
studied sample: colorectal patients post-surgery 






           
Pa 
Mean(SD) 
Energy, kcal/d 1,993.1(586.5)  1,976.4(600.3)  2,025.9(569.2)  0.631 
Protein, %TEI  
   (AMDR, 10-15%TEI) 
15.0(2.5) 15.0(2.7) 15.1(2.2) 0.914 
Carbohydrate, %TEI  
   (AMDR, 50-60%TEI) 
41.5(6.3) 41.6(6.4) 41.3(6.0) 0.858 
Lipids, %TEI  
   (AMDR, <30-35%TEI) 
38.3(5.0) 37.6(5.0) 39.6(4.8) 0.102 
SFA, %TEI  
   (AMDR, <7-8%TEI) 
10.9(2.1) 10.7(2.0) 11.1(2.1) 0.398 
MUFA, %TEI  
   (AMDR, 20%TEI) 
17.4(2.9) 17.3(3.0) 17.5(2.6) 0.841 
PUFA, %TEI  
   (AMDR, 5%TEI) 
7.0(2.6) 6.5(2.3) 8.0(2.8) 0.017 
Linoleic acid, g/d 12.4(6.2) 12.3(6.0) 12.7(6.6) 1.000 
α-linolenic acid, g/d 1.8(0.7) 1.8(0.7) 1.8(0.7) 0.918 
Cholesterol, mg/d 295.5(148.6) 293.8(161.8) 298.8(121.6)  0.797 
Fiber, g/d 20.4(5.4) 19.7(4.7) 21.8(6.6) 0.116 
Waterb, g/d 1,062.6(248.1)  1,047.0(252.4)  1,092.2(241.6)  0.467 
Alcohol, g/d 8.6(8.2) 10.4(8.9) 5.1(5.0) 0.001 
AMDR, acceptable macronutrient distribution ranges; MUFA, monounsaturated fatty 
acids; PUFA, polyunsaturated fatty acid; SD, standard deviation; SFA, saturated fatty 
acid; TEI, total energy intake; aDifferences by gender; bIntake of water from foods, not 
from drinking water. 
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Estimated intake %EAR Estimated intake 
 Mean(SD)  
Proteins, g 37.5(6.3) 78.7(25.8) 37.5(6.7) 37.6(5.5) 0.914 
Vitamins      
Thiamine, mg  0.6(0.2) 104.5(42.6) 0.5(0.2) 0.6(0.2) 0.053 
Riboflavin, mg 0.8(0.3) 123.1(43.5) 0.8(0.2) 0.9(0.3) 0.070 
Niacin, mg 15.3(3.5) 255.7(70.0) 15.2(3.6) 15.5(3.3) 0.677 
B6, mg 1.0(0.3) 140.5(55.5) 1.0(0.3) 1.1(0.3) 0.301 
Folic acid, mcg 152.2(42.2) 97.6(26.3) 149.1(38.7) 158.4(48.6) 0.779 
B12, mcg 2.9(0.9) 284.9(117.5) 3.0(1.0) 2.8(0.7) 0.344 
C, mg 89.5(38.6) 283.4(116.6) 85.2(33.8) 97.9(46.1) 0.195 
A, mcg 297.0(80.9) 87.0(27.6) 296.8(85.7) 297.5(72.4) 0.779 
D, mcg 1.0(0.6) 34.2(25.1) 1.0(0.6) 1.1(0.6) 0.148 
E, mg 4.5(3.9) 58.9(28.6) 4.2(1.6) 5.0(2.5) 0.199 
Minerals      
Ca, mg 425.9(107.0) 82.5(21.0) 410.1(104.7) 456.9(106.7) 0.075 
P, mg 701.3(119.4) 195.2(49.1) 694.0(131.0) 715.5(93.4) 0.334 
Mg, mg  143.1(27.6) 83.0(21.0) 141.8(29.3) 145.5(24.4) 0.586 
Fe, mg 7.4(2.0) 123.9(21.0) 7.2(1.9) 7.7(2.3) 0.370 
Zn, mg   4.8(1.1) 114.3(38.4) 4.8(1.1) 5.0(1.0) 0.176 
Cu, mg 0.6(0.07) 101.0(27.6) 0.6(0.07) 0.6(0.07) 0.862 
I, mcg 47.7(9.9) 62.1(15.9) 47.3(10.2) 48.6(9.3) 0.603 
Se, mcg 59.4(15.2) 212.2(70.7) 60.2(16.6) 57.9(12.3) 0.555 
EARs, estimated average requirements; SD, standard deviation; adifferences by gender.
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Table 4. Healthy Eating Index for Spanish Diet (HEISD): scores and percentage of participants who did not meet the recommendations in the 
studied sample: colorectal patients’ post-surgery 
HEISD 
components 
Scoresa, Mean(SD)   Participants who did not meet the recommendationsb, 
% 
Total (n=74) Men (n=49) Women (n=25) Pc Total  (n=74) Men (n=49) Women (n=25) Pc 
Cereals  9.9(0.5) 9.9(0.5) 9.9(0.5) 0.987 4.1 4.1 4.0 1.000 
Vegetables 9.2(1.4) 9.4(1.2) 8.9(1.6) 0.186 27.0 22.4 36.0 0.214 
Fruits 9.5(1.2) 9.3(1.3) 9.7(0.8) 0.260 18.9 22.4 12.0 0.358 
Milk and dairies 9.8(0.8) 9.8(0.9) 9.7(0.8) 0.405 8.1 6.1 12.0 0.400 
Legumes 9.1(1.8)  9.2(1.5) 8.8(2.3) 0.657 29.7 28.6 32.0 0.760 
Meats 3.2(1.8) 3.3(1.9) 3.1(1.7) 0.623 100 100 100 - 
Cold meats 4.0(2.6) 4.0(2.8) 3.9(2.4) 0.937 89.2 87.8 92.0 0.578 
Sweets 1.8(3.1) 1.6(3.0) 2.2(3.3) 0.395 87.8 87.8 88.0 0.976 
Soft-drinks 9.1(2.3)  8.9(2.3) 9.4(2.2) 0.152 14.9 18.4 8.0 0.314 
Diet variety 7.5(1.6) 7.6(1.6) 7.4(1.6) 0.512 100 100 100 - 
Total 73.0(7.1) 73.0(7.2) 73.0(7.0) 0.991 85.1 83.7 88.0 0.621 
HEISD, Healthy Eating Index for Spanish Diet; SD, standard deviation; aEach component can contribute 10 points to the total score and the 
theoretical range is 0-100; bPercentage of participants who did not meet the recommendations of the HEISD; cScore differences by gender. 
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Table 5. Scores for components of the MedDietScore (MDS) in the studied sample: 
colorectal patients’ post-surgery 
 Scoresa, Mean(SD)  
MDS components Total 
 (n=74) 
  Men 
  (n=49) 
 Women  
(n=25) 
      Pb 
Non-refined cereals 0.7(1.0)  0.5(0.9) 1.2(1.1) 0.004 
Potatoes 2.4(1.2) 2.4(1.3) 2.4(1.2) 0.727 
Fruits 2.7(0.9) 2.5(0.9) 2.9(0.9) 0.051 
Vegetables  3.1(0.9) 3.1(0.8) 3.1(1.0) 1.000 
Legumes 2.3(0.6) 2.3(0.6) 2.1(0.7) 0.344 
Fish 3.1(1.0) 3.1(1.1) 3.3(0.6) 0.194 
Red meat and products 2.8(1.3) 2.8(1.3) 3.0(1.3) 0.505 
Poultry 4.8(0.6) 4.8(0.6) 4.6(0.6)  0.061 
Full fat dairy 4.8(0.4) 4.8(0.4) 4.8(0.5) 0.824 
Olive oil 4.9(0.5) 4.9(0.4) 4.8(0.6)   0.743 
Alcoholic beverages 4.9(0.5) 4.9(0.6) 4.9(0.6)   0.475 
MDS total 36.6(3.03)      36.2(2.7)       37.3(3.5) 0.104 
MDS, MedDietScore; SD, standard deviation; aEach component can contribute 5 points 
to the total score and the theoretical range is 0-55; bdifferences by gender. 
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Table 6. Healthy Eating Index for Spanish Diet (HEISD) score and the adherence to 
MedDietScore (MDS) by lifestyle and socio-economic and demographic factors and body 
weight status in the studied sample: colorectal patients post-surgery 





P Means(SD) P 
Ageb 
   <62 y 













 Without studies and primary 
education 
 Secondary education 















Smoking status  
   Current 
   Never 














   Overweight/obese 











Physical activity during free time 
   Yes  












   Working 











Last work  
   Employer and businessman/women 
   Family help 
   Steady or temporary salaried 
















HEISD, Healthy Eating Index for Spanish Diet; MDS, MedDietScore, aTheoretical range is 0-
100; bAge variable was split at the sample median, thereby defining high and low groups on 
this variable in question; cThe answers of the variables Schooling, Economic activity and Last 





Research on the adequacy of nutrient intakes and the diet has recognized the greater 
vulnerability of certain population subgroups, such as the elderly (35) and cancer patients 
(36). Nevertheless, dietary intake data in CRC patient’s post-surgery, especially in the 
medium term post-operatively, are limited (16,17). The present pilot study is, therefore, 
addimportant seed contribution to the current literature on the dietary status of patients 
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an important seed contribution to the current literature on the dietary status of patients 
with CRC.  
 
The current study reports dietary intakes from food, dietary supplements and foods with 
added dietary ingredients that are inadequate with respect to the recommended levels 
of a number of nutrients. In relation to macronutrients, diet was characterized by 
inadequate carbohydrate intake by default and by excessive protein and fat intakes, 
these results agree with those from general population surveys (22). Scientific evidence 
demonstrates that this type of diet has a causative link to colon cancer; however, 
mechanisms of action are not fully elucidated (2).  
 
Regarding micronutrient intakes, a significant proportion of subjects did not meet daily 
requirements for folic acid, vitamins A, D and E, calcium, magnesium and iodine. 
Inadequate intakes of these nutrients were also noted by other authors in cancer patients 
(16,17) and in the general population (37). The inadequacy of dietary intake seems 
common in people of the age group of the present study (38-40). Similarly, Johnson et 
al. (41) reported that elderly persons were consuming more than the recommended 
amount of protein, but the average intakes of many vitamins and minerals were less than 
optimal based on the average intakes.  
 
It should be noted that the prevalence of inadequate folate intakes in the present study 
(66.2%) was lower than that reported by Gómez et al. (17). In any case, there is some 
evidence that folic acid, calcium, and vitamin D reduce the risk of CRC. In particular, 
recent research indicates that calcium and vitamin D might act together, rather than 
separately, to reduce the risk of colorectal adenomas (42). However, the evidence is not 
completely consistent (43).  
 
By comparing the inadequacy for nutrient intakes by gender, men had significantly less 
adequate intakes for thiamine, vitamin A, magnesium and zinc than women (P<0.05). 
Consistent with our results, Lim et al. (36) reported more dietary habit problems and poor 
nutritional balance in males with gastric cancer than those of females. And significant 
gender differences in nutrient intakes were also observed in the general population (44). 
Additionally, in the present study, patients who were overweight/obese presented higher 
inadequate intake of folic acid, vitamin A and zinc than those whose weight was normal 
(P<0.05). It should be noted that more than one half of the participants had excess 
weight. In the literature about CRC patients, data on prevalence of overweight/obesity 
do not present consistent results; thus, some studies detected a high prevalence of 
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overweight/obesity in patients with CRC (45), whereas others had associated 
malnutrition with this form of cancer (46,47).  
 
In relation to the diet quality, we applied two scores, HEISD and MDS. The evaluation of 
the overall diet from a global perspective by these types of scores is widely used in 
nutritional studies (48-50). In particular, MDS has a beneficial effect on the risk of CRC 
(13-15,51) and on the risk of tumor recurrence, metastasis and death (16,52). In the 
current study, the mean percentage for adherence to the MD was of 66.6%, and a 
significant proportion of subjects did not meet food groups recommendations; 85.1% had 
"no healthy diet or need changes" according to the HEISD. The percentage of subjects 
classified as "no healthy diet or need changes" was similar to the general population of 
the Basque Country (28), and the quality of their diet was characterized by a low score 
for non-refined cereals, especially in males. To our knowledge, there are not published 
data on gender differences in whole grain intake in Spanish population, however, for 
British adults, no significant gender differences were found (53). There is convincing 
evidence that whole grains help reduce the risk of CRC. In addition to the high content 
of bioactive compounds, whole grain also represents a source of high-quality 
carbohydrate, as assessed by a low glycemic index, because of its slow digestion and 
absorption (54). Whole grain may exert beneficial effects on colorectal carcinogenesis 
by decreasing insulin (55). Nevertheless, in the present study no significant correlation 
was found between both scores (HEISD and MDS), most likely due to methodological 
differences, because items and reference criteria are different.  
 
According to cancer stage and type of surgery, no significant differences were found 
neither for energy and nutrients intake nor for diet quality, probably due to the time spent 
after the diagnosis and treatment. To our knowledge, it is unknown whether the variance 
in adherence to dietary recommendations is consistent across all stages of CRC, or 
treatment settings. Although CRC patients admitted that they changed to a healthy diet 
after being diagnosed with CRC (56), these patients often either receive no dietary 
information or dietary advice is scarce (57,58). This fact could influence dietary adequacy 
and quality. In fact, evidence indicates that nutritional advice and education about diet 
can be effective in improving nutritional intake and status, quality of life (59) and long-
term prognosis in CRC (60).  
 
In our case, the HEISD components with more cases of non-compliance of the 
recommendations were meats, cold meats, sweets and diet variety, and the MDS 
components with a higher percentage of participants who did not comply with the 
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recommendations were non-refined cereals, legumes and potatoes. It should be noted 
that CRC patients can have less tolerance of high-fiber foods (such as legumes and non-
refined cereals). With respect to meat consumption, Zhu et al. (16) found that a high level 
of conformity with the processed meat pattern is significantly associated with an 
increased risk of all-cause mortality and recurrence in CRC; however, the prudent 
vegetable or the high-sugar patterns present no association with disease-free survival.  
 
Furthermore, participants who were 61 years of age or older obtained higher HEISD 
scores than subjects younger than 61 (P<0.05); this result agrees with the findings of 
other studies (28). Other factors related to diet quality scores (HEISD and/or MDS) were 
educational attainment, most recent job, smoking status and physical activity 
participation; nevertheless, no significant association was identified; the size effect was 
considerable. Moreover, regression analyses demonstrated that those without studies or 
primary education had a low adherence to the MD and greater thiamine inadequacy 
(P<0.05). Results concerning educational level and MDS agreed with the findings of 
other authors (61). However, care must be taken in the interpretation of our analysis of 
logistic regression due to sample size. 
 
In relation to lifestyle factors, the greatest size effect occurred in the variables of smoking 
status for both diet quality indices. In our study, tobacco consumption was associated 
with a greater inadequacy in the intake of folic acid (P<0.05) and could be associated 
with a low diet quality, even if the P-value were not significant. Other authors have 
observed relationships between smoking and dietary intake (62). Furthermore, 
significant interactions observed between smoking and CRC, suggesting a potential 
mediating effect of the MD (13,15). As in previous studies, physical activity and diet 
quality were associated (63). It should be noted that a quarter of the participants in the 
present study reported no physical activity in their free time. This proportion is higher 
than that of previous studies (64), and this is an unfavorable result, given that the known 
risks of sedentary behavior for survivors include the development of comorbid conditions 
and cancer recurrence (65,66).  
 
LIMITATIONS 
Several limitations to this study should be recognized. First, the sample size was small. 
As a result, we are increasing the sample size to be able to analyze more precisely 
dietary adequacy of this population group. Second, the data on dietary intake are self-
reported, which is assumed to be related to some degree of under- or over-reporting, 
especially in specific groups of the populations defined by weight status or gender 
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(67,68). This fact could make it difficult to estimate actual micronutrient intake and 
produces some bias that can be avoided utilizing biomarkers (69). Anyway, FFQ can 
provide valid information on intake for a large number of micronutrients (69-71). Finally, 
the lack of control of some possible confounders such as comorbidities and other 
conditions that could affect food consumption and the capacity to absorb and use of 
nutrients should be noted. 
 
CONCLUSIONS 
In conclusion, our results demonstrated that the diet of the studied group is inadequate 
in many respects, including nutrients and food intakes. The inadequacy of some nutrients 
was associated with male gender, excess of weight, smoking and low educational level, 
and the low adherence to the MD was pronounced in those with a low educational level. 
Therefore, these patients should be an important target group for the application of 
educational programs and individualized nutritional counseling sessions to improve their 
quality of life and reduce the risk of CRC mortality. Further studies are needed to confirm 
the determinants of the poor dietary habits and the inadequate nutrient intakes, keeping 
in mind surgical treatment and radiotherapy and/or chemotherapy as adjuvant 
treatments, and to know the diet changes after treatment for CRC. 
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3.2. STUDY 2: “Gene-diet interactions in colorectal cancer: 
survey design, instruments, participants and descriptive data 
of a case-control study in the Basque Country” 
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Abstract: Epidemiologic studies have revealed inconsistent evidence of gene-diet 
interaction in relation to colorectal cancer (CRC). In order to better elucidate the role of 
these types of interactions in the etiology of CRC, the aim of this study was to analyze 
them in a sample of cases and controls from the population-based screening programme 
for CRC of the Osakidetza/Basque Health Service. This case-control study analyzed 
dietetic, genetic, demographic, socioeconomic factors and lifestyles (smoking, alcohol or 
Physical activity (PA). The participants were 308 patients diagnosed with CRC and 308 
age- and sex-matched subjects as controls. Cases were more likely than controls to have 
overweight/obesity (67.5 vs. 58.1%, P<0.05), a lower intake of vitamin B2 (0.86(0.23) vs. 
0.92(0.23) mg/1,000 kcal, P<0.01) and Ca/P ratio (0.62(0.12) vs. 0.65(0.13), P<0.01). 
Moreover a higher proportion of cases than controls “always” or “often” used salt added 
to cooking (76.8 vs. 69.7%, P<0.05) and did not meet the Nutritional Objectives for 
saturated fatty acids (85.7 vs. 67.5%, P<0.001) or cholesterol (35.4 vs. 25.0%, P<0.01). 
Moreover, the results presented in this manuscript allow us to conclude that some 
environmental factors, such as weight status and dietary components, could have an 
influence on the etiology of CRC in this population.  
 
Keywords: Colorectal cancer, Diet, Genetic factors, Gene-diet interactions, Risk-
factors, Case-control study.  
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CRC is already the third leading cause of cancer death in the world, and its incidence is 
steadily rising in western countries [1]. According to GLOBOCAN 2018 data, CRCs are 
the third most commonly diagnosed form of cancer globally, comprising 11% of all cancer 
diagnoses [2]. Incidence varies geographically, more-developed regions have a higher 
incidence than less-developed ones [3]. Europe is among the seven world regions 
ranked according to increasing age-standardized incidence rate (ASRi) with an ASRi of 
30.0 per 100,000 [4] . In particular, in Spain, the ASRi for CRC is 33.4 per 100,000 (21.1 
per 100,000 in males and 12.4 per 100,000 in females) [5]. In the Basque Country, one 
of the autonomous regions of the North of Spain, this pathology is the most frequent type 
of cancer (taking into account the combined incidence both sexes) [6].  
During the recent years, mortality rates for CRC have been decreasing due to early 
screening programs [7,8] and better treatment options [9]. However, the etiology of CRC 
is complex and still not fully understood. Both genetic and environmental factors play an 
important role in the etiology of this disease [10]. Large population studies with varying 
strength of evidence have found CRC protective factors such as diet (fruits and 
vegetables, fibre, resistant starch, fish), vitamin supplements (folate, vitamin B6, vitamin 
D, calcium, magnesium), garlic and coffee, PA, and drugs (aspirin, non-steroidal anti-
inflammatory drugs, hormonal replacement therapy in postmenopausal); and CRC risk 
factors such as obesity, red/processed meat, tobacco and alcohol among others [11].  
In any case, protective and/or risk factors are not present in isolation, but coexist and 
interact with each other and with other factors, for example, both dietary and genetic 
factors affect CRC risk, in an interactive manner [12]. The recognition of these gene-diet 
interactions as a driver in CRC may open up new areas of research in disease 
epidemiology, risk assessment, and treatments. To date, epidemiologic studies have 
revealed inconsistent evidence of gene-diet interaction in relation to CRC. In order to 
better elucidate the role of these types of interactions in the etiology of CRC, the aim of 
this study was to analyze them in a sample of cases and controls from the population-
based screening programme for CRC of the Osakidetza/Basque Health Service. The 
main advantage of the present study compared to other similar researches [13-15] is that 
we confirmed that controls were free of the disease through colonoscopy. Colonoscopy 
was used as the diagnosis criteria to identify the cases in order to avoid false positives 
and negatives. 
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In particular, in this paper, we present the survey design, instruments, measurements 
and related quality management; this detailed information will allow its replication in other 
populations for a comparison of the results. In addition, we analyze differences between 
cases and controls in some data, especially those related to diet, but also in demographic 
data, weight status, lifestyle (different from diet), quality of life and stress level and use 
of drugs related with decreasing CRC risk.  
2. Materials and Methods  
Overall, this epidemiologic study is an observational analytic case-control study 
designed to address possible gene-diet interaction in relation to CRC. 
Sampling and study subjects  
Participants in this study were recruited from among patients attending any of the three 
hospitals of the Osakidetza/Basque Health Service (Basurto, Galdakao and Donostia) 
members of the Basque Country’s CRC screening programme (CRCSP). To be eligible 
for this CRCSP, the patients had to be aged between 50 and 69, asymptomatic for 
colorectal symptoms and registered with the Osakidetza/Basque Health Service [16]. 
These inclusion criteria were applied to both case and control group, that is, controls 
fulfilled the same eligibility criteria defined for the cases, with the exception of the disease 
(outcome). Recruitment and data collection through questionnaires were conducted 
between 2014 and 2016.  
All the patients who were newly diagnosed with CRC (n=601) were invited to participate 
in this study. Of those, 283 refused to participate in the study, and 10 were excluded due 
to missing information. Ultimately, 308 subjects (66.2% men) consented to participate in 
the survey and completed all the questionnaires. In addition, for each case, three age- 
(±9.0 years) and sex-matched control patients were randomly sought from the list of 
CRC-free subjects (n=1,836) who participated in the CRCSP during the same period as 
the cases. The matched controls were patients with positive results (abnormal) for 
immunochemical fecal occult blood test (iFOBT) and negative colonoscopy results 
(normal). The participation rate of the controls was 37.6%, and 17 subjects were 
excluded due to missing information. Finally, the matched case-to-control ratio was 1:1, 
and the final data set included 308 cases who were diagnosed with CRC and 308 age- 
and sex-matched controls. Further details on recruitment and data collection have been 
described elsewhere [17] .  
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The characteristics of the cases (pathological staging, location of the cancer, tumor 
grade and treatments) have been also described before (World Journal of 
Gastroenterology, in review process). Briefly, 72% were diagnosed with early-stage (I/II) 
CRC, 76% had distal location of the cancer, 80.5% of tumors were well/moderately 
differentiated and 73.7% had undergone surgical resection. The cases were invited to 
take part in this survey at least one month after finishing their last treatment (surgery, 
chemotherapy or radiotherapy) (median, 1.3 years; range, 0.1 to 4.2 years). No 
statistically significant differences were found in the time elapsed between participation 
in the CRCSP and collaboration in this survey, between cases and controls (cases, 
1.8(1.0) years, controls 1.6 (1.5) years; p = 0.119). All these clinical data were obtained 
from the Basque Country’s population-based CRCSP database, which links patient 
medical records and clinical databases and were reviewed by expert staff. 
This study was conducted according to the guidelines laid down in the Declaration of 
Helsinki, and all procedures involving patients were approved by the Clinical Research 
Ethics Committee of the Basque Country (reference numbers PI2011006 and 
PI2014042). Written informed consent was obtained from all the study participants. 
Procedures and survey modules 
The modules in this study were initially selected to cover the assessment dietary intake, 
lifestyle, demographic and socioeconomic determinants and genetic factors. Table 1 
provides an overview of the major study components. Consenting participants self-
completed and returned one general questionnaire (GQ) and a short Food Frequency 
Questionnaire (SFFQ). The questions referred to behaviours before participating in the 
CRCSP. Assistance from the study staff was available to help the patients to understand 
the items on the questionnaires. 
General questionnaire 
The GQ was used to gather information on weight status (self-reported weight and 
height), environmental factors (demographic and socio-economic factors: age and sex, 
marital status and children, birthplace, place of residence, total number of co-residents 
per household, total number of rooms (excluding the kitchen and bathrooms), 
educational attainment, economic activity and last work; and lifestyle information: PA, 
physical exercise (PE) and smoking consumption). These questions were taken from the 
Spanish Health Questionnaire [15]. Body mass index (BMI), estimated from self-reported 
height and weight was classified according to the WHO criteria for those under 65 years 
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of age [18]  and according to the criteria proposed by Silva Rodríguez et al. for those 
65 years and older [19]. 
The GQ included as well information about perceived quality of life (QoL) and stress, 
and the use of drugs related with decreasing CRC risk (antiplatelet (including non-
steroidal anti-inflammatory drugs), anticoagulants and hormone replacement therapy in 
the case of women) [20-23]. To assess the QoL and perceived stress an analog linear 
scale with a range from 0 to 100 was used [24].  
The differences in general characteristics (age, BMI, educational attainment, economic 
activity, last employment, PE and smoking habit) between cases and controls were 
previously described (World Journal of Gastroenterology, in review process). Briefly, 
significant differences between cases and controls were found for educational level, 
smoking, and weight status; with a higher percentage of cases with low-medium 
educational level, past or current smoking status and with overweight/obesity 
compared to controls (P<0.01). 
Dietary habits questionnaire 
Diets were assessed using a self-reported SFFQ that was a modified version of the 
Rodríguez et al. [25] questionnaire. This adaptation was validated with multiple 24-h 
recalls in the Basque general population [26] and in CRC diagnosed patients in a pilot 
of the present study [27]. It consisted of 67 items and requires the subjects to recall the 
number of times each food item was consumed either per week or per month. This 
SFFQ included specific questions about frequency of intake of alcoholic beverages. 
Moreover, the respondents could also record the consumption of other foods that were 
not included on the food list, as well as the use of dietetic products and nutritional 
supplements (name –generic and brand-, dose and frequency). 
 The SFFQ included additional items to ask about the consumption of fried foods, 
grilled or roast meat, added salt (cooking and at the table), as well as the average 
weekly consumption of some food types (cooked vegetables, salads, fruit/fruit 
products, fish/fish products, and meat/meat products/meat dishes). These last 
questions were taken from the EPIC-Norfolk Food Frequency Questionnaire [28-29]. 
Once the completed SFFQ was received back, it was reviewed by a dietitian. 
Consumption frequencies were standardized to “per day” and multiplied by standard 
serving sizes (grams) [30]. For items that included several foods, each food’s 




contribution was estimated with weighting coefficients that were obtained from the 
usual consumption data [31]. 
 Food items were then regrouped according to nutritional characteristics [32] and 
considering the potential contribution of food to the pathogenesis of CRC [33,34]. All 
food items that were consumed were entered into DIAL 2.12 (2011 ALCE 
INGENIERIA) [35] a type of dietary assessment software, to estimate energy intake 
(kilocalories/day, kcal/d), nutrients and dietary compounds intakes that were expressed 
in absolute values, as a percentage of the total energy intake (TEI) and as daily 
consumption per 1,000 kcal. Some nutrients and dietary compounds intakes were 
estimated by other food composition databases as detailed below. Methyl donor 
compounds (methionine, choline, and betaine), fatty acids (arachidonic, 
eicosapentaenoic and docosahexaenoic) and dietary antioxidants (pro-vitamin A 
carotenoids (α-carotene, β-carotene, and β-cryptoxanthin), lutein and lycopene) were 
estimated using the US nutrients database [36]. And flavonoids and glucosinolate 
intakes were calculated using Phenol-Explorer [37]. 
Mean daily energy intake was compared with energy requirements derived from basal 
metabolic rate that was estimated using the Harris-Benedict formula [38] multiplied by 
activity factors [39]. The activity factor was based on self-reported main daily activity. 
Nutrient intake data (from diet and dietetic products and supplements) were compared 
with the Nutritional Objectives for the Spanish Population (NOSP) [40], the estimated 
energy requirements (EER), the Estimated Average Requirements (EAR) or Adequate 
Intakes (AI) [41,42]. The EAR is the mean daily intake value which is estimated to meet 
the requirement of half of healthy individuals in a life-stage and sex group for that 
nutrient, and the AI is established when there is insufficient scientific evidence to 
determine an EAR [41,42]. Results of energy and micronutrients were expressed as a 
percentage of the EER and EAR or AI, respectively. Micronutrient data were also 
compared with Tolerable Upper Intake Levels (UL) [44-47]. And caffeine consumption 
was compared to the Denmark and the UK’s recommended limit for caffeine intake 
[48]. 
Additionally, in this survey, we also calculated a mineral score, which is a modified 
version of the score proposed by Swaminath et al. [49] who have associated this score 
with CRC risk. In the present study, this mineral score included six minerals with 
possible colon anti-carcinogenic effects (calcium, magnesium, zinc, selenium, 
potassium and iodine) and four with pro-carcinogenic properties (iron, copper, 
phosphorus and sodium). We did not include intakes of manganese, even though it 




was part of the original score, due to the lack of data on this mineral in the food 
composition database used in the present study. Mineral intake was expressed as daily 
consumption per 1,000 kcal, and then the intakes of each mineral were categorized 
into tertiles based on the distribution within the controls group (taking into account sex 
differences when they were significantly different). We applied a similar score 
methodology to that developed by Swaminath et al. [49]. 
That is, for each mineral hypothesized to reduce CRC risk, each participant was 
assigned a value equal to their tertile rank (i.e., a value of 1–3, with lower ranks 
indicating lower mineral intakes and higher ranks indicating higher mineral intakes). For 
each mineral hypothesized to have predominantly pro-carcinogenic properties in the 
colon, the values assigned to the rankings were reversed (i.e., values of 3–1, with 
lower ranks indicating higher mineral intakes and higher ranks indicating lower mineral 
intakes). Finally, each participant’s values for each mineral were summed to represent 
his/her mineral score; thus, the range of possible scores was 10–35.  
Regarding alcohol consumption, the SFFQ used in this study included specific 
questions about the frequency of intake of the following five major types of alcoholic 
beverages: beer, wine, cider, aperitif with alcohol and liquor. The alcohol consumption 
data are expressed as grams of alcohol and standard drink units (SDU) per week [50]. 
We used the SDU defined for Spain (one SDU is the equivalent to 10 g of alcohol). 
With this information, the participants were categorized into those who did and did not 
meet the recommendations [51]. Finally, adherence to the dietary recommendations 
was evaluated utilizing the Healthy Eating Index for Spanish Diet (HEISD) [52] and the 
MedDietScore (MDS) [53], as previously explained [27]. The theoretical range of the 
HEISD is 0-100 and of the MDS 0-55, higher values of these scores indicate greater 
adherence to the dietary recommendations for the Spanish population and the 
Mediterranean diet pattern, respectively. 
Adherence to guidelines for CRC prevention  
Adherence to guidelines for CRC prevention was assessed using a modified version of 
the World Cancer Research Fund/ American Institute for Cancer Research 
(WCRF/AICR) score [54]. Of the 7 recommendations (components) (6 in men) included 
in the original version of this score, we selected 5 with convincing evidence of an 
association with CRC risk [11]: PA/PE, dietary fiber, red meat and processed meat, 
alcoholic beverages and body fatness (as BMI). The recommendation on abdominal 




fatness and factors that lead to greater adult attained height were not included in this 
score because sufficient data were not available. 
The score assigned for each component was 1 when the recommendation was met. An 
intermediate category (0.5 points) was created to appraise a higher proportion of the 
variability in the population. All other individuals received 0 points. The score was 
constructed using quantitative criteria laid down in the recommendations as cut-off 
points WCRF/AICR, and therefore, higher scores indicate a greater concordance with 
the recommendations of the WCRF/AICR [11]. Moreover, each component of the score 
was added to calculate a total score for each study participant. The theoretical range 
was between 0-5 points for both sexes.  
Lifestyle changes after participating in the CRCSP 
A questionnaire developed ad hoc, that included items related to the recommendations 
with convincing evidence of an association with CRC risk [11], was used to assess 
lifestyle changes after participating in the CRCSP. This tool was applied to a 
subsample of 102 matched case-control pairs, randomly selected from the study 
sample, through phone interviews by previously trained health professionals. 
The questionnaire included the following items: PA/PE, food consumption (vegetables, 
fruit, whole cereals, red meat, processed meat, alcoholic drinks) and smoking habits. 
Possible answers were: “increase”, “decrease”, “the same” or “do not 
consume/practice”. If the answer was “increase” or “decrease”, additionally, subjects 
were asked about the reason/s for the change. Answers about the reasons were open 
and were analyzed manually and categorized as follows: “health promotion”, “food 
preference”, “changes in work, family or personal life”, “diagnostic and/or side effects of 
CRC treatment/s”, “other pathologies”, and “do not know or missing”.  
Data obtained from clinical databases 
Data about diagnosis and treatment of cases, as previously mentioned (pathological 
staging, location of the cancer, tumor grade and treatments), were obtained from 
clinical databases. Additionally, in both cases and controls, socio-economic level and 
health status (specifically health resource consumption) data were assessed with two 
indices that were obtained from the clinical databases developed by the Health 
Department of the Basque Government, namely the socioeconomic deprivation index 
(DI) and predictive risk modelling (PRM), respectively. The first one was estimated 
using the MEDEA project criteria [55] , as has been described elsewhere [17] and was 




divided into quintiles (Q), with the first being the least disadvantaged and the fifth being 
the most disadvantaged. The DI was successfully assigned to 80.2% of participants, 
while the quality of the registered information did not permit the linking of the remaining 
19.8%.  
The PRM is an index that is based on Adjusted Clinical Groups (ACG) [56], Diagnostic 
Cost Groups/Hierarchical Condition Categories (DCG-HCC) [57] and Clinical Risk 
Groups (CRG) [58]. This index combines information about diagnoses, prescriptions, 
previous costs and the use of specific procedures. It is capable of predicting the use of 
health resources [59] (), and it was stratified into four levels (L); the first included 
participants with a risk of high health resource consumption and the fourth included 
those with low health resource consumption. The PRM was successfully assigned to 
95.1% of participants, while the quality of the registered information did not permit the 
linking of the remaining 4.9%. 
The differences in these two indices (DI and PRM) between cases and controls were 
previously described (World Journal of Gastroenterology, in review process). Briefly, 
significant differences between the cases and the controls were found for DI and PRM, 
with a higher percentage of controls than cases in Q1-3 (the least disadvantaged) for 
DI, and a higher percentage of cases than controls in L1-2 (these levels included those 
with a risk of high health resource consumption) for PRM (P<0.001). 
Biological samples and genotyping 
In this survey, healthy tissues or saliva samples of 230 CRC patients and 230 controls 
were collected and genotyped. Samples were provided by the Basque Biobank for 
Research-OEHUN www.biobancovasco.org and were processed following standard 
operation procedures with appropriate ethical approval. DNA was extracted using 
AllPrep DNA/RNA kit (Qiagen) for paraffin-embedded tissue samples and AutoGenFlex 
Tissue DNA Extraction kit (Autogen) for mouthwash saliva samples, and then was 
analyzed with NanoDrop™ Spectrophotometer (ThermoFisher).  
Double-stranded DNA was quantified by fluorometry using theQuant-iT™ PicoGreen1 
dsDNA Assay Kit (Invitrogen, CA) on a DTX 880 Multimode Detector (Beckman 
Coulter) to normalize DNA concentration. SNPs were selected for analysis on the basis 
of published studies concerning: (1) SNPs associated with susceptibility for 
development of CRC [60,61]; and (2) associations between SNPs and food groups or 
dietary factors as well as gene-diet interactions in CRC. SNPs were organized in the 
context of the gene(s) at or near locus and chromosome locus. The allelic 




discrimination was assessed using the MassARRAY1 System (Agena Bioscience) on 
CeGen-PRB2-ISCII (Nodo USC) following the procedure provided by the manufacturer. 
Quality control samples were included in the genotyping assays. 
Regarding the susceptibility SNPs for CRC, after an updated summary of the published 
SNPs [60,61];  48 previously reported CRC-susceptibility SNPs were selected and 
analyzed. The results of these SNPs were described in the manuscript of Alegria-
Lertxundi et al. [17] . In summary, we have confirmed a CRC susceptibility locus and 
the existence of associations between modifiable factors and the rs6687758 SNP; 
moreover, the GRS was associated with CRC. In relation to the SNPs associated with 
food groups or dietary factors as well as gene-diet interactions in CRC, after a 
bibliographic review on the topic, 82 SNPs were selected and analyzed, results are 
currently under review. 
Quality management 
We applied a similar methodology of those used in the IDEFICS study [62]. A unique 
subject identification number was attached to each recording sheet, questionnaire, and 
sample, as in other researches. The identification number had to be entered twice 
before the document could be entered into its respective database. All data were 
entered twice independently, and deviating entries were corrected. Inconsistencies that 
were identified by additional plausibility checks were rectified. 
Timeline 
Consenting participants self-completed and returned questionnaires between 2014 and 
2016. Interviews to obtain data about lifestyle changes after participating in the CRCSP 
were carried out between 2015 and 2016, both in cases and controls after returning 
self-reported questionnaires. The collection of data from clinical databases, as well as 
the obtaining of biological samples were made after receiving and reviewing the 
questionnaires.  
Statistical analysis 
Statistical analyses for the present paper were performed using SPP 22.0 (SPSS Inc, 
Chicago, USA). Categorical variables are shown as a percentage, and continuous 
variables are shown as the means and standard deviation (SD). Normality was 
checked using the Kolmogorov-Smirnov-Lilliefors test. Paired t-test or the Wilcoxon 
rank-sum test was used to two related means comparison. The categorical variables 




were analyzed using the 2 test or the Fisher exact test. All tests were two-sided, and 
P values less than 0.05 were considered statistically significant. 
3. Results 
Table 2 provides information regarding the demographic data, weight status, lifestyle 
(such as main daily activity, alcohol consumption, dietetic products and supplement 
use), drugs use, and quality of life and stress level. It should be noted that cases had a 
significantly higher prevalence of overweight/obesity than controls (P<0.05). Although 
the percentage of controls whose main daily activity was sedentary (sitting or standing) 
was higher compared to cases, these differences were not statistically significant. In 
addition, the use of dietary products and dietary or nutritional supplements was similar 
in cases and controls; being vegetable drinks the most common dietary product used 
and mineral supplements the most common nutritional supplement used. On the other 
hand, the use of antiplatelet agents was more frequent in cases than controls (P<0.05). 
With respect to the weekly consumption of some food types, there were no significant 
differences between cases and controls in intakes of cooked vegetables, salads, 
fruit/fruit products, fish/fish products, and meat/meat products/meat dishes; neither in 
the consumption of fried foods nor grilled or roast meat nor in the frequency of use of 
added in table. However, a higher proportion of cases “always” or “often” used salt for 
cooking (76.8%) compared to controls (69.7%) (P=0.036). In any case, the average 
intake of Na from SFFQ was similar in cases and controls (Table 3).  
Table 3 shows the daily energy and nutrients intake from diet and dietary products and 
supplements. Both in cases and controls, the average intake of protein and fat, 
especially SFA, expressed in percentage of the TEI was higher than NOSP; while, the 
average consumption of carbohydrate and dietary fiber was lower than NOSP. The 
cholesterol intake was lower than the NOSP. In particular, protein intake was higher 
than NOSP in 60.7 % of the sample, fat intake in 94.2%; and carbohydrate intake was 
lower than NOSP in 99.0%, and dietary fiber in 93.0%; there were no significant 
differences in any of these variables between cases and controls. Nevertheless, the 
percentage of cases whose consumption of SFA and cholesterol did not comply with 
NOSP was higher compared to controls (SFA: 85.7% vs. 67.5%, P<0.001; cholesterol: 
35.4% vs. 25.0%, P=0.009). 
The average intake of vitamin B1, B6/protein, cholesterol and caffeine were higher in 
cases than controls (P<0.05); while vitamin B2 and the Ca/P ratio were higher in 
controls than cases (P<0.01). The percentage of cases whose vitamin B2 intake did not 




comply with NOSP was higher than controls (7.1% vs. 2.9%, P=0.029). Concerning the 
average consumption of caffeine, this was lower than the recommended limit in both 
cases and controls (400 mg/d).  
On the other hand, the percentage of EAR (from diet and dietetic products and 
supplements) for Ca, Fe and vitamin B2 was lower in cases than controls (P<0.05); 
while, the percentage of EAR for vitamin B1 and B6 was lower in controls than cases 
(P<0.05) (Table 4). The nutrients with the lowest proportions of subjects with intakes 
below EAR were: vitamin B3 (4.8%), Fe (9.7%), vitamin B12 (21.4%) and P (23.7%); 
there were no significant differences between cases and controls in these percentages. 
The percentage of the total sample (cases and controls) that exceeded the UL was: 
18.8% for Mg (of which 1% used supplements and/or dietetic products), 37.4% for Na 
and 47.7% for vitamin B3 (of which 1.6% used supplements and/or dietetic products); 
there were no significant differences between cases and controls. In cases group, 0.9% 
exceeded the UL value for the vitamin B6. 
Finally, the average mineral score was 20.2(3.4) with a range between 14 and 28, 
without significant differences between cases and controls. The distribution in tertiles of 
the mineral score showed a greater proportion of controls (76%) than cases (24%) in 
the second tertile (P<0.001), and a greater proportion of cases than controls in the third 
tertile (59.6% vs. 40.0%, P< 0.001; respectively).  
 




Table 1. Overview of the measurements and variables collected in this survey 













Educational attainment, economic activity, last 
employment, total number of co-residents per household 
and total number of rooms, excluding the kitchen and 
bathrooms. 
HCI. 
Lifestyle  PA (main daily activity), PE (at least 20 minutes per 
session), smoking habit (yes or no, age at start, number of 
cigarettes per day, years without smoking), and alcohol 
consumption (frequency and type of alcohol, these items 
were included in the SFFQ).  
Dietary habits: SFFQ, dietetic products and nutrient 
supplements consumption. 
Energy intake, macro/micronutrients (based on food 
composition tables), adequacy of energy and nutrients 
intake (percentage of the EER, NOSP, AI and UL), 
mineral score and diet quality index (HEISD and MDS). 
Adherence to guidelines for CRC prevention (PA/PE, 
dietary fiber, red meat and processed meat, alcoholic 
beverages and BMI) (subsample randomly selected). 
Quality of life 
and stress  
Perceived quality of life and stress. 






Date of the iFOBT 





Pathological staging, location of the cancer, differentiation, 
tumor grade and treatments (type and data of surgery, 
radiation therapy and/or chemotherapy). 

















PA/PE, food consumption (vegetables, fruits, whole 
cereals, red meat, processed meat, alcoholic drinks) and 
smoking habits.  
Genotyping  48 SNPs of susceptibility 
82 SNPs that could be associated with food groups or dietary factors and gene-
diet interactions 
To be continued in the next page. 
 





AI: adequate intakes; BMI: body mass index; CRCSP: colorectal cancer screening 
program; DI: deprivation index; EER: estimated energy requirements; HCI: Household 
crowding index; HEISD: Healthy Eating Index for Spanish Diet; HRT: hormone 
replacement therapy; iFOBT: immunochemical fecal occult blood test; MDS, 
MedDietScore; NOSP: Nutritional objectives for the Spanish population; PA: physical 
activity; PE: physical exercise; PRM: predictive risk modelling; SFFQ: short food 
frequency questionnaire; SNP: single nucleotide polymorphism; UL: daily tolerable upper 
limits. 
*Text in italics corresponds to data derived from direct measurements. 
Results presented in this manuscript are highlighted in bold 
 
Table 2. Demographic data, weight status, lifestyle, drugs use, quality of life and stress 
level in cases and controls studied 





Sex, men 66.2 66.2  
Age, y 61.5 5.2 61.1 5.5 0.093 
BMI, kg/m2 27.5 4.4 26.8 4.4 0.049 
   Overweight/obesity 67.5  58.1  0.015 
Main daily activity 
   Sitting 
   Standing 
   Walking 


















Alcohol consumption, SDU 







Dietetic products and supplement useb 9.7  13.0  0.306 
Among those who consumed dietetic products and/or supplementsc   
Dietetic products use 
   Milk/dairyd 
   Vegetable drinkse 














   Vitamins 










Continuation of Table 1 
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   Complex vitamin-mineral products 
   n-3 PUFA 
   n-6 PUFA 














   Antiplatelet 
   Anticoagulants 













QoLg 71.5 14.0 69.8 15.2 0.141 
Stress levelg 40.4 26.4 41.1 24.8 0.846 
 
BMI: body mass index; HRT: hormone replacement therapy; PUFA: polyunsaturated 
fatty acids; QoL: quality of life; SD: standard deviation; SDU: standard drink unit. 
aDifferences between cases and controls. Significant results are highlighted in bold. 
bPercentage calculated on the number of cases and controls. 
cThis question presented multiple answers. Percentage based on the number of answers 
obtained in each item. 
dEnriched with calcium, omega-3, lactose-free milk 
eRice, oat or soy drinks. 
fPercentage of females 
gTo assess the QoL and perceived stress an analog linear scale with a range from 0 to 
100 was used 
 
Table 3. Daily energy and nutrients intake (from diet and dietetic products and 
supplements) in cases and control studied 
Daily intake from diet and 







Mean SD Mean SD 
Energy, kcal/d 1774.3 388.0 1743.1 390.9 0.205 
Macronutrients 
Protein, % TEI  15.7b 2.3 16.1 7.1 0.681 
   NOSP, 10–15% TEI     
Carbohydrates,% TEI  36.2 4.9 36.7 5.6 0.277 
   NOSP, 50-60% TEI     
Fat, %TEI  42.5 4.5 42.1 5.1 0.256 
To be continued in the next page. 
 
Continuation of Table 2 
 




Daily intake from diet and 







 Mean SD Mean SD  
NOSP, <30-35%  TEI     
     SFA, % TEI  12.7 2.5 12.4 2.8 0.179 
   NOSP, <7–8% TEI     
MUFA, % TEI 19.6 2.7 19.7 2.8 0.631 
   NOSP, 20% TEI     
PUFA, % TEI  6.6 2.0 6.3 1.7 0.183 
   NOSP, 5% TEI     
Linoleic acid, % TEI 5.1 1.9 4.8 1.5 0.118 
   NOSP, 3% TEI      
α-linolenic acid, % TEI 0.7 0.2 0.7 0.2 0.422 
   NOSP, 1-2% TEI      
EPA, mg 334.7 192.8 329.9 209.9 0.542 
DHA, mg 582.4 321.7 563.3 316.9 0.380 
   NOSP, 300 mg      
Minerals and electrolytes  
Ca, mg 759.4 238.0 780.6 227.0 0.225 
   NOSP, 800-1,000 mg     
P, mg 1220.2 314.5 1207.9 297.6 0.648 
Ca/Pc 0.6 0.1 0.6 0.1 0.009b 
   NOSP, 1,3/1      
Fe, mg 14.1 3.9 14.4 4.2 0.765 
Mg, mg 263.1b 73.7 263.8 63.1 0.760 
K, mg 2616.0 615.3 2627.7 610.2 0.954 
I, µg 88.8 39.9 87.3 24.7 0.961 
   NOSP, 150 µg      
Nad, mg 1950.8 1041.4 1820.1 1004.3 0.081 
   NOSP, <2,000 mg/d     
Se, µg 88.3 24.3 87.3 24.4 0.682 
Cu, mg 1.0 0.3 1.0 0.3 0.568 
Zn, mg 9.4 2.8 9.3 2.9 0.375 
Vitamins   
Continuation of Table 3 
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Daily intake from diet and 







 Mean SD Mean SD  
Vitamin B1e, mg/1,000 kcal 1.0 7.6 0.6 0.2 0.003 
   NOSP, 0,4 mg/1,000 kcal     
Vitamin B2f, mg/1,000 kcal 0.9 0.2 0.9 0.2 0.002 
   NOSP, 0,6 mg/1,000 kcal     
Vitamin B3, mg/1,000 kcal 17.1 3.3 17.2 3.3 0.117 
   NOSP, 6,6 mg/1,000 kcal     
Vitamin B6 (mg)/protein (g) 0.04 0.2 0.03 0.01 0.020 
   NOSP, > 0.02 vitamin B6 (mg)/protein (g)   
Folate, µg 267.2 80.1 273.3 76.5 0.406 
   NOSP, >300-400 µg     
Vitamin B12e, µg 6.7 28.5 4.9 1.7 0.094 
Vitamin C, mg 149.3 66.0 147.8 59.9 0.611 
Vitamin A, µg 532.4 206.9 522.0 181.4 0.420 
Vitamin D, µg 2.1 1.0 2.3 1.9 0.799 
   NOSP (>50 y old), 10 µg     
Vitamin E, mg 0.6 0.1 0.6 0.1 0.139 
   NOSP, > 0.4 vitamin E (mg)/PUFA (g)    
Others  
Cholesterol, mg 274.7b 96.7 256.2 95.3 0.019 
Fiber, g 19.9 6.5 20.1 6.0 0.459 
Caffeine, mg 15.1 9.7 13.8 11.7 0.025 
Waterg, ml 1062.3b 264.8 1069.9 261.2 0.769 
DHA: docosahexaenoic acid; EPA: eicosapentaenoic acid; MUFA: monounsaturated 
fatty acids; NOSP, Nutritional objectives for the Spanish population; PUFA: 
polyunsaturated fatty acids; SD, standard deviation; SFA: saturated fatty acids; TEI: total 
energy intake. 
aDifferences between cases and controls. Significant results are highlighted in bold. 
bThis variable followed a normal distribution. 
cThe Ca/P ratio was 0.62(0.12) in cases and 0.65(0.13) in controls. 
dSodium from foods, does not include the amount of salt added 
eThis high SD is due to the use of nutritional supplements by one of the cases.  
fVitamin B2 intake per 1,000 kcal was 0.86(0.23) in cases and 0.92(0.23) in controls. 
gIntake of water from foods, but not from water from beverages. 
    Continuation of Table 3 




Table 4. Energy and nutrients intake (from diet and dietetic products and supplements) 
expressed as a percentage of the estimated energy requirement (EER), the Estimated 
Average Requirements (EAR) or Adequate Intakes (AI) in cases and controls studied 
% of energy requirement 






Mean SD Mean SD 
Energy  114.4 32.7 107.0 31.3 0.056 
Minerals and electrolytes 
Ca 49.7b 11.1 52.7 13.4 0.025 
P  118.9 18.1 120.1 18.5 0.469 
Fe 142.5 35.7 147.5 36.4 0.044 
Mg 47.5 13.2 48.1 12.0 0.094 
Kc 55.7 13.1 55.9 13.0 0.081 
I 53.2 22.9 53.0 10.5 0.236 
Nac 150.1 80.1 140.0 77.3 0.954 
Se 111.9 24.6 112.3 24.6 0.598 
Cu 80.6 13.4 81.1 13.1 0.360 
Zn 64.0 19.5 64.1 18.7 0.938 
Vitamins  
Vitamin B1d 110.7 847.4 66.5 19.4 0.003 
Vitamin B2 84.6 25.5 89.9 24.8 0.002 
Vitamin B3 147.4 30.5 150.5 29.0. 0.121 
Vitamin B6 110.8 73.6 81.2 19.6 0.010 
Folate 47.8 13.7 49.8 13.1 0.060 
Vitamin B12d 185.2 763.1 139.2 36.5 0.350 
Vitamin C 124.0 55.5 124.5 51.7 0.865 
Vitamin A  52.5 19.9 52.4 17.5 0.943 
Vitamin D  11.9 5.7 13.1 11.9 0.956 
Vitamin E  38.3 16.3 35.7 12.2 0.053 
AI : adequate intakes ; EAR : estimated average requirements ; SD : standard deviation 
aDifferences between cases and controls. Significant results are highlighted in bold. 
bThis variable followed a normal distribution. 
cNutrient intake expressed as a percentage of the AI (the rest of the nutrients were 
expressed as a percentage of the EAR). 
dThis high SD is due to the use of nutritional supplements by one of the cases.  
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This study was successful in obtaining a sample of cases and controls from the 
population-based CRCSP of the Basque Health Service (Osakidetza), all of whom 
agreed to participate in the full study protocol (self-reported data, clinical databases and 
genotyping). More men than women participated (1.96:1.0), and they were mostly elderly 
people (average age in cases= 61.5; and in controls=61.1 years), which was consistent 
with previous literature on CRCSP of the Osakidetza/Basque Health Service [63]. 
Although the average participation rate in this CRCSP was higher in women than men 
(70.9% vs. 65.6%), the proportion of CRC diagnosed was higher in men than in women 
(4.8% vs. 2.1%) [63]. 
With regard to the characteristics of the sample studied the prevalence of 
overweight/obesity was higher in cases than controls. This result is in agreement with 
previous studies [64-66] that have confirmed that obesity is associated with an increased 
risk of CRC. Even though the biological mechanisms underlying the association between 
body-fat in excess and CRC remain unclear [67], evidence seems to support the 
important role of metabolic syndrome, insulin resistance [68], systemic inflammation and 
immunity [69], microbial dysbiosis [70] , as well as certain genetic factors especially in 
early-onset CRC [71,72]. Elucidating the mediating role of these factors in obesity-
induced CRC should be very useful in the prevention and treatment of this type of cancer. 
In addition to the direct contribution of obesity to CRC risk, body-fat in excess, in turn, 
could be associated to other risk factors for CRC, such as unhealthy diet and sedentary 
lifestyle [73,74] (). Notably, we also observed a slightly higher proportion of controls 
whose main daily activity was sedentary compared to cases, but this result could be 
influenced by a greater awareness of the associations between diseases and lifestyle 
factors among cases.  
Regarding the diet, no significant differences were found for the food group studied, 
except for the frequency of use of salt added to cooking that was significantly higher in 
cases than controls. In other case-control studies, a positive association between sodium 
intake and CRC was also observed  [75]. In any case, our average intake of Na from 
SFFQ was similar in cases than controls, probably due to the difficulty to estimate this 
intake from self-reported data on salt added [76].  
From the nutritional point of view, the diet of participants, both cases and controls, was 
characterized by high intakes of protein, fat, SFA, and low intakes of carbohydrates and 
dietary fibre; thus, it was a western diet pattern. This dietary pattern has been associated 
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before with an elevated CRC incidence [77,78]. Moreover, the percentage of cases 
whose consumption of SFA and cholesterol did not comply with NOSP was higher than 
controls. This result is in agreement with those reported by other authors that have 
observed a higher CRC risk among subjects with high intake of both SFA and cholesterol 
(highest vs. lowest) [79]. Arafaet et al. [80] also reported a higher intake of saturated fats 
and cholesterol among CRC diagnosed subjects as compared to controls. The 
mechanisms involved in the influence of fat on the colorectal carcinogenesis is complex 
and appear to be related with its effect on the insulin-signal pathway and the c-Hun N-
terminal kinase pathway that promote the colonic cell proliferation [81].  
On the other hand, in the present study, we have not found a higher intake in controls 
than in cases of protective factors associated with a decrease in CRC risk according to 
the scientific literature, such as, for example, Ca, Mg, fiber diet, vitamin D, B6 or regular 
use of certain drugs [9]. However, the average intake of vitamin B2 and the Ca/P ratio 
was higher in controls than cases. Some studies have indicated before that vitamin B2 
intake is inversely associated with CRC risk [82]. Although this vitamin has received less 
attention than other ones, as protective factor of epithelial cancers (including CRC), the 
interest in vitamin B2 is increasing due the role of flavins in folate metabolism and the 
possible synergistic protective effect between these two vitamins for cancer [83]. With 
respect to Ca/P ratio, Botron et al. [84] reported a case-control study in which they 
analyzed the possible association between this ratio and colorectal carcinogenesis, and 
found positive associations, but they did not observe any modulation by P intake of the 
association between dietary Ca intake and CRC.  
Finally, on the contrary, the hypothesis that higher intakes of minerals with colon anti-
carcinogenic effects, combined with lower intakes of those minerals with pro-
carcinogenic effects may be associated with lower CRC risk was not supported. A 
greater proportion of controls than cases positioned in the second tertile of the minerals 
score, in contrast to what has been observed in the third tertile.  
Strengths and limitations  
The main strength is the fact that information is provided based on a standardised 
protocol including not only dietary and genetic factors, but also other possible 
determinants of CRC such as health determinants and weight status, among others. 
Another strength of this study compared to others [13-15] is that colonoscopy was used 
as diagnosis criteria to identify the cases in order to avoid false positives and negatives. 
However, there are some limitations that should be mentioned. First, recall bias inherent 
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in a case-control study design cannot be ruled out. Second, self-reported data could be 
subject to measurement errors and the problem of food omissions due to memory failure 
and under-reporting of unhealthy habits among disease subjects. However, previous 
validation studies indicate that the self-reported dietary information is reported with 
sufficient accuracy for use in epidemiology analysis [85]; and it should be noted that 
dietary changes are usually modest after participating in the CRCSP due to a lack of 
information and personalized advice [86,87]. Finally, to avoid selection bias of controls, 
we obtained controls from the same CRCSP and in the same period as cases, thus, it 
was confirmed that they did not suffer from CRC by colonoscopy.  
5. Conclusions 
This study provides valuable data for analyzing the complexity of gene-diet interaction in 
relation to CRC in a sample from a screening programme. These data include not only 
lifestyle and genetic determinants of CRC risk but also demographic, socio-economic 
data, weight status, perceived quality of life and stress, use of drugs related with 
decreasing CRC risk and lifestyle changes after participating in the CRCSP. Thus, this 
research provides valuable data for analyzing the determinants of this pathology and for 
designing prevention strategies. The authors hope that this report could help other 
researchers replicate this survey in other populations in order to easily and accurately 
compare their results. However, it is worth noting that some questionnaires include 
culturally sensitive topics, such as dietary habits and should be adapted to and validated 
in the population of interest. In addition, the results presented in this manuscript allow us 
to conclude that cases were more likely than controls to have overweight/obesity, a 
higher frequency of consumption of salt added for cooking, a lower intake of vitamin B2 
and Ca/P ratio, and not to have adequate intakes of SFA and cholesterol. Thus, some 
environmental factors, such as weight status and dietary components, could influence 
on the etiology of CRC in this population. 
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The results obtained to date concerning food groups, diet quality and colorectal cancer 
(CRC) risk vary according to criteria used and the study populations.  
 
AIM 
To study the relationships between food groups, diet quality and CRC risk, in an adult 
population of the Basque Country (North of Spain). 
 
METHODS 
This observational study included 308 patients diagnosed with CRC and 308 age- and 
sex-matched subjects as controls. During recruitment, dietary, anthropometric, lifestyle, 
99




socioeconomic, demographic and health status information was collected. Adherence to 
the dietary recommendations was evaluated utilizing the Healthy Eating Index for the 
Spanish Diet and the MedDietScore. Conditional logistic regressions were used to 
evaluate the associations of food group intakes, diet quality scores, categorized in 
tertiles, with CRC risk.  
 
RESULTS 
The adjusted models for potential confounding factors showed a direct association 
between milk/dairy products consumption, in particular high-fat cheeses (OR third tertile 
vs first tertile=1.87, 95% CI 1.11-3.16), and CRC risk. While the consumption of fiber-
containing foods, especially whole grains (OR third tertile vs first tertile=0.62, 95% CI 
0.39-0.98), and fatty fish (OR=0.53, 95% CI 0.27-0.99) was associated with a lower risk 
for CRC. Moreover, higher MD adherence was associated with a reduced CRC risk in 
adjusted models (OR=0.40, 95% CI 0.20-0.80).  
 
CONCLUSION 
Direct associations were found for high-fat cheese, whereas an inverse relation was 
reported for fiber-containing foods and fatty fish, as well as adherence to a 
Mediterranean dietary pattern. 
 
Keywords: Colorectal cancer; Food group; Dietary quality; Mediterranean diet; Risk-
factors; Case-control study 
 
 
Core tip: This matched case-control study supports the role of diet in colorectal cancer 
(CRC) risk. The results suggest that high consumption of high-fat cheeses is associated 
with CRC risk, whereas, a high intake of fiber-containing foods, especially whole grains, 
and fatty fish, as well as adherence to the Mediterranean dietary pattern, was associated 
with a lower risk for CRC. Future studies are needed to better understand the influence 
of the dietary habits on CRC prevention in this population that can provide leads for the 
design and tailoring of future interventions, and guide counselling strategies for 
promoting a healthy lifestyle. 
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Colorectal cancer (CRC) is a major public health challenge worldwide. CRC is the third-
most commonly diagnosed malignancy and the fourth leading cause of cancer deaths in 
the world, accounting for approximately 1.8 million new cases and almost 900,000 
deaths in 2018[1]. In Europe, CRC is the leading malignancy in terms of incidence and 
the second in mortality in both sexes[2]. CRC is linked to western lifestyles, in particular, 
to diet, physical inactivity, smoking, alcohol consumption, and body weight[3,4]. 
Epidemiological evidence suggests that dietary factors may both protect against and 
promote the development of CRC. A comprehensive review[5] shows robust evidence 
about the protective role of dietary fiber. Other foods, such as milk or garlic, also may be 
protective. Conversely, red meat and processed meat intake and alcoholic drinks 
increase CRC risk. This food group approach has the advantage of reducing some of 
the problems inherent to analyses of nutrient intake (e.g., inaccuracy and 
incompleteness of food-composition tables). Furthermore, it offers an advantage from a 
preventive perspective since food group results are easier to transform into dietary 
recommendations than those of nutrients[6].  
In this regard, foods are not consumed in isolation but as part of a dietary pattern; 
therefore, the actual effect of diet on disease risk may be observed only when all 
components are considered jointly[6]. For this purpose, several diet quality indexes have 
been developed using point systems to measure whole diet quality based on the 
alignment of food choices with dietary recommendations. Some of these indices have 
been used to begin assessing the relationships between overall diet quality and CRC 
risk, and the results show that high scores in these indices are associated with a lower 
CRC risk[7-10]. However, the results vary considerably according to the index used and 
other factors such as sex and age. Therefore, there is a need to further examine these 
relationships in diverse population studies.  
The current case-control study was undertaken in the North of Spain to elucidate the 
relationships between food group consumption, diet quality and CRC risk, and identify 
possible differences in consumption depending on tumor location, in an adult population 
that participated in a CRC screening programme (CRCSP) in the Basque Country. To 
our knowledge, this is the first study in the Basque country population, in which both 
CRC incidence and mortality have increased in recent years[11]. There are few studies in 
this regard in Spain[12,13]. And both in these Spanish studies and in others carried out in 
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other Mediterranean countries controls were apparently healthy subjects without clinical 
symptoms or signs of any type of cancer[14].  
MATERIALS AND METHODS 
Study subjects 
This is an observational, matched case-control study in a population group residing in 
the Basque Country (North of Spain). Participants in this study were recruited from 
among patients attending any of the three hospitals of the Osakidetza/Basque Health 
Service (Basurto, Galdakao and Donostia) members of the Basque Country CRCSP. To 
be eligible for this CRCSP, the patients had to be aged between 50 and 69, 
asymptomatic for colorectal symptoms and registered with the Osakidetza/Basque 
Health Service[11]. These inclusion criteria were applied to both case and control group, 
that is, controls fulfilled the same eligibility criteria defined for the cases, with the 
exception of the disease (outcome). Recruitment and data collection for the present 
study were conducted between 2014 and 2016.  
All the patients who were newly diagnosed with CRC (n=601) were invited to participate 
in this study. Of those, 283 refused to participate in the study, and 10 were excluded due 
to missing information. Ultimately, 308 subjects (66.2% men) consented to participate in 
the survey and completed all the questionnaires. In addition, for each case, three age- 
(±9.0 years) and sex-matched control patients were randomly sought from the list of 
CRC-free subjects (n=1,836) who participated in the CRCSP during the same period as 
the cases. The matched controls were patients with positive results (abnormal) for 
immunochemical fecal occult blood test (iFOBT) and negative colonoscopy results 
(normal). The participation rate of the controls was 37.6%, and 17 subjects were 
excluded due to missing information. Finally, the matched case-to-control ratio was 1:1, 
and the final data set included 308 cases who were diagnosed with CRC and 308 age- 
and sex-matched controls. Further details on recruitment and data collection have been 
described elsewhere[15]. The main advantage of the present study compared to other 
above-mentioned researches[12-14] is that we confirmed that controls were free of the 
disease through colonoscopy. Colonoscopy was used as diagnostic criteria to identify 
the cases in order to avoid false positives and negatives. 
The pathological staging was based on the 7th edition of the AJCC cancer staging 
manual[16] as follows: I (57.1%), IIA (13.6%), IIB (1.0%), IIC (0.3%), IIIA (7.5%), IIIB 
(14.6%), IIIC (1.9%), IVA (2.9%), and IVB (1.0%). The location of the cancer was distal 
in 76% and proximal (to the splenic flexure of the colon) in 24.0% of the samples. 
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Concerning the tumor grade classification, we adopted a two-grade classification that 
was divided into low grade (well or moderately differentiated) (80.5%) and high grade 
(poorly differentiated, anaplastic, or undifferentiated) (4.5%); the percentage of missing 
data for this classification was 14.9%. 
Some of the cases had undergone surgical resection (73.7%) and/or adjuvant 
treatments, chemotherapy (34.1%), and chemotherapy and radiation (6.8%). The 
percentages of subjects according to the type of surgical procedure were as follows: 
26.3% sigmoidectomy, 17.5% right hemicolectomy resection, 18.8% low anterior 
resection, 6.5% left hemicolectomy resection, 2.3% transverse colectomy, 1.0% 
abdominoperineal resection, 1.0% total colectomy, and 0.3% transanal endoscopic 
operation. The cases were invited to take part in this survey at least one month after 
finishing their last treatment (surgery, chemotherapy or radiotherapy) (median, 1.3 years; 
range, 0.1 to 4.2 years). All the clinical data were obtained from the Basque Country's 
population-based CRCSP database, which links patient medical records and clinical 
databases and reviewed by expert staff. This review allowed the monitorization of all 
cases from the submission of the sample through the analysis, colonoscopy, pathology 
and follow-up. 
This study was conducted according to the guidelines laid down in the Declaration of 
Helsinki, and all procedures involving patients were approved by the Clinical Research 
Ethics Committee of the Basque Country (reference numbers PI2011006 and 
PI2014042). Written informed consent was obtained from all the study participants. 
Consenting participants self-completed and returned a detailed food frequency 
questionnaire (FFQ) and one general questionnaire (GQ). The questions referred to the 
behaviors before participating in the CRCSP. Assistance from the study staff was 
available to help the patients to understand the items on the questionnaires. The quality 
management applied in the present study has been described in a previous article[15]. 
Dietary assessment 
Diets were assessed using a short FFQ that was a modified version of the Rodríguez et 
al[17] (2008) questionnaire. This adaptation was validated with multiple 24-h recalls in the 
Basque general population[18] and in CRC diagnosed patients in a pilot of the present 
study[19]. It consists of 67 items and requires the subjects to recall the number of times 
each food item was consumed either per week or per month. This FFQ included specific 
questions about the frequency of intake of alcoholic beverages. Moreover, the 
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respondents could also record the consumption of other foods that were not included on 
the food list.  
Consumption frequencies were standardized to “per day” and multiplied by standard 
serving sizes (grams)[20]. For items that included several foods, each food’s contribution 
was estimated with weighting coefficients that were obtained from the usual consumption 
data[21]. Food items were then regrouped according to nutritional characteristics[22] and 
considering the potential contribution of food to the pathogenesis of CRC[23,24]. Details on 
the items included in each food group are shown in Table 1. All food items that were 
consumed were entered into DIAL 2.12 (2011 ALCE INGENIERIA)[25], a type of dietary 
assessment software, to estimate energy intake (kilocalories/day, kcal/d). 
Adherence to the dietary recommendations was evaluated utilizing the Healthy Eating 
Index for Spanish Diet (HEISD)[26] and the MedDietScore (MDS)[27], as previously 
described[19].The theoretical range of the HEISD is 0-100 and of the MDS 0-55, higher 
values of these scores indicate greater adherence to the dietary recommendations for 
the Spanish population and the Mediterranean diet pattern, respectively. HEISD was 
divided into the following categories: poor diet (<50 points), needs improvement (50-80 
points) and proper diet (>80 points)[26]; and the MDS into the following ones: low 
adherence to MD (0-34 points) and high adherence (>35 points). The cut-off point of 
MDS was established taking into account that scores below 34 points were associated 
with a higher risk of coronary heart disease, being the relative odds 1.42[27]. 
General questionnaire 
A general questionnaire was used to gather information on weight status (self-reported 
weight and height) and environmental factors (demographic factors: age and sex; and 
lifestyle information: physical exercise (PE) and smoking consumption). These questions 
were taken from the Spanish Health Questionnaire[28]. Body mass index (BMI) estimated 
from self-reported height and weight was classified according to the WHO criteria for 
those under 65 years of age[29] and according to the criteria proposed by Silva Rodríguez 
et al[30] (2014) for those 65 years and older.  
Additionally, socioeconomic and health status data were assessed with two indices that 
were obtained from the clinical databases developed by the Health Department of the 
Basque Government, namely the socioeconomic deprivation index (DI) and predictive 
risk modelling (PRM), respectively. The first one was estimated using the MEDEA project 
criteria[31], as has been described elsewhere[12] and was divided into quintiles (Q), with 
the first being the least disadvantaged and the fifth being the most disadvantaged. The 
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DI was successfully assigned to 80.2% of participants, while the quality of the registered 
information did not permit the linking of the remaining 19.8%.  
The PRM is an index that is based on Adjusted Clinical Groups (ACG)[32], Diagnostic 
Cost Groups/Hierarchical Condition Categories (DCG-HCC)[33] and Clinical Risk Groups 
(CRG)[34]. This index combines information about diagnoses, prescriptions, previous 
costs and the use of specific procedures. It is capable of predicting the use of health 
resources[35], and it was stratified into four levels (L); the first included participants with a 
risk of high health resource consumption and the fourth included those with low health 
resource consumption. The PRM was successfully assigned to 95.1% of participants, 
while the quality of the registered information did not permit the linking of the remaining 
4.9%. 
Statistical analysis 
Statistical analyses were performed using SPSS 22.0 (SPSS Inc, Chicago, USA) and 
STATA 13.0 (StataCorp LP, Texas, USA). Categorical variables are shown as a 
percentage, and continuous variables are shown as the means and standard deviations 
(SD). Normality was checked using the Kolmogorov-Smirnov-Lilliefors test. Differences 
between continuous variables were calculated with a Wilcoxon test, and a McNemar’s 
test was used for categorical variables. 
Conditional logistic regression was used to calculate odds ratios (ORs) and 95% 
confidence intervals (95% CI) for CRC risk according to tertiles of food group intakes and 
diet quality scores for unadjusted and adjusted models. Intake of all food groups and 
total diet quality scores were categorized into tertiles by the distribution in the control 
population, taking into account sex differences when they were significant. The lowest 
tertile was used as the reference group. Tertile cut-offs for HEISD were: 1st tertile (T1), 
69; 2nd tertile (T2), 69-74.5 and 3rd tertile (T3), >74.5; and for MDS: T1, <35; T2, 35-37 
and T3, >37. 
Based on known risk factors for CRC[36,37,38], covariates in adjusted models included age, 
sex, weight status, energy intake, PE level, smoking status, intensity of smoking (in 
current and past smokers) and time not smoking (in past smokers), DI and PRM. 
Quantitative covariates (cigarettes/d and years not smoking) were dichotomized by 
mean or median, according to the normality test. We used the cut-off of Romaguera et 
al. (2012)[39] to create two PE levels expressed in minutes/day (min/d) of cycling/sports: 
sedentary-light (<15 min/d) and moderate-vigorous (≥15 min/d). Age was dichotomized 
using the same age ranges that were used in the sample selection process (50-59 years 
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old vs 60-69 years old). Qualitative ones, such as DI and PRM were dichotomized taking 
into account the distribution of frequencies to obtain similar sample sizes for each 
category (DI, Q1-3 vs Q4-5; PRM, L3-4 vs L1-2). Energy intake was included as a quantitative 
variable in the adjusted models. We included participants with missing data for the 
covariates as a separate category. The reference categories were those that, according 
to the literature, have a lower CRC risk. All tests were 2-sided, and P-values less than 
0.05 were considered statistically significant. 
RESULTS 
Comparisons of general characteristics between the cases and the controls are 
presented in Table 2. Significant differences between the cases and the controls were 
found for educational level, smoking and weight status, with a higher percentage of cases 
with low-medium educational level, past or current smoking status and with 
overweight/obesity compared to the controls (P<0.01).  
Table 3 shows food group intakes expressed as mean values and SD according to case-
control status. No significant differences were found between the two groups for the 
majority of foods groups, except for a higher consumption of eggs and a lower intake of 
whole grains in the cases than the controls (P<0.05). 
The ORs for CRC risk by the main food group and food subgroup intakes are presented 
in Table 4 and 5, respectively. The adjusted ORs for CRC risk increased with higher red 
and processed meat, eggs, milk/dairy products intakes; whereas it decreased with higher 
fiber-containing foods and nut intakes. The food group with the highest adjusted OR for 
CRC risk was milk/dairy products. Fish consumption showed an association with CRC 
risk in the unadjusted analysis but not in the adjusted analysis. For some of these food 
groups, specifically for red and processed meat, fish, eggs and nuts, the null value 1 was 
contained in the confidence interval. Concerning the food subgroup intakes, the ORs for 
CRC risk increased with higher high-fat cheese intakes, while it decreased with higher 
fatty fish, in the adjusted analysis.  
Supplementary Table 1 describes food group intakes of cases according to tumor 
location and their matched controls. Food group intakes were not substantially different 
between proximal and distal cancer cases, except for fish, milk/dairy products and fat. 
The fish consumption was higher in both case subgroups (proximal and distal cancer 
cases) in comparison with their matched controls (P<0.001). However, the milk/dairy 
products intake was higher in proximal tumor cases and was lower in distal tumor cases 
than in their matched controls (P<0.001). Finally, the fat intake was higher in proximal 
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tumor cases in comparison with their matched controls (P<0.05). The sample sizes did 
not allow the assessment of food group intakes related to disease risk, stratifying 
according to the tumor location. 
The components and total scores of the HEISD and MDS are displayed in Table 6. 
According to HEISD, 91.9% of the participants (cases and controls) followed a diet 
classified as “needs improvement”, 7.6% followed a “good diet” and 0.5 followed a “poor 
diet”. Significant differences were neither observed in the HEISD classification nor the 
components scores nor in the total score. However, the total score for this dietary quality 
index and the score of diet variety components were higher for cases with the proximal 
location of cancer than for their matched controls (P<0.05) (Supplementary Table 2). No 
association was found between this index and risk of CRC, in the conditional logistic 
regressions.  
Concerning the MDS, in the total sample, 39.8% showed low adherence to the MD and 
the remaining percentage had high adherence, without significant differences in the MDS 
classification between the cases and the controls. However, the scores for whole grains 
and total index were lower for cases than for controls (P<0.05). This last result was 
confirmed using conditional logistic regressions, showing that those participants with 
higher MDS had a lower CRC risk than those with a lower score, in both unadjusted 
(model I: T3 vs T1, OR 0.57, 95% CI 0.37-0.89, P=0.013) and adjusted models (model II: 
T3 vs T1, OR 0.40, 95% CI 0.20-0.80, P=0.009). No significant differences were observed 
in total MDS between cases stratified by tumor location and their matched controls, but 
the total score was higher for cases with the proximal location of cancer than for those 
with distal location (P<0.05) (Supplementary Table 2). Moreover, the score for potatoes 
and whole grain components were lower for cases with the distal location of cancer than 
for their matched controls (P<0.05). 
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Table 1. Food group definitions 
Food group Food items 
Red and processed meat 
Red meat Beef, pork and lamb, minced meat, hamburgers, 
meatballs... 
Processed meat Ham, sausage, salami, mortadella, black pudding or blood 
sausage... 
Egg Egg 
Fish White fish (hake, grouper, sole, cod) and fatty fish (sardine, 




Whole milk, semi-skimmed milk, skimmed milk, whole 
yogurt, skimmed yogurt and dairy desserts 
Cheese Burgos cheese, curd, cottage and cheeses low in calories, 
mature, semi-mature and creamy cheese 
Fiber-containing foods 
Fruits Orange, tangerine, apple, pear, banana, peach, raisins, 
prunes, dried figs... natural fruit juices 
Vegetables Salads, green beans, chard, spinach... garnish vegetables 
(eggplant, mushrooms, peppers...), garlic, onion 
Whole grains Whole grain pasta, brown rice, whole grain cookies, whole 
breakfast cereals (Muesli, All-Bran)... 
Nuts Walnuts, almonds, hazelnuts, peanuts... 
Fat Vegetable oils (olive, sunflower, corn, soy), butter, 
margarine, mayonnaise... 
Sweet and added 
sugar 
Chocolate, breakfast cereals, cookies, muffins, donuts, 
honey, sugar, commercial fruit juice, soft-drinks, cakes, 
pies... 
Alcoholic beverages Beer, wine, hard cider, vermouth, whiskey, rum, gin, 
brandy, cocktails... 
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Table 2. General characteristics of the sample studied 
Characteristics Cases (n=308) Controls (n=308) P 
Sex, men, n(%) 204(66.2) 204(66.2)  





36.7  29.2   
Technical/secondary 
education 
48.0  44.5   
University degree 15.3  26.3  0.005 
Economic activity, % 
Working 27.9  32.1   
Unemployed 5.2  3.2   
Retired 58.8  56.2   
Housework  8.1  8.4  0.496 
Last work, %      
Employer or 
businessman/women 
19.2  17.9   
Steady salaried 
employee 
75.0  71.8   
Temporary salaried 
employee or 







Household help and 
other activities 
without salary 
5.1  5.8  0.073 
Smoking status, %  
Never  27.9  38.6   
Past/current  72.1  61.4  0.004 
Time to quit smoking 
≥ 11 y 67.2  66.7   
< 11 y 32.8  33.3  0.931 
Intensity of smoking1 
≤15 cigarettes/d 50.7  33.1   
>15 cigarettes/d 49.3  66.9  0.003 
To be continued in the next page. 
 




Characteristics Cases (n=308) Controls (n=308) P 
Physical exercise, % 







≥ 15 minutes/d of 
cycling/sports 
20.8  34.1  <0.001 
BMI, % 
Underweight 6.5  7.8   
 
0.033 
Normal weight 26.0  34.1  
Overweight/obesity 67.5  58.1  
Energy intake (kcal/d), 
mean SD 
1769.9 383.4 1736.6 388.2 0.172 
DI,%2 
Q1-3 47.1  65.6   
Q4-5 18.8  29.5  <0.001 
PRM,%2      
L1-2 15.6  12.3   
L3-4 83.4  79.2  <0.001 
1Percentages were calculated excluding never smokers;  
2Valid percentages. BMI: body mass index; d: day; DI: deprivation index (this index was 
successfully assigned to 80.2% of the study sample); L: level; PRM: predictive risk 
modelling (this index was successfully assigned to 95.1% of the study sample); Q: 
quintile; SD: standard deviation; y: years. 
  
Continuation of Table 2.  




Table 3. Food group intakes of the sample studied 





 Mean SD Mean SD  
Red and processed meat 70.9 36.6 66.0 39.7 0.064 
   Red meat 











Total fish  
   White fish 
















Eggs 20.8 12.7 18.7 11.5 0.038 
Milk/dairy products 
   Non-cheese dairy products 
   Total cheeses 
      Fresh cheeses1 


























Fiber-containing foods 570.3 243.9 564.8 214.1 0.761 
   Fruits (including natural juices) 330.2 202.5 322.6 168.2 0.791 
   Vegetables 202.1 88.8 200.6 90.9 0.803 
   Whole grains 14.4 19.9 18.8 23.4 0.012 
Fat 35.5 6.9 34.6 6.4 0.064 
Nuts 9.1 10.1 10.9 10.5 0.055 
Sweets and added sugar 108.3 95.4 110.7 116.5 0.969 
Alcoholic beverages 103.4 100.7 96.8 105.9 0.269 
1Fresh cheeses, e.g., Burgos cheese and cheeses low in calories;  
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Table 4. Association between main food group in and colorectal cancer risk 




Model I2 Model II3 Model III4 
  OR (95% CI) OR (95% CI) OR (95% CI) 
Red and processed meat 
T1 90/102 1.00 1.00 1.00 
T2  97/103 1.06(0.72-1.57) 1.02(0.61-1.72) 1.08(0.61-1.94) 
T3 121/109 1.32(0.91-1.93) 1.65(0.99-2.75) 1.26(0.71-2.23) 
P  0.314 <0.001 - 
Fish     
T1 95/105 1.00 1.00 1.00 
T2 77/103 0.82(0.53-1.25) 0.97(0.56-1.68) 0.83(0.46-1.51) 
T3 136/105 1.49(1.01-2.20) 1.06(0.62-1.79) 1.25(0.68-2.29) 
P  0.008 <0.001 - 
Eggs     
T1 71/98 1.00 1.00 1.00 
T2  107/116 1.15(0.77-1.72) 1.04(0.62-1.76) 0.97(0.61-1.93) 
T3  130/104 1.55(1.03-2.33) 1.72(1.00-2.94) 1.26(0.71-2.23) 
P  0.081 <0.001  
Milk/dairy products     
T1 60/102 1.00 1.00 1.00 
T2 127/104 2.05(1.35-3.11) 2.02(1.19-3.42) 1.97(1.10-3.53) 
T3 121/102 2.00(1.31-3.05) 2.12(1.25-3.84) 1.80(0.95-3.42) 
P  <0.001 <0.001 - 
Fiber-containing foods     
T1 121/102 1.00 1.00 1.00 
T2 75/101 0.60(0.39-0.92) 0.47(0.26-0.85) 0.49(0.25-0.95) 
T3 112/105 0.86(0.58-1.28) 0.63(0.36-1.11) 0.65(0.35-1.21) 
P  0.048 <0.001 - 
Nuts     
T1 121/102 1.00 1.00 1.00 
T2 75/101 0.60(0.39-0.92) 0.47(0.26-0.85) 0.49(0.25-0.95) 
T3 112/105 0.86(0.58-1.28) 0.63(0.36-1.11) 0.65(0.35-1.21) 
To be continued in the next page. 
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Model I2 Model II3 Model III4 
  OR (95% CI) OR (95% CI) OR (95% CI) 
P  0.048 <0.001 - 
Fat     
T1 86/100 1.00 1.00 1.00 
T2 101/105 1.12(0.75-1.67) 0.94(0.56-1.59) 0.83(0.45-1.51) 
T3  121/100 1.34(0.92-1.97) 1.46(0.85-2.50) 1.25(0.68-2.29) 
P  0.297 <0.001 - 
Sweets and added sugar     
T1 82/120 1.00 1.00 1.00 
T2 120/103 1.47(0.99-2.20) 1.67(0.98-2.86) 1.88(1.01-3.52) 
T3 106/103 1.30(0.87-1.94) 1.63(0.92-2.89) 1.39(0.72-2.67) 
P  0.159 <0.001 - 
Alcoholic beverage     
T1 90/103 1.00 1.00 1.00 
T2 107/101 1.20(0.81-1.77) 1.05(0.63-1.75) 1.10(0.63-1.92) 
T3 111/104 1.19(0.83-1.72) 0.82(0.50-1.36) 0.75(0.42-1.32) 
P  0.558 <0.001 - 
1Food groups consumption was categorized into tertiles according to the distribution in controls, and by sexes for food groups with significant 
differences according to sex; Tertiles of food groups: red and processed meat, T1<47.7 grams/day, T2 47.7-78.5, T3>78.5; total fish, T1<42.8, T2 
42.8-67.2, T3>67.2; eggs, T1<15.7, T2 15.7-23.5, T3>23.5; milk/dairy products, T1<72.0, T2 72.0-232.1, T3>232.1;fat, T1<30.8, T2 30.8-34.8, 
T3>34.8; nuts, T1<2.9, T2 2.9-12.8, T3>12.8; sweets and added sugar, T1<50.1, T2 50.1-117.3, T3>117.3; Tertiles of food groups for men: fiber-
containing foods, T1<424.3, T2 424.3-617.8, T3>617.8; alcoholic beverages, T1<66.7, T2 66.7-137.2, T3>137.2; Tertiles of food groups for women: 
fiber-containing foods, T1<537.9, T2 537.9-723.6, T3>723.6; T1< 8.3; T2 8.3-85.7; T33>85.7. 2Model I, analyses were performed using crude 
conditional logistic regression, without taking into account confounding factors. 3Model II, analyses were performed using conditional logistic 
regression analysis adjusted for age (50-59 years old, 60-69 years old), sex, Body Mass Index (underweight/normal weight, overweight/obesity), 
energy intake (kcal/day), physical exercise level (< 15 minutes/day of cycling/sports, ≥15 minutes/day), smoking status and intensity of smoking 
(never; past: quit smoking ≥ 11 years ago, quit < 11 years ago; smoker: ≤15 cigarettes/day,>15 cigarettes/day), Deprivation Index (quintile 1-
3,quintile 4-5) and Predictive Risk Modelling (level 1-2, level 3-4), including food groups separately; participants with missing data for the 
confounding variables were included as a separate category for these variables. 4Model III, model II including all the mean food groups. CI: 
confidence interval; No.: number; OR: odd ratio; T: tertile. 
Continuation of Table 4. 
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Table 5. Association between food subgroup intakes and colorectal cancer risk 
Food subgroup intakes1 No. 
Case/Control 
Model I2 Model II3 Model III4 
  OR(95% CI) OR(95% CI) OR(95%CI) 
Red meat 
T1  88/101 1.00 1.00 1.00 
T2  103/98 1.20(0.81-1.79) 1.38(0.82-2.34) 1.10(0.62-1.96) 
T3 117/109 1.22(0.84-1.78) 1.41(0.87-2.30) 1.17(0.67-2.03) 
P  0.534 <0.001 - 
Processed meat     
T1 102/103 1.00 1.00 1.00 
T2 82/99 0.84(0.57-1.24) 0.62(0.36-1.07) 0.67(0.38-1.18) 
T3 124/106 1.21(0.83-1.77) 1.54(0.91-2.60) 1.54(0.88-2.70) 
P  0.206 <0.001 - 
White fish     
T1 95/105 1.00 1.00 1.00 
T2 77/103 0.82(0.53-1.25) 0.97(0.56-1.68) 0.96(0.36-2.53) 
T3 136/105 1.49(1.01-2.20) 1.06(0.62-1.79) 1.29(0.74-2.25) 
P  0.008 <0.001 - 
Fatty fish     
T1 119/110 1.00 1.00 1.00 
T2 105/102 1.05(0.71-1.55) 0.93(0.56-1.55) 0.89(0.43-1.69) 
T3 74/96 0.72(0.49-1.08) 0.50(0.29-0.87) 0.53(0.27-0.99) 
P  0.145 <0.001 - 
Fresh cheese     
T1 150/153 1.00 1.00 1.00 
T2 224/33 0.64(0.32-1.28) 1.06(0.44-2.55) 1.11(0.66-1.87) 
T3 134/122 1.11(0.80-1.55) 1.10(0.70-1.72) 0.92(0.58-1.46) 
P  0.272 <0.001 - 
Other cheeses     
T1 96/116 1.00 1.00 1.00 
T2 71/75 1.16(0.76-1.77) 1.51(0.86-2.63) 1.83(1.15-2.89) 
T3 141/117 1.46(1.01-2.12) 1.85(1.12-3.05) 1.87(1.11-3.16) 
To be continued in the next page. 
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Model I2 Model II3 Model III4 
  OR (95% CI) OR (95% CI) OR (95% CI) 
P  0.112 <0.001 - 
Fruits     
T1 109/99 1.00 1.00 1.00 
T2 98/110 0.82(0.56-1.19) 1.08(0.63-1.85) 1.03(0.58-1.83) 
T3 101/99 0.92(0.62-1.37) 0.70(0.40-1.22) 0.68(0.37-1.26) 
P  0.567 <0.001 - 
Vegetables     
T1 97/102 1.00 1.00 1.00 
T2 111/103 1.14(0.76-1.71) 0.98(0.55-1.73) 1.10(0.60-2.04) 
T3 100/103 1.03(0.68-1.57) 0.94(0.52-1.70) 1.10(0.58-2.11) 
P  0.789 <0.001 - 
Whole grains     
T1 144/128 1.00 1.00 1.00 
T2 83/77 0.92(0.62-1.38) 0.86(0.52-1.42) 0.98(0.58-1.65) 
T3 81/103 0.68(0.46-1.01) 0.62(0.37-1.06) 0.62(0.39-0.98) 
     P  0.135 <0.001  
1Food groups consumption was categorized into tertiles according to the distribution in controls, and by sexes for food groups with significant 
differences according to sex; Tertiles of food groups: red meat, T1<33.5 grams/day, T2 33.5-54.9, T3>54.9; processed meat, T1<11.6, T2 11.6-
22.8, T3>22.8; non-cheese dairy, T1<225.0, T2 225.0-325.0, T3>325.0; cheese, T1 <7.5, T2 7.5-20.0, T3>20.0; vegetables, T1<152.9, T2 152.9-
237.2, T3>237.2;Tertiles of food groups for men: fruits, T1<207.5, T2 207.5-392.9, T3>392.9; whole grains, T1<1.0, T2 1.0-17.5, T3>17.5; Tertiles 
of food groups for women: fruits T1<242.9, T2 242.9-425.0,: whole grains, T1<2.0, T2 2.0-30.0, T3>30.0. 2Model I, analyses were performed using 
crude conditional logistic regression, without taking into account confounding factors. 3Model II, analyses were performed using conditional logistic 
regression analysis adjusted for age (50-59 years old, 60-69 years old), sex, Body Mass Index (underweight/normal weight, overweight/obesity), 
energy intake (kcal/day), physical exercise level (< 15 minutes/day of cycling/sports, ≥15 minutes/day), smoking status and intensity of smoking 
(never; past: quit smoking ≥ 11 years ago, quit < 11 years ago; smoker: ≤15 cigarettes/day,>15 cigarettes/day), Deprivation Index (quintile 1-
3,quintile 4-5) and Predictive Risk Modelling (level 1-2, level 3-4), including food groups separately; participants with missing data for the 
confounding variables were included as a separate category for these variables. 4Model III, model II including all the mean food groups. CI: 
confidence interval; No.: number; OR: odd ratio; T: tertile. 
 
 
Continuation of Table 5. 
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Table 6. Diet quality indices in the sample studied 
 Cases (n=308) Controls (n=308) P 
 Mean SD Mean SD  
HEISD components1      
Meats 3.1 1.7 3.1 1.7 0.811 
Processed meats 2.8 2.0 3.1 2.2 0.162 
Legumes 8.6 2.1 8.5 2.3 0.716 
Milk/Dairy  9.8 1.2 9.8 1.1 0.797 
Fruits 9.1 1.8 9.1 1.9 0.464 
Vegetables 8.9 1.7 8.9 1.6 0.816 
Grains 9.9 0.9 9.9 1.9 0.862 
Sweets 1.6 3.1 1.6 3.0 0.847 
Soft-drink 8.8 2.5 8.7 2.6 0.583 
Variety 8.0 1.7 8.0 1.7 0.646 
Total HEISD  70.7 7.2 70.8 7.9 0.906 
 Mean SD Mean SD  
MDS components2      
Red meats and 
processed meats 
0.7 1.0 0.8 1.2 0.134 
Poultry 2.9 1.2 2.9 1.2 0.335 
Fish 3.8 1.1 3.8 1.2 0.771 
Legumes 2.4 1.2 2.3 1.1 0.482 
Full fat dairy 2.0 1.8 2.0 1.9 0.618 
Vegetables 4.9 0.6 4.9 0.5 0.599 
Fruits 4.6 1.0 4.6 1.0 0.726 
Potatoes 2.2 1.5 2.4 1.5 0.054 
Whole grains 2.0 2.2 2.3 2.3 0.044 
Alcoholic 
beverages 
4.9 0.4 4.9 0.4 0.729 
Olive oil 4.9 0.6 4.8 0.8 0.446 
Total MDS 35.3 4.5 36.0 4.3 0.027 
1Each component can contribute 10 points to the total score and the theoretical range is 
0–100. 
2Each component can contribute five points to the total score and the theoretical range is 
0–55. HEISD: Healthy Eating Index for Spanish Diet; MDS: Mediterranean Diet Score; SD: 
standard deviation. 
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Supplementary Table S1. Food group intakes by tumor location 
 








Pa Pb Pc 




67.3 38.5 55.6 32.7 72.1 36.0 69.3 41.2 0.206 0.109 0.230 
Red meat 48.2 27.9 39.0 26.2 50.2 31.4 48.3 32.2 0.795 0.081 0.435 
Processed 
meat 
19.1 16.3 16.6 14.9 21.8 16.6 21.0 17.8 0.128 0.244 0.340 
Fish 78.9 38.0 47.1 25.3 76.2 39.6 44.9 28.5 0.558 <0.001 <0.001 
Eggs 21.2 13.5 17.6 10.9 20.7 12.5 19.0 11.6 0.948 0.099 0.125 
Milk/dairy 
products 





270.2 128.2 260.0 123.7 274.3 123.1 267.1 164.0 0.465 0.755 0.132 
Total 
cheeses 
18.9 13.6 15.9 14.9 18.8 18.5 17.5 17.4 0.479 0.053 0.593 
To be continued in the next page. 
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aDifferences by tumor location (comparison of independent samples). 
bDifferences between the proximal cancer cases and their paired controls (comparison of related samples). 
cDifferences between the distal cancer cases and their paired controls (comparison of related samples). 
dIncluding natural fruit juices. SD: standard deviation. 








Pa Pb Pc 




594.3 233.5 634.2 204.0 562.2 247.3 542.9 212.8 0.264 0.144 0.703 
Fruitsd 341.4 181.9 373.5 154.5 326.6 208.9 306.5 169.5 0.399 0.202 0.678 
Vegetables 212.2 96.5 214.3 89.4 198.9 86.2 196.3 91.1 0.246 0.672 0.573 
Whole 
grains 
16.6 19.4 23.7 26.7 13.7 20.1 17.2 22.0 0.062 0.063 0.068 
Fat 35.4 7.0 32.3 4.7 35.6 6.8 35.2 6.7 0.782 0.023 0.386 




101.8 91.8 83.0 90.1 110.4 96.6 119.4 124.7 0.420 0.134 0.399 
Alcoholic 
beverage 
117.3 128.9 81.7 89.2 99.1 89.8 101.6 110.4 0.418 0.057 0.765 
Continuation of Supplementary Table S1 
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Supplementary Table S2. Dietary quality indexes and their components by tumor location 








Pa Pb Pc 
 Mean SD Mean SD Mean SD Mean SD    
HEISD components            
Meats 3.0 1.6 3.2 1.8 3.2 1.7 3.1 1.7 0.583 0.491 0.912 
Processed meats 3.2 2.0 3.4 2.1 2.7 2.0 3.0 2.2 0.083 0.544 0.209 
Legumes 8.6 1.9 8.5 2.5 8.6 2.1 8.5 2.2 0.515 0.851 0.604 
Milk/dairy 9.7 1.7 9.7 1.4 9.8 1.1 9.8 1.0 0.791 0.794 0.872 
Fruits 9.3 1.7 9.7 1.0 9.0 1.9 8.9 2.1 0.200 0.064 0.952 
Vegetables 8.8 1.9 9.1 1.7 9.0 1.6 8.9 1.6 0.488 0.1135 0.543 
Grains 10.0 0.3 9.9 0.4 9.9 0.6 9.9 0.6 0.159 0.564 1.000 
Sweets 1.9 3.7 2.7 3.8 1.5 2.9 1.3 2.7 0.830 0.145 0.443 
Soft-drink 9.0 2.4 9.0 2.3 8.8 2.6 8.7 2.7 0.407 0.929 0.517 
Variety 8.2 1.7 8.6 1.5 8.0 1.6 7.8 1.7 0.294 0.037 0.600 
Total HEISD 71.6 7.2 73.9 7.8 70.4 7.1 69.9 7.7 0.157 0.019 0.294 
MDS components            
Red meats and 
processed meats 
0.9 1.1 1.1 1.4 0.6 1.0 0.8 1.1 0.091 0.485 0.168 
To be continued in the next page. 
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Pa Pb Pc 
 Mean SD Mean SD Mean SD Mean SD    
Poultry 2.9 1.1 2.9 1.3 2.9 1.1 2.9 1.1 0.583 0.470 0.485 
Fish 4.0 1.1 3.8 1.2 3.8 1.1 3.8 1.2 0.233 0.294 0.816 
Legumes 2.4 1.1 2.3 1.2 2.4 1.2 2.4 1.1 0.566 0.340 0.810 
Full fat dairy 2.1 1.8 2.4 2.0 1.9 1.8 1.9 1.9 0.438 0.267 0.977 
Vegetables 4.9 0.6 4.9 0.6 4.9 0.6 4.9 0.4 0.518 0.891 0.528 
Fruits 4.7 0.9 4.9 0.5 4.6 1.0 4.6 1.1 0.529 0.107 0.819 
Potatoes 2.2 1.3 2.2 1.6 2.2 1.5 2.5 1.4 0.742 0.812 0.040 
Whole grains 2.3 2.2 2.6 2.4 1.8 2.2 2.3 2.2 0.051 0.587 0.045 
Alcoholic 
beverages 
4.9 0.7 4.9 0.2 5.0 0.2 4.9 0.5 0.307 0.167 0.168 
Olive oil 5.0 0.3 5.0 0.2 4.9 0.6 4.8 0.9 0.265 0.785 0.394 
Total MDS 36.2 5.0 37.1 4.7 35.0 4.3 35.7 4.1 0.037 0.257 0.055 
aDifferences by tumor location (comparison of independent samples). 
bDifferences between the proximal cancer cases and their paired controls (comparison of related samples). 
cDifferences between the distal cancer cases and their paired controls (comparison of related samples). HEISD: Healthy Eating Index for Spanish 
Diet; MDS: Mediterranean Diet Score; SD: standard deviation. 
Continuation of Supplementary Table S2 
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The results from this observational study indicate that high consumption of milk/dairy 
products, in particular high-fat cheeses, is associated with CRC risk, while a high intake 
of fiber-containing foods, specially whole grains, and fatty fish was associated with a 
lower risk for CRC. Moreover, a higher MD adherence in general and particularly a higher 
score for whole grains have been associated with a reduced CRC risk.  
As other authors have previously reported[40] milk/dairy products were the food group 
with the highest adjusted OR for CRC risk, which is not in agreement with the probable 
evidence of protection of this food group against CRC[5]. Some cohort studies support 
the protective effect of total dairy products and milk[41-43]. This effect has been 
hypothetically associated with calcium, vitamin D, fats and other components such as 
lactoferrin or lactic bacteria in the case of fermented dairy products milk[41,42]. However, 
case-control studies published to date are heterogeneous and, on average, do not 
provide evidence of an association between total intake of total dairy products, milk, 
cheese or yogurt and CRC risk[41]. Regarding milk/dairy products consumption according 
to anatomical subsites of cases, the intake was higher in proximal tumor cases and lower 
in distal cases than in their matched controls. Although according to scientific literature, 
the effect of this food group seems to be similar across all locations of the bowel[43]. 
In general, epidemiological studies have not found evidence of either reduction or 
increase of CRC risk specifically associated with the consumption of cheese[41,42]. 
Although there are few pieces of research on cheese consumption that reported an 
inverse association with CRC[44] in the present research, high-fat cheeses are shown to 
be possible risk factors for CRC development. Some studies showed a positive 
relationship between fatty foods and CRC incidence[45]. Dairy products, e.g., mature, 
semi-mature and creamy cheeses, are rich in saturated fat, so this relationship might be 
due to the content of fat in these products. Several studies have suggested that high-fat 
consumption increases bile acid discharge. Moreover, an increase in the concentration 
of bile acids above physiological levels has been reported to promote CRC[46,47]. In any 
case, the association between milk/dairy products consumption and the risk of 
developing CRC is complex and some researchers indicated that the fat content 
contained within dairy products does not influence this association[43]. 
In line with previous studies[48-50], we also found that the consumption of fiber-containing 
foods was inversely associated with CRC risk. Specifically, consumption of more than 
424.3 g/d in men and 537.9 g/d in women of fiber-containing foods decreased CRC risk 
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by about 50% (OR 0.5) compared to lower consumption, in adjusted models. The 
preventive effect of dietary fiber can be explained by biological mechanisms that include 
increasing amounts of feces, decreasing gastrointestinal transit time, diluting intestinal 
cancer-causing factors, interfering absorption of those, and lowering intestinal acidity[51]. 
In addition, fermentation of fiber produced butyrate. This short-chain fatty acid showed 
anti-inflammatory, anti-proliferation and antineoplastic properties in colonocyte cells 
metabolism through microbiota homeostasis and genetic/epigenetic regulation[52]. 
Furthermore, our findings suggest that high consumption of whole grains (higher than 
17.5 g/d in men and 30.0 g/d in women) may decrease the risk of CRC, after controlling 
confounding factors. There is convincing evidence that whole grains help to reduce CRC 
risk[5,53]. The observed reduction in CRC risk associated with high consumption of whole 
grains may partly be attributed to dietary fiber, resistant starch, and oligosaccharides that 
can influence the gut environment. Insoluble fiber increases the bulk of luminal contents, 
diluting potential carcinogens and promoters in the colon and decreasing transit time, 
and, consequently, reduces the exposure of the colonic epithelium to harmful 
compounds[54,55]. Additionally, other components such as vitamins (especially B-
vitamins), minerals (e.g. magnesium and zinc), phenolic compounds, antinutrients (e.g. 
tannins), and phytoestrogens may also contribute to this protection[54]. 
On the other hand, the consumption of fatty fish (higher than 42.8 g/d) was associated 
with a decreased risk in CRC by about 50% (OR 0.5) compared to lower consumption, 
after adjusting models for covariates. It should be noted that the Basque Country 
population has a higher consumption of total fish and fatty fish compared to other 
Spanish autonomous communities[55,56]. Recent cohort studies have observed that fatty 
fish was inversely associated with CRC incidence[57,58] and they have related this 
association with exposure to long-chain n-3 polyunsaturated fatty acids[57]. Evidence 
from animal and in vitro studies indicates that n-3 fatty acids present in fatty fish may 
inhibit carcinogenesis[59]. High intake of n-3 fatty acids suppresses the production of 
arachidonic acid-derived eicosanoids such as prostaglandin E2 and leukotriene B431. 
N-3 fatty acids could also suppress the expression of inducible nitric oxide synthase 
(NOS) and nuclear transcription factor κ B (NF-κ B)[60].  
In relation to the diet quality, our findings on the MDS and CRC risk are supported by 
those of other researchers[13,61-63], who found significant associations between lower risk 
of CRC and adherence to Mediterranean dietary pattern. However, the HEISD was not 
associated with CRC risk, discrepancies in results obtained with the two dietary quality 
indices analysed are probably due to differences in their constructs and scoring criteria. 
122
Dietary and genetic factors in colorectal cancer  Participants, methods and results 
 
 
The overall MDS was inversely associated with CRC risk, being higher the total score in 
cases with the proximal location of cancer than for those with the distal location. These 
last results contrast with previous findings, which showed that the protective effects of 
adherence to the MD were mainly for distal colon and rectal cancer and not for proximal 
colon cancer[64]. In the total sample, investigation of the separate score components 
showed that whole grain score was lower for cases than for controls. This result is 
consistent with that obtained for the association between whole grains consumption and 
CRC risk.  
Our study has several limitations. First, recall bias inherent in a case-control study design 
cannot be ruled out. The primary concern of this study is the low participation rate, which 
may have limited the representativeness of study samples. The decision to participate 
or not may be influenced by several factors, including social, educational and health 
conditions, which may again correlate with outcome risk factors. Second, self-reported 
data could be subject to measurement errors and the problem of food omissions due to 
memory failure and underreporting of unhealthy habits among disease subjects. 
However, previous validation studies indicate that the self-reported dietary information is 
reported with sufficient accuracy for use in epidemiology analyses[65]; and it should be 
noted that dietary changes are usually modest after participating in the CRCSP due to a 
lack of information and personalized advice[66,67]. Another limitation of this type of study 
could be the selection of controls (selection bias). To avoid this type of bias, we obtained 
controls from the same CRCSP and in the same period as cases, thus, it was confirmed 
that they did not suffer from CRC by colonoscopy. 
Despite these limitations, the results allow us to conclude that high consumption of high-
fat cheeses is associated with CRC risk, whereas, a high intake of fiber-containing foods, 
especially whole grains, and fatty fish, and adherence to the Mediterranean dietary 
pattern was associated with a lower risk for CRC. Future studies are needed to better 
understand the influence of the dietary habits on CRC prevention in this population that 
can provide leads for the design and tailoring of future interventions, and guide 
counselling strategies for promoting a healthy lifestyle. 
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Epidemiological evidence suggests that some foods may both protect against and 
promote the development of colorectal cancer (CRC). However, foods are not consumed 
in isolation but as part of a dietary pattern; therefore, the actual effect of diet on disease 
risk may be observed only when all components are considered jointly. For this purpose, 
several diet quality indexes have been developed using point systems to measure whole 
diet quality based on the alignment of food choices with dietary recommendations.  
Research motivation  
Some diet quality indexes have been used to begin assessing the relationships between 
overall diet quality and CRC risk, and the results show that high scores in these indices 
are associated with a lower CRC risk. However, the results vary considerably according 
to the index used and other factors such as sex and age. Therefore, there is a need to 
further examine these relationships in diverse population studies.  
Research objectives 
To study the relationships between food groups, diet quality and CRC risk, in an adult 
population of the Basque Country (North of Spain). 
Research methods 
This observational study included 308 patients diagnosed with CRC and 308 age- and 
sex-matched subjects as controls. During recruitment, dietary, anthropometric, lifestyle, 
socioeconomic, demographic and health status information was collected. Dietary intake 
was assessed using a short food frequency questionnaire that was adapted and 
validated for this population. Adherence to the dietary recommendations was evaluated 
utilizing the Healthy Eating Index for the Spanish Diet and the MedDietScore. Statistical 
analyses were performed using SPSS 22.0 (SPSS Inc, Chicago, USA) and STATA 13.0 
(StataCorp LP, Texas, USA). Conditional logistic regressions were used to evaluate the 








The adjusted models for potential confounding factors showed a direct association 
between milk/dairy products consumption, in particular high-fat cheeses (OR third tertile 
vs first tertile=1.87, 95% CI 1.11-3.16), and CRC risk. While the consumption of fiber-
containing foods, especially whole grains (OR third tertile vs first tertile=0.62, 95% CI 
0.39-0.98), and fatty fish (OR=0.53, 95% CI 0.27-0.99) was associated with a lower risk 
for CRC. Moreover, higher MD adherence was associated with a reduced CRC risk in 
adjusted models (OR=0.40, 95% CI 0.20-0.80).  
Research conclusions 
Direct associations were found for high-fat cheese, whereas an inverse relation was 
reported for fiber-containing foods and fatty fish, as well as adherence to a 
Mediterranean dietary pattern. 
Research perspectives 
Future studies are needed to better understand the influence of the dietary habits on 
CRC prevention in this population that can provide leads for the design and tailoring of 
future interventions, and guide counselling strategies for promoting a healthy lifestyle. 
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Abstract 
Given the significant population diversity in genetic variation, we aimed to investigate 
whether single nucleotide polymorphisms (SNPs) previously identified in studies of 
colorectal cancer (CRC) susceptibility were also relevant to the population of the Basque 
Country (North of Spain). We genotyped 230 CRC cases and 230 healthy controls for 48 
previously reported CRC-susceptibility SNPs. Only the rs6687758 in DUPS10 exhibited 
a statistically significant association with CRC risk based on the crude analysis. The 
rs6687758 AG genotype conferred about 2.13-fold increased risk for CRC compared to 
the AA genotype. Moreover, we found significant associations in cases between smoking 
status, physical activity, and the rs6687758 SNP. The results of a Genetic Risk Score 
(GRS) showed that the risk alleles were more frequent in cases than controls and the 
score was associated with CRC in crude analysis. In conclusion, we have confirmed a 
CRC susceptibility locus and the existence of associations between modifiable factors 
and the rs6687758 SNP; moreover, the GRS was associated with CRC. However, further 
experimental validations are needed to establish the role of this SNP, the function of the 
gene identified, as well as the contribution of the interaction between environmental 
factors and this locus to the risk of CRC. 
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Colorectal cancer (CRC)is the fourth most common type of tumour, being 6.1% of the 
total new cases of cancer diagnosed in 2018and one of the major causes of cancer-
related morbidity and mortality globally(9.2% of cancer deaths) [1].There is wide 
geographical variation in incidence with rates varying 8-fold (colon cancer) and 6-fold 
(rectal cancer) in both sexes worldwide [1].In this sense, Spain is one of the countries 
with the highest incidence of CRC, and taking into account both sexes, it was the most 
frequent cancer diagnosed in 2018 with 13.7% of new cancer cases [2] and is the main 
cause of cancer related deaths [3]. Considering the magnitude of the problem, the use 
of screening tests for early detection and effective treatment of CRC during the initial 
stages would have a significant impact on public health. In this sense, US Preventive 
Services Task Force and the American Cancer Society recommend the screening for 
CRC by annual faecal occult blood testing (FOBT), flexible sigmoidoscopy or (every 5 
years) or colonoscopy (every 10 years), in subjects aged 50 years or older [4]. 
The mechanisms underlying CRC occurrence and progression are complicated and 
mainly involve genetic and environmental factors, such as sex [5,6], diet and physical 
activity [5,7].Various oncogenes and tumour suppressors, such as KRAS, APC, BRAF, 
TP53, and SMAD4, have been identified by CRC-related studies and may be useful for 
diagnosing and treating CRC in the future [5,8,9]. There is a direct association between 
sporadic tumour occurrence and susceptibility variants carried by an individual [10]. 
Many candidate gene [11] and genome-wide association studies (GWAS) [12] have 
evaluated common genetic risk factors for CRC; however, only a few of these have been 
replicated in subsequent studies [10].Thus, in this study, we aimed to test the hypothesis 
that some of the previously reported CRC-related SNPs are associated with CRC 
susceptibility in the Basque population, in which there are no previous studies of this 
kind. Therefore, we investigated possible associations between 48 susceptibility SNPs 
and development of sporadic CRC in the adult population of the Basque Country.   
Methods 
Design 
This is an observational, matched case-control study in a population group residing in 
the Basque Country (Spain). 
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Participants in this study were recruited among patients attending, between January 
2012 and December 2014, any of the three hospitals of the Osakidetza/Basque Health 
Service (Basurto, Galdakao and Donostia)belong of the Basque Country Colorectal 
Cancer Screening Programme (CRCSP) [13].To be eligible for this CRCSP, average risk 
people from 50 to 69 years, asymptomatic for colorectal symptoms and registered with 
the Osakidetza/Basque Health Service [13]. Subjects with symptoms suggesting CRC 
or with high CRC risk, such as individuals with familial adenomatous polyposis or 
hereditary nonpolyposis are managed outside this programme and are not included in 
this analysis. Subjects were invited to participate in this study by the gastroenterologists 
who performed the colonoscopies as a confirmatory test. 
The recruitment and data collection for the present study were conducted between 2014 
and 2016. All the patients who were newly diagnosed with CRC (n=601) were invited to 
participate in this study, that is, the individuals with a positive result, (abnormal) to an 
immunochemical faecal occult blood test (iFOBT), being the faecal-Haemoglobin cut-off 
point of 20 µg Hb/g faeces for both sexes [13] and a colonoscopy [13]. Of those, 283 
refused to participate in the study, and 10 were excluded due to missing information. 
Ultimately, 308 subjects (66.2% men) consented to participate in the survey and 
completed all the questionnaires. 
In addition, for each case, three age- (9.0 years) and sex-matched control patients were 
randomly sought from the list of CRC-free subjects (n=1,836) who participated in the 
CRCSP during the same period as the cases. The matched controls were patients with 
positive results (abnormal) for iFOBT and negative colonoscopy results (normal). The 
participation rate of the controls was 37.6%, and 17 subjects were excluded due to 
missing information. Finally, the matched case-to-control ratio was 1:1, and the final 
dataset included 308 cases who were diagnosed with CRC and 308 age- and sex-
matched controls. The flowchart displaying the selection process for the CRC cases and 
controls is shown in Fig 1. Thirty-three cases, 39 controls and 6 cases-controls initially 
included in this study were excluded from the genetic analysis because incomplete 
genotyping by insufficient DNA available for the assay, and the respective partners of 
cases and controls were also excluded of the study. Finally, genotyping data were 
obtained from 230 cases and 230 controls. 
  
140




Fig 1. Flow chart of the process of obtaining the sample. CCR, Colorectal cancer. 
The time spent between the participation in the CRCSP and in the present study was 
1.8(1.0) years (range: 0.4-4.6) in cases and 1.6(1.5) years (range: 0.2-3.7) in controls, 
without significant differences (P=0.119). Consenting participants self-completed and 
returned a detailed Food Frequency Questionnaire (FFQ) and one general questionnaire 
(GQ). The questions referred to the behaviours before participating in the CRCSP. 
Assistance from the study staff was available to help the patients to understand the items 
on the questionnaires. 
This study was conducted according to the guidelines laid down in the Declaration of 
Helsinki, and all procedures involving patients were approved by the Clinical Research 
Ethics Committee of the Basque Country (reference numbers PI2011006 and 
PI2014042). Written informed consent was obtained from all the study participants. 
Biological Samples and Genotyping 
In this study, healthy tissues or saliva samples of 230 CRC patients and 230 controls 
were collected and genotyped. Samples were provided by the Basque Biobank for 
Research-OEHUN www.biobancovasco.org and were processed following standard 
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operating procedures with appropriate ethical approval. DNA was extracted using 
AllPrep DNA / RNA kit (Qiagen) for paraffin-embedded tissue samples and AutoGenFlex 
Tissue DNA Extraction kit (Autogen) for mouthwash saliva samples and then was 
quantified with NanoDrop™ Spectrophotometer (ThermoFisher).  
Double-stranded DNA was quantified by fluorometry using theQuant-iT™ PicoGreen® 
dsDNA Assay Kit (Invitrogen, CA) on a DTX 880 Multimode Detector (Beckman Coulter) 
to normalize DNA concentration.After an updated summary of the published SNPs 
associated with susceptibility for development of CRC [14,15], those shown in Table 1 
were selected. These SNPs were organized in the context of the gene(s) at or near locus 
and chromosome locus. The allelic discrimination was assessed using the 
MassARRAY® System (Agena Bioscience) on CeGen-PRB2-ISCII (Nodo USC) 
following the procedure provided by the manufacturer. Quality control samples were 
included in the genotyping assays. 
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Table 1. 48 SNPs associated with susceptibility for the development of CRC and analyzed in this study. 













rs12080929  TRABD2B, intron variant  1p33 0.87 C [61] rs1535 
 
FADS2, intron variant, 
FADS1, upstream gene 
variant 
11q12.2 1.15 A [69] 
 
rs6687758  DUSP10,  
regulatory region variant 
1q41 1.04 G [62] rs3802842 
 
COLCA1, upstream gene 
variant, COLCA2, intron 
variant 














1.14 T [70] 
rs10911251  LAMC1, intron variant  1q25.3 1.11 A [62] rs3217810e 
 





1.19 T [62] 
rs11903757  NABP1/SDPR,  
Intergenic variant 
2q.32.3 1.14 C [62] rs3217901 
 





rs10936599  MYNN,  
upstream gene variant 
3q26.2 1.02 C [62] rs10774214 
 
CCND2, intron variant, 









Intron variant, non coding 
transcript variant 








1.10 T [62] 
rs2736100  TERT, 3 prime UTR variant  5p15.33 1.07 A [63] rs11169552 
 
LARP4/DIP2B, ATF1, 
upstream gene variant 
12q13.1
2 
1.05 C [62] 
rs1321311  SRSF3/CDKN1A,  
regulatory region variant 
6p21.2 1.07 A [62] rs59336 
 




1.15 T [62] 
rs11987193  DUSP4, intergenic variant  8p12 0.79 T [61] rs4444235 BMP4/ATP5C1P1/CDKN
3/MIR5580, downstream 
gene variant 
14q22.2 1.11 C [73] 
To be continued in the next page. 
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downstream gene variant 
8q23.3 1.25 C [63] rs1957636 
 
LOC105370507, 
regulatory region variant 




CCAT2, intron variant, non 
coding transcript variant,  
CCAT2, non coding 
transcript exon variant 
8q24.21 1.15 G [63] rs4779584 
 
 
SCG5, GREM1, FMN1, 
intergenic variant 
 
15q13.3 1.18 T [70] 
rs10505477 
  
CASC8, intron variant, non 
coding transcript variant 
8q24.21 1.11 A [64] rs16969681 
 
 




15q13.3 1.18 T [75] 
rs7014346 
  
CASC8, intron variant, non 
coding transcript variant, 
POU5F1B, intron variant 








15q13.3 1.12 A [76] 
rs719725 TPD52L3/UHRF2/GLDC,  
intergenic variant 
9p24.1 1.08 A [61] rs9929218 
 
CDH1, intron variant 
 
16q22.1 1.10 A [75] 
rs10795668  LOC105376400,  
upstream gene variant 
10p14 1.32 A [66] rs12603526 
 
NXN, intron variant 
 
17p13.3 1.10 C [69] 
rs704017 
  
ZMIZ1-AS1, intron variant, 
non coding transcript variant 
10q22.3 1.13 G [67] rs4939827 
 
 
SMAD7, intron variant 
 
 
18q21.1 1.16 T [77] 
rs1035209  ABCC2/MRP2, intergenic 
variant 
10q24.2 1.13 T [68] rs10411210 
 




1.15 C [73] 
rs12241008 
  
VTI1A, intron variant 
  
10q25.2 1.19 C [38] rs1800469 
 
TGFB1, upstream gene 
variant 
B9D2, downstream gene 
variant,  
TMEM91, intron variant 






Continuation of Table 1. 
To be continued in the next page. 
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TCF7L2, intron variant 
 
10q25.2 1.14 A [69] rs2241714 
 
TGFB1, TMEM91, 
upstream gene variant, 
B9D2, missense variant 
19q13.2 1.09 C [70] 
rs1665650  HSPA12A, intron variant  10.q25.
3 
0.95 T [64] rs961253 BMP2/HAO1/FERMT1, 
upstream gene variant 




gene variant, MYRF, intron 
variant 
11q12.2 1.16 G [64] rs4813802 BMP2/HAO1/FERMT1, 
regulatory region variant 
 
20p12.3 1.10 C [70] 
rs4246215  TNEM258, upstream gene 
variant 
FEN1, 3 prime UTR variant, 
FADS1,  
downstream gene variant, 
MIR611, upstream gene 
variant, FADS2, intron 
variant 





downstream gene variant 
20p12.3 1.10 C [72] 





gene variant,  
GPR143, intron variant 
Xp22.2 1.04 C [31] 
Chr, Chromosome; OR, odds ratio; SNP, single nucleotide polymorphism 
aOdds ratios of previous studies are reported to calculate weighted Genetic Score 
b Superscript numbers correspond with the studies in References 
 
Continuation of Table 1. 
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The questionnaire mentioned above, the GQ was used to gather information on weight 
status (self-reported weight and height) and environmental factors (demographic factors: 
age and sex; and lifestyle information: physical activity (PA) and smoking consumption). 
These questions were taken from the Spanish Health Questionnaire [16]. Body mass 
index (BMI), estimated from self-reported height and weight was classified according to 
the WHO criteria for those under 65 years of age [17] and according to the criteria 
proposed by Silva Rodríguez et al. for those 65 years and older [18]. 
Diet was assessed using a short FFQ that is a modified version of the Rodríguez et al. 
questionnaire [19]. This adaptation was validated with multiple 24- recalls in a subsample 
of the participants [20]. It consists of 67 items and requires the subjects to recall the 
number of times each food item was consumed either per week or per month. The 
respondents might also record the consumption of other foods that were not included on 
the food list.  
Average portion sizes were employed to convert FFQ consumptions [21]. For items that 
included several foods, each food’s contribution was estimated with weighting 
coefficients that were obtained from the usual consumption data [22]. All the food items 
that were consumed were entered into DIAL 2.12 (2011ALCE INGENIERIA), a type of 
dietary assessment software, to estimate energy intake (kcal/d).Moreover, the FFQ 
included specific questions about their frequency of intake of five major types of alcohol 
beverages: beer, wine, cider, aperitif with alcohol and liquor. In terms of the amount 
consumed, 10 g of alcohol was considered a standard drink [23]. Participants were 
categorized into non-drinker/moderate consumption and risk consumption, according to 
the SENC criteria that consider moderate drinking is up to 1 standard drink per day for 
women and up to 2 standard drinks per day for men [23]. Alcohol consumption was also 
expressed in tertiles of ml per day according to sex (men: T1, ≤ 70.6; T2, 70.7-138.8; T3, 
≥ 138.9; and women: T1 ≤ 5.8; T2, 5.9-69.8; T3, ≥ 69.9). 
Additionally, socioeconomic data was assessed with an index that was obtained from 
the clinical databases developed by the Health Department of the Basque Government, 
namely the socioeconomic deprivation index (DI). This index was estimated using the 
MEDEA project criteria [24] from simple indicators in the 2001 Census, namely 
unemployment, manual workers, casual workers, low education level and low education 
level among young people. The DI was divided into quintiles (Q), with the first being the 
least disadvantaged and the fifth being the most disadvantaged. The DI was successfully 
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assigned to 82.4% of participants, while the address information quality did not permit 
the linking of the remaining 17.6%. 
Quality management 
In the present research, we apply a similar quality management that those used in the 
IDEFICS study [25]. A unique subject identification number was attached to each 
recording sheet, questionnaire, and sample, as in other researches. The identification 
number had to be entered twice before the document could be entered into its respective 
database. All data were entered twice independently, and deviating entries were 
corrected. Inconsistencies that were identified by additional plausibility checks were 
rectified.  
Statistical analysis 
Statistical analyses were performed using SPSS 22.0 (SPSS Inc, Chicago, USA), 
STATA 13.0 (StataCorp LP, Texas, USA). Categorical variables are shown as a 
percentage, and continuous variables are shown as the means and standard deviations 
(s.d.). Normality was checked using Kolmogorov-Smirnov-Lilliefors test. Paired t-test or 
Wilcoxon rank-sum test was used to two related means comparison, and a χ2 test was 
used to evaluate differences. Tests for association and deviation from Hardy-Weinberg 
equilibrium were performed separately in CRC patients and healthy controls. When 
expected frequencies were lesser than 5, Fisher’s exact test was used. 
In the case-control study, we estimated the odds ratio (OR) and 95% confidence interval 
(95% CI) for the polymorphism selected using conditional logistic regression adjusted for 
age (50-59 years old vs. 60-69 years old),sex(women vs. men), BMI 
(underweight/normal weight vs. overweight/obesity), physical activity (≥15 min/d vs.<15 
min/d), smoking status (never smoker vs. current and former smoker and quit smoking: 
≥ 11 years ago vs.< 11 years ago), alcohol consumption (T1, T2 and T3) and Deprivation 
Index (DI) (quintile 1-3 vs. quintile 4-5) as categorical variables and energy intake as 
quantitative (kcal/d).ORs were calculated for the codominant model, dominant model, 
recessive model, and allelic comparison. The most frequent genotype (homozygous) 
was considered the reference group to calculate ORs in a codominant and dominant 
model, and the most frequent genotype (homozygous) and the heterozygous genotype 
containing the risk allele were considered the reference group in the recessive model. 
The significance level was corrected using a Bonferroni correction by dividing the 
standard P value (two-tailed) (0.05) by the total number of SNPs analyzed (n=48), 
assuming alpha was equal to 0.001 (α=0.05/48). 
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Additionally, correspondence analysis (CA) was performed using PAST 3.21 to identify 
potential associations between SNPs associated with CRC and associated data.CA is a 
multivariate statistical technique which provides Cartesian diagrams based on the 
association of the variables examined. All variables were represented in graphs and the 
more closed are the points the more higher is the level of association between variables 
[26]. 
To assess genetic susceptibility, two methods were used as a simple, unweighted count 
method (count Genetic Risk Scores, c-GRS) and a weighted method (w-GRS) [27,28]. 
Both methods assumed each SNP to be independently associated with risk [29]. An 
additive genetic model was assumed: weightings of 0, 1, and 2 were given according to 
the number of risk alleles present [29,30]. 
The count method assumed that each SNP contributed equally to CRC risk and was 
calculated by summing the number of risk alleles across the panel of SNPs tested. This 
produced a score between 0 and twice the number of SNPs, i.e., representing the total 
number of risk alleles. The weighted GRS was calculated by multiplying each β-
coefficient for the CRC phenotype from the discovery set by the number of corresponding 
risk alleles (0, 1, or 2 copies of the risk allele except for the SNP rs5934683 in 
chromosome X that was coded 0, 0.5, and 1) and then summing the products [31]. 
Finally, we defined the GRS as the count of risk alleles across all 48 SNPs, ranging from 
0 to 95 for c-GRS and 0 to 105 for w-GRS. Since the published effects of each SNP were 
similar, an unweighted GRS was preferred. However, we also explored the models using 
weights derived from the GWAS publications and models fitted to our data [32]. 
Gene expression association analyses 
Gene expression changes in tumour and normal colon tissue associated to SNPs with 
significant association with CRC risk were analyzed using publicly available data and 
bioinformatic tools. In the first place Genomic Data Commons Data Portal (GDC) 
(https://portal.gdc.cancer.gov) was used to examine data generated by the TCGA (The 
Cancer Genome Atlas) research network (https://www.cancer.gov/tcga), but for SNPs 
with unavailable data in GDC portal alternative bioinformatic tools were applied. On the 
one hand, gene expression data from between case and control samples of colon and 
rectum adenocarcinomas were compared using GEPIA (Gene Expression Profiling 
Interactive Analysis ) (http://gepia.cancer-pku.cn/index.html) [33] . On the other hand, 
GTEx (The Genotype-Tissue expression project) (https://gtexportal.org/home/) was used 
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to check the relationship between SNPs and the expression level of genes related to 
these SNPs in colon tissue of healthy donors.   
Results 
Table 2 shows the comparisons of associated data between cases and controls. Cases 
had a higher consumption of cigarettes/day and were more engaged in regular physical 
activity at a medium-high level as compared with controls. In addition, in the total sample, 
there were more smokers in men than in women (70.6% vs. 54.5%; P<0.001); and had 
a higher consumption of cigarettes/day (11.6(11.1) vs. 9.0(11.4); P=0.030). Among 
controls 51.9% of women and 65.4% of men were smokers (P=0.049); and among cases, 
57.1% of women and 75.8% of men were smokers (P=0.004). 
The distribution of genotypes and alleles at SNPs selected in the CRC group and in the 
control group that deviated from the Hardy-Weinberg equilibrium are shown in 
Supplementary Material(S1 Table).The SNPs that were not following the Hardy-
Weinberg equilibrium in cases were rs12080929 and rs5934683.None of the genotype 
or allele frequencies for the SNPs analysed reached statistically significant differences 
between cases and controls, after Bonferroni correction application. 
Table 3 presents some results of the association of susceptibility genotypes and alleles 
with the risk of CRC in the codominant model. Other SNPs analyzed in this study are 
shown in Supplementary Material (S2 Table). Adjusting for potential confounders did not 
appreciably alter the observed ORs. Only the rs6687758 exhibited a statistically 
significant association with CRC risk based on the crude analysis. The AG genotype of 
rs6687758 conferred about 2.13-fold increased risk for CRC compared to the AA 
genotype. 








Age, years, mean(s.d.) 61.5(5.4) 60.9(5.5) 0.333 
BMI classification, %    
NonOv/Ob 42.2 33.0  
Ov/Ob 57.8 67.0 0.043 
Physical activity level, %    
Low 65.7 77.4  
Medium and high 34.3 22.6 0.005 
To be continued in the next page. 
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Smoking status, %b    
Non-smoker 30.4 39.1  
Smoker 69.6 60.9 0.050 
Cigarettes, cigarettes/day, mean(s.d.) 10.7(11.2) 8.3(10.9) 0.007 
Number of cigarettes, %b    
< 15  49.3 66.9  
≥ 15  50.7 33.1 0.003 
Alcoholic beverage intake, ml/day, mean(s.d.) 98.0(91.5) 97.2(107.5) 0.637 
Tertiles of alcohol intake, ml/dayc, %    
T1 32.6 33.9  
T2 31.3 35.7  
T3 36.1 30.4 0.404 
Standard drink units, classification, %     
Abstemious /low risk 72.1 79.1  
High risk 27.9 20.9 0.078 
DI, %b    
Q1-Q3 73.5 69.6  
Q4-Q5 26.5 30.4 0.409 
BMI, body mass index; DI, deprivation index; Ob, obesity; Ov, overweight, Q, quintile; 
s.d. standard deviation 
aP<0.05 wassignificant 
bValid percentages 
cMen: T1, ≤ 70.6; T2, 70.7-138.8; T3, ≥ 138.9; and women: T1 ≤ 5.8; T2, 5.9-69.8; T3, ≥ 
69.9 
 
Table 3. Association between genetic variants associated with susceptibility and 





Model Ib Model IIc 
OR (95% CI) Pd-
value 
OR (95% CI) Pd-
value 
rs6687758      
AA 136/169 1.00 - 1.00 - 
AG 87/51 2.13(1.39-3.25) <0.001 1.95(1.05-3.60) 0.034 
GG 7/9 1.02(0.37-2.82) 0.967 1.06(0.21-5.28) 0.945 
A 359/389 1.00 - 1.00 - 
G 101/69 1.60(1.13-2.28) 0.009 1.54(0.97-2.46) 0.067 
rs6691170      
GG 72/87 1.00 - 1.00 - 
To be continued in the next page. 
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A, adenine; C, cytosine; CI, confidence interval; G, guanine; OR, odds ratio; rs, reference 
single nucleotide polymorphism; SNP, single nucleotide polymorphism; T, thymine 
aThe most frequent genotype (homozygous) was considered the reference group 
bModel I, crude conditional logistic regression model 
cModel II, conditional logistic regression adjusted forage, sex, BMI, physical activity, 





Model Ib Model IIc 




GT 112/108 1.22(0.82-1.82) 0.331 1.20(0.64-2.26) 0.570 
TT 45/31 1.79(1.01-3.16) 0.045 1.70(0.74-3.89) 0.207 
G 256/282 1.00 - 1.00 - 
T 202/170 1.23(0.94-1.62) 0.124 1.27(0.89-1.79) 0.185 
rs719725      
AA 63/91 1.00 - 1.00 - 
AC 116/106 1.46(0.97-2.18) 0.068 1.99(1.07-3.71) 0.030 
CC 51/31 2.14(1.27-3.64) 0.005 1.80(0.78-4.17) 0.168 
A 242/288 1.00 - 1.00 - 
C 218/168 1.60(1.22-2.11) <0.001 1.49(1.05-2.10) 0.025 
rs12241008      
TT 196/204 1.00 - 1.00 - 
CT 33/24 1.47(0.82-2.64) 0.192 1.49(0.75-2.95) 0.253 
CC ½ 0.50(0.05-5.51) 0.571 0.78(0.05-12.84) 0.862 
T 425/435 1.00 - 1.00 - 
C 35/28 1.22(0.72-2.09) 0.455 1.34(0.66-2.72) 0.412 
rs7136702      
CC 80/91 1.00 - 1.00 - 
CT 108/114 1.11(0.75-1.65) 0.593 1.03(0.56-1.89) 0.826 
TT 42/25 1.98(1.09-3.64) 0.026 2.83(1.12-7.17) 0.028 
C 268/296 1.00 - 1.00 - 
T 192/164 1.34(1.03-1.74) 0.030 1.28(0.91-1.80) 0.154 
rs2241714      
CC 116/101 1.00 - 1.00 - 
CT 94/105 0.79(0.55-1.15) 0.217 0.54(0.31-0.95) 0.034 
TT 20/23 0.72(0.37-1.38) 0.321 0.28(0.09-0.89) 0.031 
C 326/307 1.00 - 1.00 - 
T 134/151 0.80(0.61-1.06) 0.125 0.74(0.51-1.07) 0.114 
rs961253      
CC 101/124 1.00 - 1.00 - 
AC 103/76 1.65(1.11-2.46) 0.013 1.79(0.67-4.78) 0.247 
AA 26/30 1.03(0.57-1.85) 0.925 1.04(0.41-2.63) 0.941 
C 305/324 1.00 - 1.00 - 
A 155/136 1.20(0.90-1.59) 0.208 1.11(0.76-1.62) 0.584 
Continuation of Table 3. 
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with missing data for the confounding variables were included as a separate category for 
these variables 
dP<0.001 was significant 
 
Moreover, there was an association between smoking status, physical activity and the 
rs6687758 SNP for CRC risk in cases (Fig 2).We did not find an association between 
the risk genotype for rs6687758 and other associated variables (BMI, sex, alcohol 
consumption, DI and age).The results of CA for all cases are shown in a Cartesian 
diagram. The first three axes accounted for more than 50.0% of the total variance in all 
cases (axis 1: 23.0%; axis 2: 19.6% and axis 3: 13.4%).An inverse association can be 
observed between the variable DI (which plotted at the negative end of axis 1) and age, 
positioned in the positive segment of axis 1. Overall, axis 1 represents a gradient that 
runs from low values for DI (0: Q1-Q3; 1: Q4-Q5) to high values for age (0:50-59 y; 1:60-
69 y).From the genetic viewpoint, the SNP that showed the closest association with 
associated variables wasrs6687758, which also plotted in the quadrant delimited by the 
positive segments of axis 1 and 2.  
 
Fig 2. Cartesian diagram of correspondence analysis for studied associations 
between genetic and environmental factors in cases. BMI, body mass index; DI, 
deprivation index; PA, physical activity. 
Analyses performed to study possible changes in gene expression associated with 
rs6687758 in tumour versus normal colon tissue showed that gene DUSP10 is more 
expressed in colon sigmoid tissue when rs6687758 has GG genotype (in healthy 
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individuals) (S1 Fig), but also, that it has higher expression in cases of colon and rectum 
adenocarcinomas than in healthy persons (S2 Fig). 
For SNP rs719725,an increased CRC risk was found to be associated with the CC 
genotype in dominant and recessive models for crude analysis, compared with the AA 
and AC genotype (ORCC: 1.77; 95% CI=1.09-2.86; P=0.020 in recessive model and 
ORAC+CC: 1.64; 95% CI = 1.12-2.38; P=0.010 in dominant model). Moreover, significantly 
elevated CRC risk was found to be associated with rs2736100, rs11987193and 
rs961253by using dominant model (for rs2736100 ORAA+AC:1.72; 95%CI = 1.00-2.94; 
P=0.048 in adjusted model; for rs11987193 ORCC+CT: 1.45; 95%CI = 1.01-2.49; P=0.046 
in crude analysis; and for rs961253 ORAA+AC: 1.47; 95%CI = 1.02-2.11; P=0.038 in crude 
analysis). 
Finally, the unweighted GRS of the sample studied was 38.6(4.6) (range: 25-52), with 
statistically significant differences between cases and controls (39.2(4.4) (range: 28-
50.5) vs. 37.95(4.6) (range: 25-52); P=0.002). The GRS built as the unweighted count of 
risk alleles was significantly associated with CRC risk, with an average per-allele OR of 
1.07 (95%CI=1.02-1.11; P=0.002) in crude analysis. However, this association was not 
statistically significant in the adjusted model (OR: 1.04; 95% CI=1.00-1.10; P=0.066).On 
the other hand, w-GRS was 44.7(5.5) for the total sample, with statistically significant 
differences between cases and controls (45.3(5.4) (range: 32.2-58.6)vs.44.1(5.6) (range: 
27.7-57.6); P=0.036).The w-GRS was associated with CRC risk (OR: 1.04; 95% 




S1 Table. Deviation from Hardy-Weinberg equilibrium and differences in allele 


















rs12080929 TT 123(53.5)  132(57.4)   
 CT 8938.7)  83(36.1)   
 CC 18(7.8) <0.001 15(6.5) 0.690 0.670 
 T 335(72.8)  347(75.4)   
 C 125(27.2) - 113(24.6) - 0.653 
rs6687758 AA 136(59.1)  169(73.8)   
 AG 887(37.8)  51(23.3)   
 GG 7(3.0) 0.116 9(3.9) 0.050 0.001 
 A 359(78.0)  389(84.6)   
 G 101(22.0) - 69(15.4) - 0.016 
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rs6691170 GG 72(31.4)  87(38.5)   
 GT 112(48.9)  108(47.8)   
 TT 45(19.7) 0.903 31(13.7) 0.784 0.132 
 G 256(55.7)  282(61.3)   
 T 202(44.3) - 170(38.7) - 0.150 
rs10911251 AA 87(37.8)  74(32.3)   
 AC 110(47.8)  107(46.7)   
 CC 33(14.3) 0.852 48(21.0) 0.420 0.145 
 A 284(61.7)  255(55.4)   
 C 176(38.3) - 203(44.6) - 0.066 
rs11903757 TT 150(65.2)  168(73.4)   
 CT 74(32.2)  57(24.9)   
 CC 6(2.6) 0.376 4(1.7) 0.934 0.170 
 T 374(81.3)  393(85.4)   
 C 86(18.7) - 65(14.6) - 0.044 
rs10936599 CC 150(65.2)  135(58.7)   
 CT 74(32.2)  81(35.2)   
 TT 6(2.6) 0.376 14(6.1) 0.692 0.116 
 C 374(81.3)  351(76.3)   
 T 86(18.7) - 109(23.7) - 0.053 
rs647161 AA 101(44.9)  104(45.6)   
 AC 95(42.2)  105(46.1)   
 CC 29(12.9) 0.374 19(8.3) 0.292 0.273 
 A 297(64.6)  313(68.0)   
 C 153(35.4) - 143(32.0) - 0.359 
rs2736100 CC 61(26.6)  69(30.0)   
 AC 121(52.8)  119(51.7)   
 AA 47(20.5) 0.358 42(18.3) 0.455 0.674 
 C 243(52.8)  257(55.9)   
 A 215(47.2) - 203 (44.1) - 0.235 
rs1321311 CC 116(50.9)  129 (56.3)   
 AC 102(44.7)  88 (38.4)   
 AA 10(4.4) 0.033 12 (5.2) 0.544 0.384 
 C 334(72.6)  346 (75.2)   
 A 122(27.4) - 112 (24.8) - 0.086 
rs11987193 CC 105(45.7)  127 (55.2)   
 CT 110(47.8)  90 (39.1)   
 TT 15(6.5) 0.050 13 (5.7) 0.570 0.121 
 C 320(69.6)  344 (74.8)   
 T 140(30.4) - 116 (25.2) - 0.067 
rs16892766 AA 202(87.8)  209(90.9)   
 AC 27(11.7)  21(9.1)   
 CC 1(0.4) 1.000 0(0.0) 0.907 0.393 
 A 431(93.7)  439(95.4)   
 C 29(6.3) - 21(4.6) - 0.130 
rs6983267 GG 75(32.6)  64(27.8)   
 GT 115(50.0)  117(50.9)   
 TT 40(17.4) 0.719 49(21.3) 0.742 0.407 
 G 265(57.6)  245(53.3)   
 T 195(42.4) - 215(46.7) - 0.144 
Continuation of Supplementary Table S1. 
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rs10505477 AA 71(32.3)  64(30.9)   
 AG 110(50.0)  110(47.8)   
 GG 39(17.7) 0.667 53(23.0) 0.667 0.304 
 A 252(54.8)  238(51.7)   
 G 188(45.2) - 216(48.3) - 0.110 
rs7014346 GG 95(4.3)  108(47.2)   
 AG 107(46.5)  90(39.3)   
 AA 28(12.2) 0.800 31(13.5) 0.085 0.294 
 G 297(64.6)  306(66.5)   
 A 163(35.4) - 152(33.5) - 0.357 
rs719725 AA 63(27.4)  91(39.9)   
 AC 116(50.4)  106(46.5)   
 CC 51(22.2) 0.862 31(13.6) 0.988 0.005 
 A 242(52.6)  288(62.6)   
 C 218(47.4) - 168(37.4) - 0.002 
rs10795668 GG 110(47.8)  104(45.4)   
 AG 100(43.5)  104(45.4)   
 AA 20(8.7) 0.685 21(9.2) 0.490 0.874 
 G 320(69.6)  312(67.8)   
 A 140(30.4 - 146(32.2) - 0.222 
rs704017 AA 67(29.5)  63(27.4)   
 AG 116(51.1)  121(52.6)   
 GG 44(19.4) 0.623 46(20.0 0.772 0.881 
 A 250(54.3)  247(53.7)   
 G 204(45.7) - 213(46.3) - 0.632 
rs1035209 CC 146(63.8)  154(67.2)   
 CT 75(32.8)  61(26.5)   
 TT 8(3.5) 0.666 14(6.1) 0.024 0.193 
 C 367(79.8)  369(80.2)   
 T 91(20.2) - 89(19.8) - 0.870 
rs12241008 TT 196(85.2)  204(88.7)   
 CT 33(14.3)  24(10.4)   
 CC 1(0.4) 0.973 2(0.9) 0.419 0.442 
 T 425(92.4)  432(93.9)   
 C 35(7.6) - 28(6.1) - 0.430 
rs11196172 GG 174(76.0)  172(74.8)   
 AG 53(23.1)  49(21.3)   
 AA 2(0.9) 0.640 9(3.9) 0.092 0.099 
 G 401(87.2)  393(85.4)   
 A 57(12.8) - 67(14.6) - 0.257 
rs1665650 CC 139(60.4)  149(64.8)   
 CT 75(32.6)  73(31.7)   
 TT 16(7.0) 0.189 8(3.5) 0.797 0.219 
 C 353(76.7)  371(80.6)   
 T 107(23.3) - 89(19.4) - 0.230 
rs174537 GG 113(49.3)  102(44.5)   
 GT 98(42.8)  103(45.0)   
 TT 18(7.9) 0.609 24(10.5) 0.790 0.462 
 G 324(70.4)  307(66.7)   
 T 134(29.6) - 151(33.3) - 0.255 
To be continued in the next page. 
 
Continuation of Supplementary Table S1. 
155



















rs4246215 GG 113(49.1)  101(43.9)   
 GT 98(42.6)  105(45.7)   
 TT 19(8.3) 0.727 24(10.4) 0.668 0.473 
 G 324(70.5)  307(66.7)   
 T 136(29.5) - 153(33.3) - 0.238 
rs174550 TT 114(49.6)  101(43.9)   
 CT 97(42.2)  104(45.2)   
 CC 19(8.3) 0.818 25(10.9) 0.797 0.397 
 T 325(70.7)  306(66.5   
 C 135(29.3) - 154(33.5) - 0.121 
rs1535 AA 116(50.4)  96(41.7)   
 AG 93(40.4)  107(46.5)   
 GG 21(9.1) 0.705 27(11.7) 0.733 0.164 
 A 325(70.7)  299(65.0)   
 G 135(29.3) - 161(35.0) - 0.067 
rs3802842 AA 109(47.6)  107(46.5)   
 AC 99(43.2)  104(45.2)   
 CC 21(9.2) 0.827 19(8.3) 0.367 0.887 
 A 317(68.9)  318(69.1)   
 C 141(31.1) - 142(30.9) - 0.965 
rs10849432 TT 171(74.3)  174(75.7)   
 CT 57(24.8)  53(23.0)   
 CC 2(0.9) 0.495 3(1.3) 0.902 0.839 
 T 399(86.7)  401(87.2)   
 C 61(13.3) - 59(2.8) - 0.923 
rs3217810 CC 182(79.5)  191(83.4)   
 CT 45(19.7)  38(16.6)   
 TT 2(0.9) 0.909 0(0.0) 0.646 0.271 
 C 409(88.9)  420(91.3)   
 T 49(11.1) - 38(8.7) - 0.923 
rs3217901 AA 85(37.1)  90(39.5)   
 AG 111(48.5)  111(48.7)   
 GG 33(37.1) 0.738 27(11.8) 0.413 0.691 
 A 281(61.1)  291(63.3)   
 G 177(38.9) - 165(36.7) - 0.236 
rs10774214 CC 106(46.7)  109(47.4)   
 CT 101(44.5)  95(41.3)   
 TT 20(8.7) 0.557 26(11.3) 0.446 0.610 
 C 313(68.0)  313(68.0)   
 T 141(32.0) - 147(32.0) - 0.675 
rs7136702 CC 80(34.8)  91(39.6)   
 CT 108(46.9)  114(49.6)   
 TT 42(18.3) 0.601 25(10.8) 0.224 0.075 
 C 268(58.3)  296(64.3)   
 T 192(41.7) - 164(35.7) - 0.043 
rs11169552 CC 151(65.9)  128(56.9)   
 CT 71(31.0)  89(39.6)   
 TT 7(3.1) 0.698 8(3.6) 0.113 0.139 
 C 373(81.1)  345(75.0)   
 T 85(18.9) - 105(25.0) - 0.229 
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rs59336 AA 63(27.4)  58(25.2)   
 AT 110(47.8)  109(47.4)   
 TT 57(24.8) 0.516 63(27.4) 0.433 0.774 
 A 236(51.3)  225(48.9)   
 T 224(48.7) - 235(51.1) - 0.323 
rs4444235 CC 61(26.5)  69(30.0)   
 CT 118(51.3)  113(49.1)   
 TT 51(22.2) 0.671 48(20.9) 0.890 0.708 
 C 240(52.2)  251(54.6)   
 T 220(47.8) - 209(45.4) - 0.644 
rs1957636 CC 80(34.9)  97(42.2)   
 CT 109(47.6)  95(41.3)   
 TT 40(17.5) 0.784 38(16.5) 0.079 0.267 
 C 269(58.5)  289(62.8)   
 T 189(41.5) - 171(37.2) - 0.411 
rs4779584 CC 164(71.6)  166(72.2)   
 CT 60 26.2)  57(24.8)   
 TT 5(2.2) 0.858 7(3.0) 0.442 0.811 
 C 388(84.3)  389(84.6)   
 T 67(15.7) - 71(15.4) - 0.627 
rs16969681 CC 191(83.0)  180(78.3)   
 CT 37(16.1)  48(20.9)   
 TT 2(0.9) 1.000 2(0.9) 0.856 0.378 
 C 419(91.1)  408(88.7)   
 T 41(8.9) - 61(11.3) - 0.660 
rs11632715 GG 84(36.7)  84(36.8)   
 AG 108(47.2)  105(46.1)   
 AA 37(16.2) 0.817 39(17.1) 0.530 0.955 
 G 276(60.3)  273(59.9)   
 A 182(39.7)  183(40.1) - 0.808 
rs9929218 GG 111(48.5)  111(48.3)   
 AG 101(44.1)  100(43.5)   
 AA 17(7.4) 0.357 19(8.3) 0.593 0.945 
 G 323(70.2)  322 (70.0)   
 A 135(29.8) - 135 (30.0) - 1.000 
rs12603526 TT 228(99.1)  228(99.1)   
 CT 2(0.9)  2(0.9)   
 CC 0(0.0) 1.000 0(0.0) 1.000 1.000 
 T 458(99.6)  458(99.6)   
 C 2(0.4) - 2(0.4) - 1.000 
rs4939827 TT 66(28.8)  70(30.6)   
 CT 125(54.6)  112(48.9)   
 CC 38(16.6) 0.101 47(20.5) 0.857 0.410 
 T 257(55.9)  252(54.8)   
 C 201(44.1) - 206(45.2) - 0.232 
rs10411210 CC 180(78.6)  178(77.4)   
 CT 45(19.7)  51(22.2)   
 TT 4(1.7) 0.699 1(0.4) 0.362 0.336 
 C 405(88.0)  407(88.5)   
 T 53(12.0) - 53(12.5) - 0.743 
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rs1800469 GG 118(51.8)  104(45.4)   
 AG 91(39.9)  102(44.5)   
 AA 19(8.3) 0.806 23(10.0) 0.783 0.389 
 G 327(71.1)  310(67.4)   
 A 129(28.9) - 148(32.6) - 0.127 
rs2241714 CC 116(50.4)  101(44.1)   
 CT 94(40.9)  105(45.9)   
 TT 20(8.7) 0.877 23(10.0) 0.572 0.396 
 C 326(70.9)  307(66.7)   
 T 134(29.1) - 151(33.3) - 0.220 
rs961253 CC 101(43.9)  124(53.9)   
 AC 103(44.8)  76(33.0)   
 AA 26(11.3) 0.973 30(13.0) 0.002 0.035 
 C 305(66.3)  324(70.4)   
 A 155(33.7) - 136(29.6) - 0.157 
rs4813802 TT 113(49.3)  112(48.9)   
 GT 88(38.4)  94(41.0)   
 GG 28(12.2) 0.100 23(10.0) 0.618 0.707 
 T 314(68.3)  318(69.1)   
 G 144(31.7) - 140(30.9) - 0.775 
rs2423279 TT 94(40.9)  109(47.4)   
 CT 113(49.1)  101(43.9)   
 CC 23(10.0) 0.192 20(8.7) 0.618 0.370 
 T 301(65.4)  319(69.3)   
 C 159(34.6) - 141(30.7) - 0.325 
rs5934683 C 102(37.6)  116(32.2)   
 CT 41(17.9)  40(17.4)   
 T 86(44.5) <0.001 74(50.4) 0.001 0.405 
 C 245(53.3)  272(59.1)   
 T 213(46.7) - 188(41.9) - 0.127 
A, adenine; C, cytosine; G, guanine; HWE, Hardy-Weinberg equilibrium; rs, reference 
single nucleotide polymorphism; SNP, single nucleotide polymorphism; T, thymine. 
aValid percentages. 
 bP<0.001 was significant. 
 cDifferences in allele frequencies and genotype distribution between cases and controls. 
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S2 Table. Association between genetic variants associated with susceptibility and the 
risk of CRC in the codominant model. 
Gene, SNP 
IDa 
Model Ib Model IIc 
OR (95%CI) Pd-value OR (95%CI) Pd- 
value 
TRABD2B (Chr 1) 
rs12080929     
TT 1.00 - 1.00 - 
CT 1.15(0.78-1.68) 0.480 0.81(0.25-2.61) 0.721 
CC 1.30(0.62-2.76) 0.488 0.52(0.17-1.58) 0.249 
T 1.00 - 1.00 - 
C 1.14(0.84-1.55) 0.390 1.30(0086-1.97) 0.218 
LAMC1 (Chr 1) 
rs10911251     
AA 1.00 - 1.00 - 
AC 0.88(0.59-1.30) 0.525 0.77(0.41-1.45) 0.422 
CC 0.56(0.32-0.99) 0.046 0.40(0.16-0.98) 0.045 
A 1.00 - 1.00 - 
C 0.76(0.58-0.99) 0.043 0.71(0.51-0.99) 0.046 
NABP1/SDPR (Chr 2) 
rs11903757     
TT 1.00 - 1.00 - 
CT 1.42(0.95-2.14) 0.090 3.81(0.55-26.36) 0.175 
CC 1.67(0.47-5.99) 0.430 1.67(0.93-3.00) 0.087 
T 1.00 - 1.00 - 
C 1.47(1.03-2.10) 0.035 1.54(0.96-2.45) 0.073 
MYNN (Chr 3) 
rs10936599     
CC 1.00 - 1.00 - 
CT 0.84(0.57-1.22) 0.350 0.89(0.49-1.61) 0.692 
TT 0.40(0.15-1.06) 0.065 0.39(0.10-1.52) 0.175 
C 1.00 - 1.00 - 
T 0.75(0.55-1.04) 0.083 0.81(0.54-1.21) 0.302 
PITX1/H2AFY 
rs647161     
AA 1.00 - 1.00 - 
AC 0.97(0.66-1.44) 0.897 1.09(0.60-1.96) 0.784 
CC 1.70(0.87-3.37) 0.123 2.84(0.93-8.65) 0.066 
A 1.00 - 1.00 - 
C 1.13(0.86-1.50) 0.359 1.07(0.75-1.53) 0.705 
TERT (Chr 5) 
rs2736100     
CC 1.00 - 1.00 - 
AC 1.14(0.73-1.77) 0.562 2.83(1.13-4.83) 0.023 
AA 1.25(0.73-2.16) 0.420 1.87(0.81-4.34) 0.143 
C 1.00 - 1.00 - 
A 1.13(0.87-1.48) 0.348 1.13(0.81-1.59) 0.468 
SRSF3/CDKN1A (Chr 6) 
rs1321311     
CC 1.00 - 1.00 - 
AC 1.45(0.56-3.78) 0.439 1.19(0.25-3.79) 0.962 
AA 1.08(0.41-2.79) 0.881 0.97(0.65-2.20) 0.572 
C 1.00 - 1.00 - 
A 1.12(0.84-1.51) 0.439 1.23(0.84-1.80) 0..278 
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Model Ib Model IIc 
 OR (95%CI) Pd-value OR (95%CI) Pd-value 
DUSP4 (Chr 8) 
rs11987193     
CC 1.00  1.00 - 
CT 1.45(1.00-2.10) 0.050 1.15(0.67-1.99) 0.614 
TT 1.47(0.65-3.29) 0.353 1.35(0.39-4.63) 0.636 
C 1.00 - 1.00 - 
T 1.32(0.99-1.77) 0.057 1.13(0.78-1.64) 0.527 
TRPS1/EIF3H/UTP23 (Chr 8) 
rs16892766     
AA 1.00 - 1.00 - 
AC 1.33(0.72-2.46) 0.356 2.06(0.80-5.35) 0.136 
CC NA - NA - 
A 1.00 - 1.00 - 
C 1.65(0.90-3.05) 0.102 2.24(1.02-4.88) 0.043 
CCAT2 (Chr 8) 
rs6983267     
GG 1.00 - 1.00 - 
GT 0.83(0.53-1.29) 0.399 0.81(0.41-1.60) 0.546 
TT 0.69(0.41-1.19) 0.183 0.75(0.33-1.68) 0.483 
G 1.00 - 1.00 - 
T 0.82(0.63-1.06) 0.131 0.78(0.56-1.09) 0.145 
CASC8 (Chr 8) 
rs10505477     
AA 1.00 - 1.00 - 
AG 0.94(0.60-1.47) 0.794 0.98(0.50-1.95) 0.962 
GG 0.70(0.41-1.19) 0.184 0.71(0.32-1.57) 0.402 
A 1.00 - 1.00 - 
G 0.80(0.61-1.04) 0.089 0.78(0.56-1.09) 0.149 
rs7014346  -   
GG 1.00 0.986 1.00 - 
AG 1.30(0.90-1.89) 0.167 1.46(0.83-2.57) 0.188 
AA 0.99(0.55-1.79) - 1.56(0.62-3.96) 0.345 
G 1.00 0.374 1.00 - 
A 1.13(0.86-1.48)  1.23(0.87-1.73) 0.240 
KRT8P16/TCEB1P3 (Chr 10). 
rs10795668     
GG 1.00 - 1.00 - 
AG 1.11(0.76-1.61) 0.591 1.16(0.66-2.02) 0.611 
AA 1.12(0.56-2.26) 0.744 0.34(0.10-1.11) 0.074 
G 1.00 - 1.00 - 
A 1.09(0.82-1.44) 0.563 1.09(0.75-1.58) 0.655 
ZMIZ1-AS1 (Chr 10) 
rs704017     
AA 1.00 - 1.00 - 
AG 0.91(0.58-1.42) 0.731 1.03(0.50-2.11) 0.938 
GG 0.91(0.52-1.58) 0.670 0.73(0.30-1.79) 0.497 
A 1.00 - 1.00 - 
G 1.08 (0.83-1.42) 0.542 0.87(0.61-1.23) 0.417 
ABCC2/MRP2 (Chr 10) 
rs1035209     
CC 1.00 - 1.00 - 
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Model Ib Model IIc 
 OR (95%CI) Pd-value OR (95%CI) Pd-value 
CT 1.29(0.85-1.94) 0.235 1.74(0.93-3.24) 0.081 
TT 0.61(0.25-1.47) 0.270 0.72(0.19-2.70) 0.627 
C 1.00 - 1.00 - 
T 1.01 (0.71-1.34) 0.973 0.88(0.56-1.38) 0.576 
TCF7L2 (Chr 10) 
rs11196172     
GG 1.00 - 1.00 - 
AG 1.11(0.71-1.76) 0.642 0.95(0.49-1.86) 0.889 
AA 0.22(0.05-1.03) 0.054 0.13(0.01-1.63) 0.114 
G 1.00 - 1.00 - 
A 0.80(0.54-1.18) 0.260 0.96(0.57-1.61) 0.871 
HSPA12A (Chr 10) 
rs1665650     
CC 1.00 - 1.00 - 
CT 1.13(0.76-1.69) 0.566 1.05(0.57-1.96) 0.874 
TT 2.46(0.93-6.52) 0.070 2.19(0.58-8.31) 0.248 
C 1.00 - 1.00 - 
T 1.25(0.90-1.73) 0.184 1.18(0.77-1.80) 0.437 
MYRF, FEN1, FADS1, FADS2 (Chr 11)  
rs174537     
GG 1.00 - 1.00 - 
GT 0.85(0.57-1.26) 0.407 0.85(0.48-1.49) 0.566 
TT 0.71(0.37-1.32) 0.274 0.70(0.27-1.79) 0.472 
G 1.00 - 1.00 - 
T 0.85(0.64-1.12) 0.253 0.76(54-1.09) 0.135 
rs4246215     
GG 1.00 - 1.00  
GT 0.84(0.57-1.24) 0.382 0.80(0.46-1.40) 0.437 
TT 0.74(0.40-1.38) 0.349 0.83(0.33-2.14) 0.707 
G 1.00 - 1.00 - 
T 0.86(0.65-1.13) 0.276 0.77(0.54-1.09) 0.145 
rs174550     
TT 1.00 - 1.00 - 
CT 0.82(0.56-1.23) 0.270 1.22(0.45-3.34) 0.694 
CC 0.71(0.38-1.31) 0.353 1.44(0.56-3.68) 0.452 
T 1.00 - 1.00 - 
C 0.81(0.61-1.08) 0.159 0.69(0.47-0.99) 0.047 
rs1535     
AA 1.00 - 1.00 - 
AG 0.73(0.49-1.07) 0.106 0.80(0.45-1.40) 0.427 
GG 0.68(0.37-1.23) 0.203 0.68(0.27-1.71) 0.414 
A 1.00 - 1.00 - 
G 0.78(0.59-1.03) 0.079 0.69(0.48-0.98) 0.037 
LOC120376, FL45803, c11orf53, POU2AF1 (Chr 11) 
rs3802842     
AA 1.00 - 1.00 - 
AC 0.95(0.65-1.38) 0.780 0.96(0.53-1.74) 0.899 
CC 1.08(0.56-2.06) 0.833 1.03(0.36-2.94) 0.958 
A 1.00 - 1.00 - 
C 0.99(0.74-1.32) 0.941 1.14(0.78-1.67) 0.485 
CD9 (Chr 9) 
rs10849432     
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 OR (95%CI) Pd-value OR (95%CI) Pd-value 
TT 1.00 - 1.00 - 
CT 1.10(0.71-1.70) 0.659 1.47(0.11-19.03) 0.768 
CC 0.67(0.11-3.99) 0.657 0.88(0.45-1.71) 0.709 
T 1.00 - 1.00 - 
C 0.92(0.62-1.35) 0.658 1.24(0.74-2.07 0.420 
CCND2 (Chr 12) 
rs3217810     
CC 1.00 - 1.00 - 
CT 1.32(0.79-2.21) 0.295 1.21(0.57-2.56) 0.620 
TT NA - NA - 
C 1.00 - 1.00 - 
T 1.56(0.98-2.47) 0.059 1.26(0.73-2.20) 0.408 
rs3217901     
AA 1.00 - 1.00 - 
AG 1.05(0.71-1.55) 0.799 1.10(0.59-2.04) 0.761 
GG 1.30(0.72-2.35) 0.388 0.94(0.38-2.36) 0.897 
A 1.00 - 1.00 - 
G 1.15(0.88-1.53) 0.293 1.22(0.85-1.74) 0.285 
rs10774214     
CC 1.00 - 1.00 - 
CT 1.08(0.73-1.60) 0.688 0.80(0.44-1.44) 0.452 
TT 0.81(0.43-1.52) 0.509 0.72(0.28-1.81) 0.480 
C 1.00 - 1.00 - 
T 1.08(0.81-1.44) 0.616 1.19(0.82-1.71) 0.353 
ATF1 (Chr 12) 
rs11169552     
CC 1.00 - 1.00 - 
CT 0.69(0.47-1.02) 0.061 0.53(0.29-0.98) 0.044 
TT 0.77(0.28-2.16) 0.622 0.90(0.18-4.51) 0.897 
     
C 1.00 - 1.00 - 
T 0.80(0.58-1.10) 0.165 0.78(0.52-1.19) 0.247 
TBX3 (Chr 12) 
rs59336     
AA 1.00 - 1.00 - 
AT 0.92(0.58-1.44) 0.706 0.83(0.42-1.65) 0.604 
TT 0.83(0.49-1.39) 0.472 0.46(0.19-1.10) 0.081 
A 1.00 - 1.00 - 
T 0.84(0.65-1.10) 0.210 1.25(0.89-1.76) 0.206 
BMP4/ATP5C1P1/CDKN3/MIR5580 (Chr 14) 
rs4444235     
CC 1.00 - 1.00 - 
CT 1.21(0.76-1.92) 0.416 1.50(0.73-3.07) 0.272 
TT 1.23(0.71-2.13) 0.460 0.56(0.24-1.34) 0.194 
C 1.00 - 1.00 - 
T 1.02(0.79-1.33) 0.867 1.12(0.79-1.60) 0.515 
rs1957636     
CC 1.00 - 1.00 - 
CT 1.46(0.95-2.26) 0.085 1.45(0.75-2.80) 0.271 
TT 1.28(0.73-2.23) 0.384 0.68(0.30-1.54) 0.360 
C 1.00 - 1.00 - 
T 1.09(0.83-1.43) 0.534 0.99(0.69-1.41) 0.947 
To be continued in the next page. 
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 OR (95%CI) Pd-value OR (95%CI) Pd-value 
SCG5, GREM1, FMN1 (Chr 15) 
rs4779584     
CC 1.00 - 1.00 - 
CT 1.09(0.71-1.69) 0.698 0.79(0.39-1.60) 0.519 
TT 0.61(0.15-2.58) 0.504 0.31(0.06-1.70) 0.177 
C 1.00 - 1.00 - 
T 1.11(0.77-1.58) 0.584 0.06(0.56-1.45) 0.679 
rs16969681  0.193   
CC 1.00 - 1.00 - 
CT 0.73(0.46-1.17) 0.193 0.69(0.33-1.46) 0.332 
TT 0.93(0.13-6.62) 0.938 0.67(0.05-8.47) 0.756 
C 1.00 - 1.00 - 
T 0.88(0.57-1.37) 0.577 0.77(0.42-1.42) 0.402 
rs11632715     
GG 1.00 - 1.00 - 
AG 1.06(0.70-1.61) 0.796 1.13(0.57-2.25) 0.727 
AA 1.00(0.59-1.71) 0.991 0.58(0.27-1.27) 0.173 
G 1.00 - 1.00 - 
A 0.97(0.74-1.28) 0.854 0.96(0.67-1.37)) 0.815 
CDH1 (Chr 16) 
rs9929218     
GG 1.00 - 1.00 - 
     
AG 1.02(0.70-1.50) 0.900 1.24(0.71-2.18) 0.930 
AA 0.90(0.45-1.78) 0.776 0.95(0.32-2.83) 0.447 
G 1.00 - 1.00 - 
A 0.94(0.71-1.25) 0.663 1.10(0.76-1.61) 0.605 
NXN (Chr 17) 
rs12603526     
TT 1.00 - 1.00 - 
CT 1.00(0.14-7.10) 1.000 1.49(0.08-28.04) 0.790 
CC NA - NA - 
T 1.00 - 1.00 - 
C 1.00(0.14-7.10) 1.000 0.74(0.10-5.65) 0.774 
SMAD7 (Chr 18) 
rs4939827     
TT 1.00 - 1.00 - 
CT 1.19(0.79-1.81) 0.408 1.14(0.60-2.17) 0.691 
CC 0.90(0.52-1.54) 0.694 0.80(0.35-1.82) 0.592 
T 1.00 - 1.00 - 
C 0.87(0.66-1.13) 0.288 0.90(0.64-1.27) 0.554 
RHPN2 (Chr 19) 
rs10411210     
CC 1.00 - 1.00 - 
CT 0.90(0.59-1.39) 0.646 0.52(0.26-1.03) 0.060 
TT 3.77(0.42-34.22) 0.238 4.44(0.33-58.89) 0.262 
C 1.00 - 1.00 - 
T 1.01(0.67-1.52) 0.959 0.98(0.57-1.68) 0.942 
TGFB1 (Chr 19) 
rs1800469     
GG 1.00 - 1.00 - 
AG 0.80(0.55-1.15) 0.257 0.56(0.32-0.99) 0.047 
To be continued in the next page. 
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 OR (95%CI) Pd-value OR (95%CI) Pd-value 
AA 0.68(0.35-1.33) 0.230 0.32(0.10-0.99) 0.049 
G 1.00 - 1.00 - 
A 0.80(0.60-1.06) 0.115 0.77(0.53-1.12) 0.171 
BMP2/HAO1/FERMT1 (Chr 20) 
rs4813802     
TT 1.00 - 1.00 - 
GT 0.91(0.62-1.33) 0.550 0.90(1.28-9.70) 0.754 
GG 1.20(0.66-2.21) 0.627 3.52(1.28-9.70) 0.015 
T 1.00 - 1.00 - 
G 1.03(0.77-1.37) 0.855 0.82(0.56-1.18) 0.283 
HAO1/PLCB1 
rs2423279     
TT 1.00 - 1.00 - 
CT 1.26(0.87-1.83) 0.213 1.04(0.61-1.79) 0.880 
CC 1.28(0.68-2.43) 0.441 0.63(0.23-1.68) 0.352 
T 1.00 - 1.00 - 
C 1.19(0.89-1.57) 0.235 1.12(0.78-1.60) 0.534 
SHROOM (Chr X) 
rs5934683     
C 1.00 - 1.00 - 
CT 1.16(0.63-2.18) 0.626 1.20(0.47-3.09) 0.702 
T 1.30(0.87-1.94) 0.207 1.47(0.79-2.75) 0.225 
C 1.00 - 1.00 - 
T 1.20(0.91-1.59) 0.197 1.21(0.83-1.76) 0.322 
A, adenine; C, cytosine; CI, confidence interval; G, guanine; NA, no available data; OR, 
odds ratio; rs, reference single nucleotide polymorphism; SNP, single nucleotide 
polymorphism; T, thymine. 
aThe most frequent genotype was considered the reference group. 
bModel I, crude conditional logistic regression model. 
cModel II, conditional logistic regression adjusted for: age, sex, BMI, physical activity, 
smoking status, alcohol consumption, Deprivation Index and energy intake. Participants 
with missing data for the confounding variables were included as a separate category for 
these variables.  
dP<0.001 was significant. 
 
Continuation of Supplementary Table S2. 
164
Dietary and genetic factors in colorectal cancer  Participants, methods and results 
 
 
S1 Fig. eQTL violin plot showing gene association results for DUSP10 gene, 
rs6687758 and colon sigmoid healthy tissue. A, adenine. G, guanine. Data Source: 
GTEx Analysis Release V8 (dbGaP Accession phs000424.v8.p2). 
 
S2 Fig. Box plot for comparing the difference of expression for  DUSP10 gene 
between cases (in red) and controls (in grey) in colon adenocarcinoma and rectum 
adenocarcinoma. COAD, colon adenocarcinoma. N, normal. READ, rectum 
adenocarcinoma. T, tumour. The method for differential analysis is one-way ANOVA, 
using disease state (Tumor or Normal) as variable for  calculating differential expression. 
Data Source: TCGA and GTEx data, using GEPIA. 
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Discussion 
In this study, we investigated SNPs associated with susceptibility for the development of 
CRC in a Basque population who took part in the population screening programme. We 
found that out of 48 analysed SNPs, only the rs6687758 was associated with the risk of 
CRC in this population. This is in agreement with previous GWAS that reported a positive 
association between this SNP and CRC also in European population [15,34]. Some 
authors have also observed relationships between this SNP and colorectal polyp risk 
[35]; although this SNPs is not associated significantly with adenoma risk and has their 
effects on the malignant stage of colorectal tumorigenesis [36]. The frequency of the risk 
allele of rs6687758 (G) in the European population (22.2%) [37] is similar to that 
registered in the cases of the present study and higher than that of the controls. 
The other 47 risk SNPs did not replicate in our population. This may be due to differences 
in the underlying linkage patterns given the ethnic differences in populations studied. 
Twenty-one of the SNPs analyzed have been replicated in Asian, American-Caucasian 
or African, but not in European (rs11903757, rs1321311, rs10505477, rs719725, 
rs704017, rs12241008, rs11196172, rs174537, rs4246215, rs174550, rs1535, 
rs10849432, rs3217901, rs4444235, rs11632715, rs4939827, rs10411210, rs1800469, 
rs2241714, rs961253 and rs4813802); and 4 were not replicated in population studies; 
however, they were associated with susceptibility for development of CRC in GWAS 
(rs1665650, rs59336, rs1957636 and rs12603526). The effect sizes of some of these 
associations were small (OR <1.20, P<0.05, for rs1321311, rs12241008, and rs704017) 
[38-40]. Additionally, it may be that the distribution of environmental factors in our 
population differs from that of the populations in which these genetic variants were 
discovered. 
The SNP rs6687758 is in a regulatory region, flanking the promoter of DUSP10, at ~250 
kb from the start of the gene. Hence, it is likely to affect the expression of this gene. 
Polymorphisms in DUSP10 gene (dual specificity protein phosphatase 10) have been 
previously demonstrated to be associated with CRC risk [41,42]. In this study, we 
confirmed this CRC susceptibility locus in the Basque population sample. Earlier 
analyses have found frequent dysregulation of dual specificity protein phosphatase 10 
(DUSP10/MKP-5) in CRC [41]. DUSP10 belongs to the dual kinase phosphatase family. 
These proteins are associated with cellular proliferation and differentiation, and they act 
as tumour suppressors [41,43]. 
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Target kinases of DUSPs are inactivated by dephosphorylation of both 
phosphoserine/threonine and phosphotyrosine residues [41,42]. They act at several 
levels, taking part in fine-tuning signalling cascades. DUSPs negatively regulate 
members of the mitogen-activated protein kinase (MAPK) superfamily [41,44], which are 
implicated in some activities that are often dysregulated in cancer, such as cell 
proliferation, survival, and migration [41]. MAPK signalling also plays a key role in 
determining the response of tumour cells to cancer therapies, since its abnormal 
signalling has important consequences for the development and progression of human 
cancer [44]. Several studies have already shown the involvement of DUSPs as major 
modulators of critical signalling pathways dysregulated in different cancers [43], such as 
in the case of the overexpression of DUSP1/MKP-1 in the early phases of cancer and its 
decreasing during tumour progression [42]. 
There is abundant evidence that DUSP10, in particular, may play an important role in 
tumorigenesis and could alter CRC risk [45,46]. It inactivates p38 and JNK in vitro 
[41,47], and its upregulation are very common in CRC[48]. The activation of JNK protein 
is due to the protein kinase G (PKG)/MEKK1/SEK1/JNK cascade, and it is related with 
cell proliferation and inducing apoptosis [41,49]. Moreover, p38 is involved in the 
promotion of cellular senescence as a means of eluding oncogene-induced 
transformation; it participates in cell cycle regulation suppressing cell proliferation and 
tumorigenesis [41,49]. 
On the other hand, the results extracted from gene expression association analyses 
show a higher expression of DUSP10gene in CRC cases, but also that there is a higher 
expression of this gene in colon tissue of healthy controls when they have the GG 
genotype for rs6687758. Thus, it would be likely to find a relationship between higher 
expression of the gene and the presence of allele G in rs6687758 in tumour tissue. 
Nonetheless, it would be interesting to further explore this aspect through future analyses 
to compare gene expression between individuals carrying the risk variant and control 
individuals. Previous studies have pointed in the same direction that there is overall 
increase in patients’ relapse-free survival when DUSP10 expression is upregulated, and 
that DUSP10 mRNA was increased in the tumour compared with normal tissue adjacent 
to the tumours [46,49,50]. 
We found an association between smoking status and the rs6687758 SNP for CRC risk 
in cases .Other authors have also observed this association [51].Benzo[a]pyrene, one of 
the carcinogenic compounds included in cigarette smoke, up-regulated COX-2 in mouse 
cells [52], which in turn could either activate or be dependent on the MAPK pathway, 
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suggesting a possible gene-smoking interaction [53,54].Concerning the association 
between physical activity, the rs6687758 SNP and CRC risk, as far as we know, there 
are no precedents in the literature. However, other studies have found interactions 
between polymorphisms associated with growth hormone (GH1) and insulin-like growth 
factor I (IGF-I) (rs647161, rs2665802), physical activity and CRC [53,54]. According our 
results, rs6687758, medium-high physical activity level and CRC would be associated. 
However, this outcome, contrary o what it could be expected, could be related to changes 
in the lifestyles, including physical activity level, in cases after diagnosis [55]. 
We also analyzed unweighted and weighted GRS models. We observed that cases had 
more risk alleles than controls, this result was according to expectations considering the 
previous studies [56]. In the crude analysis, we observed that patients that had a higher 
number of risk alleles had a higher risk of CRC. Other authors observed similar results 
using an adjusted unweighted model [32]. However, some other authors did not find this 
association [57]. It should be noted that common allele variants generally have modest 
effect sizes [58], but the combination of multiple loci with modest effects into a global 
GRS might improve the identification of patients with genetic risk for common complex 
diseases, such cancer [59]. In this sense, Ortlepp et al. [60] concluded that more than 
200 polymorphisms might be necessary for “reasonable” genetic discrimination. 
Our study has several limitations and strengths. The principal limitations of this study 
were the small sample size that makes difficult to detect possible associations between 
polymorphisms and disease risk since some genotypes showed very low frequencies in 
our population. Another disadvantage of the small sample size is that they can produce 
false-positive results; in order to avoid it, the Bonferroni correction was used. The 
strengths of the study were that although controls tested positive in iFOBT, in CRCSP 
were confirmed that they were free of the disease through colonoscopy. Colonoscopy 
was used as diagnosis criteria to identify the cases in order to avoid false positives and 
negatives. 
In conclusion, most SNPs analyzed were not associated with risk of CRC. Only one of 
the 48 SNPs analyzed, rs6687758, was associated with risk of CRC, in this population 
(on crude analysis). Moreover, there were significant associations between smoking 
status, physical activity, the rs6687758SNP and CRC risk. On the other hand, the results 
of the GRS showed that the risk alleles were more frequent in cases than controls and 
this score was associated with this type of cancer in crude analysis. Therefore, in this 
study, we have confirmed a CRC susceptibility locus and the existence of associations 
between modifiable factors such as smoking and physical activity and the presence of 
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the risk genotype for rs6687758. However, further experimental validations are needed 
to establish the role of this SNP, the function of the gene identified, as well as the 
contribution of the interaction between environmental factors and this polymorphism to 
the risk of CRC.  
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The main objective of this thesis was to study the association between dietary and 
genetic factors and the risk of development of CRC in a sample of cases and controls 
from the population-based CRCSP of the Osakidetza/Basque Health Service. To 
achieve this aim, a case-control study based on a standardised protocol was carried out, 
which included not only dietary and genetic factors but also certain health determinants 
(such as age, lifestyle and socioeconomic conditions), weight status, perceived quality 
of life and stress and use of drugs related to decreasing the CRC risk. In addition, the 
other aim of this thesis was to assess the adequacy of the nutrients consumed and the 
diet quality in a group of CRC patients postsurgery. 
 
Pilot study of CRC patients postsurgery 
Before starting the case-control study, we conducted a pilot study in a group of CRC 
patients postsurgery who participated in the CRCSP of the Osakidetza/Basque Health 
Service. The objectives of this pilot study were, on one hand, to assess the adequacy of 
the nutrients consumed and the diet quality and, on the other hand, to identify possible 
associations between nutritional adequacy and diet quality and certain health 
determinants (such as age, weight status, lifestyles and socioeconomic conditions) in the 
aforementioned group. Regarding diet of CRC patients in this pilot study, this tended to 
follow the western pattern. This dietary pattern is characterized by a high protein and fat 
intake and a low consumption of carbohydrates. Scientific evidence demonstrates that 
this type of diet has a causative link to colon cancer; however, the mechanisms of action 
have not been fully elucidated [1].  
Regarding micronutrient intakes, a significant proportion of subjects did not meet daily 
requirements for folic acid, vitamins A, D and E, Ca, Mg and I. Inadequate intakes of 
these nutrients were also noted by other authors in cancer patients [2,3] and in the 
general population [4]. In addition, the inadequacy for nutrient intakes was greater in men 
than women for the following micronutrients: thiamine, vitamin A, Mg and Zn (P<0.05). 
Consistent with our results, Lim et al. [5] reported more dietary habit problems and poor 
nutritional balance in males with gastric cancer than in females. Moreover, in the present 
study, patients who were overweight/obese presented greater inadequate intake of folic 
acid, vitamin A and Zn than those whose weight was normal (P<0.05). 
In relation to the diet quality, the mean percentage for adherence to the MD was 66.6%, 
and a significant proportion of subjects did not meet food group recommendations; 
85.1% had "no healthy diet or need changes" according to the HEISD. The percentage 
of subjects classified as "no healthy diet or need changes" was similar to the general 
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population of the Basque Country [6]. Although CRC patients claimed to have changed 
to a healthy diet after being diagnosed with CRC [7,8], these patients often either receive 
no dietary information or dietary advice is scarce [9,10]. This fact could influence dietary 
adequacy and quality. Furthermore, participants who were 61 years of age or older 
obtained higher HEISD scores than subjects younger than 61 (P<0.05); this result agrees 
with the findings of other studies [6].  
Other factors related to diet quality scores (HEISD and/or MDS) were educational 
attainment, most recent occupation, smoking status and physical activity participation. 
Although no significant association was identified, there was a medium size effect. In 
addition, regression analyses demonstrated that those without studies or primary 
education had a low adherence to the MD and greater thiamine inadequacy (P<0.05). 
Results concerning educational level and MDS agreed with the findings of other authors 
[11]. However, care must be taken in the interpretation of our analysis of logistic 
regression due to sample size. In relation to lifestyle factors, the greatest size effect 
occurred in the smoking status variable for both diet quality indices. In our study, tobacco 
consumption was associated with a greater inadequacy in the intake of folic acid 
(P<0.05) and could be associated with a low diet quality, even though the P-value was 
not significant. Other authors have observed relationships between smoking and dietary 
intake [12]. Furthermore, significant interactions were observed between smoking and 
CRC, suggesting a potential mediating effect of the MD [13,14].  
In summary, our results demonstrated that the diet of the studied group was inadequate 
in many respects, including nutrients and food intakes. The inadequacy of some nutrients 
was associated with male gender, excess weight, smoking and low educational level, 
and the low adherence to the MD was pronounced in those with a low educational level. 
These results confirm the hypothesis that the diet of CRC patients postsurgery is 
inadequate in many respects, including nutrients and food intakes, and this dietetic and 
nutritional inadequacy is associated with certain health determinants. 
 
Participants in the case-control study of the CRCSP of the Osakidetza/Basque Health 
Service 
To contextualize this section of the doctoral thesis, the rate of participation, as well as 
certain characteristics of cases and controls should be mentioned. The participation rate 
of the cases was 52.9% and that of the controls was 37.6%. More men than women 
participated (1.96:1.0), most being elderly people (average age in cases= 61.5; and in 
controls=61.1 years), which was consistent with previous literature on CRCSP of the 
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Osakidetza/Basque Health Service [15]. Although the average participation rate in this 
CRCSP was higher in women than men (70.9% vs. 65.6%), the proportion of CRC 
diagnosed was higher in men than in women (4.8% vs. 2.1%) [15]. Regarding 
pathological staging of the cases, 72% were diagnosed with in early-stage (I/II) CRC, 
76% had distal location of the cancer, 80.5% of tumours were well/moderately 
differentiated and 73.7% had undergone surgical resection. The cases were invited to 
take part in this survey at least one month after finishing their last treatment (surgery, 
chemotherapy or radiotherapy) (median, 1.3 years; range, 0.1 to 4.2 years). No 
statistically significant differences were found either in the time elapsed between 
participation in the CRCSP and collaboration in this survey or between cases and 
controls. 
Significant differences between cases and controls were found for educational level, 
smoking, and weight status; with a higher percentage of cases with low-medium 
educational level, past or current smoking status and with overweight/obesity compared 
to controls (P<0.01). This last result is in agreement with previous studies [16-18] that 
have confirmed that obesity is associated with an increased risk of CRC. Even though 
the biological mechanisms underlying the association between excess body-fat and CRC 
remain unclear [19], evidence seems to support the important role of metabolic 
syndrome, insulin resistance [20], systemic inflammation and immunity [21], microbial 
dysbiosis [22] , as well as certain genetic factors especially in early-onset CRC [23,24]. 
Elucidating the mediating role of these factors in obesity-induced CRC should be very 
useful in the prevention and treatment of this type of cancer. In addition to the direct 
contribution of obesity to CRC risk, excess body-fat could, in turn, be associated with 
other risk factors for CRC, such as unhealthy diet and sedentary lifestyle [25,26]. It is 
worth noting that we also observed a slightly higher proportion of controls whose main 
daily activity was sedentary compared to cases, but this result could be influenced by a 
greater awareness of the associations between diseases and lifestyle factors in cases.  
On the other hand, in this study, we have not found a more frequent use of certain drugs 
related to a decreasing CRC risk [27]. In addition, alcohol consumption, perceived quality 
of life and stress levels did not differ between cases and controls. Lastly, significant 
differences between cases and controls were found for DI and PRM, with a higher 
percentage of controls than cases in Q1-3 (the least disadvantaged) for DI, and a higher 
percentage of cases than controls in L1-2 (these levels included those with a risk of high 
health resource consumption) for PRM (P<0.001). Briefly, results indicated significant 
differences in favour of controls for smoking habit, weight status, socioeconomic level 
and health status. So, the hypothesis that there are significant differences between cases 
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and controls with regard to lifestyle, weight status, use of drugs related to decreasing 
CRC risk, socioeconomic level, health status, quality of life and stress level was 
supported in part. 
 
Diet of the case-control sample of the CRCSP of the Osakidetza/Basque Health Service 
The diet of the case-control sample was assessed from several point of views: (1) 
adequacy of nutrient intake; (2) food groups; and (3) diet quality. First, the diet of 
participants, both cases and controls, was characterized by high intakes of protein, fat, 
SFA, and low intakes of carbohydrates and dietary fibre; thus, following a western diet 
pattern. This dietary pattern has been associated before with an elevated CRC incidence 
[28]. Moreover, the percentage of cases whose consumption of SFA and cholesterol did 
not comply with NOSP was higher than that for controls. This result is in agreement with 
those reported by other authors who observed a higher CRC risk among subjects with 
high intake of both SFA and cholesterol (highest vs. lowest) [29,30]. The mechanisms 
involved in the influence of fat on the colorectal carcinogenesis are complex and appear 
to be related with its effect on the insulin-signal pathway and the c-Jun N-terminal kinase 
(JNK) pathway that promote the colonic cell proliferation [31].  
On the other hand, in the present study, we have not found a higher intake in controls 
than in cases of protective factors associated with a decrease in CRC risk according to 
the scientific literature, such as, for example, Ca, Mg, fibre diet, vitamin D or B6 [27]. 
However, the average intake of vitamin B2 and the Ca/P ratio was higher in controls than 
in cases. Some studies have indicated before that vitamin B2 intake is inversely 
associated with CRC risk [32]. With respect to the Ca/P ratio, Botron et al. [33] reported 
a case-control study in which they analysed the possible association between this ratio 
and colorectal carcinogenesis, and found positive associations, but the intake of 
phosphorous did not appear to have any modulating effect on the relation between 
dietary Ca intake and CRC.  
In addition, the frequency of use of salt added to cooking was significantly higher in cases 
than controls. In other case-control studies, a positive association between sodium intake 
and CRC was also observed [34]. In any case, our average intake of Na from SFFQ was 
similar for cases and for controls, probably due to the difficulty to estimate this intake 
from self-reported data on added salt [35]. In summary, the results were in agreement 
with the hypothesis that diet, from the nutritional perspective, is significantly different 
between cases and controls, being in some aspects more favourable in controls, 
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particularly with regard to intake of SFA, cholesterol, vitamin B2, the Ca/P ratio and the 
use of salt added to cooking. 
Second, in respect to consumption by food groups, a high consumption of high-fat 
cheeses was associated with CRC risk, whereas, a high intake of fibre-containing foods, 
especially whole grains, and fatty fish, was associated with a lower risk for CRC. As other 
authors have previously reported [36] milk/dairy products was the food group with the 
highest adjusted OR for CRC risk, which is not in agreement with the likelihood of 
evidence that this food group may have a protector effect against CRC [37]. However, 
case-control studies published to date are heterogeneous and, on average, do not 
provide evidence of an association between total intake of total dairy products, milk, 
cheese or yogurt and CRC risk [37]. Regarding milk/dairy product consumption 
according to anatomical subsites of cases, the intake was higher in proximal tumour 
cases and lower in distal cases than in their matched controls. Although according to 
scientific literature, the effect of this food group seems to be similar across all locations 
of the bowel [38]. 
In general, epidemiological studies have not found evidence of either a reduction or an 
increase in CRC risk specifically associated with the consumption of cheese [39,40]. 
Although there are few research papers on cheese consumption that have reported an 
inverse association with CRC [41], in this research, high-fat cheeses are shown to be 
possible risk factors for CRC development. Some studies showed a positive relationship 
between fatty foods and CRC incidence [42]. Dairy products, e.g., mature, semi-mature 
and creamy cheeses, are rich in saturated fat, so this relationship might be due to the 
content of fat in these products. In any case, the association between milk/dairy product 
consumption and the risk of developing CRC is complex and some researchers indicated 
that the fat content contained within dairy products does not influence this association 
[38]. 
In line with previous studies [43-45], we also found that the consumption of fibre-
containing foods was inversely associated with CRC risk. The preventive effect of dietary 
fibre can be explained by biological mechanisms that include increasing amounts of 
faeces, decreasing gastrointestinal transit time, diluting intestinal cancer-causing factors, 
interfering absorption of those, and the lowering of intestinal acidity [46]. Furthermore, 
our findings suggest that high consumption of whole grains (higher than 17.5 g/d in men 
and 30.0 g/d in women) may decrease the risk of CRC, after controlling confounding 
factors. There is convincing evidence that whole grains help to reduce CRC risk 
[37,47,48]. The observed reduction in CRC risk associated with high consumption of 
whole grains may partly be attributed to dietary fibre, resistant starch, and 
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oligosaccharides that can influence the gut environment. In addition, recent research 
about the influence of dietary intake on gene expression in colon tissue has observed 
that the genes that are differentially expressed with a high intake of whole grain and 
vegetable consumption are associated with NF-κB signalling, regulation of apoptosis, 
cytoskeleton dynamics, and carbohydrate metabolism [49]. 
On the other hand, the consumption of fatty fish was associated with a decreased risk in 
CRC, after adjusting models for covariates. It should be noted that the consumption of 
total fish and fatty fish is higher in the Basque Country compared to other Spanish 
autonomous communities [50,51]. Recent cohort studies have observed that fatty fish 
was inversely associated with CRC incidence [52,53] and they have related this 
association with exposure to long-chain n-3 polyunsaturated fatty acids [52]. Evidence 
from animal and in vitro studies indicates that n-3 fatty acids present in fatty fish may 
inhibit carcinogenesis [54]. According to the hypothesis raised by Larsson et al. (2004) 
[55], n-3 fatty acids can suppress arachidonic acid-derived eicosanoid biosynthesis; 
influence transcription factor activity, gene expression, and signal transduction 
pathways; modulate estrogen metabolism; increase or decrease the production of free 
radicals and reactive oxygen species; and influence insulin sensitivity and membrane 
fluidity. 
In summary, these results confirm part of Hypothesis 3 of the thesis, about the 
association between certain foods with increasing or decreasing risk for CRC. Although 
association between CRC risk and certain foods such as red meat and processed meat 
or alcoholic drinks, that are well documented in the literature [37], were not confirmed in 
this case-control sample. Furthermore, food group intakes were not substantially 
different between proximal and distal cancer cases, except for fish, milk/dairy products 
and fat. 
Finally, adherence to the MD pattern was associated with a lower risk of CRC. These 
findings on the MDS and CRC risk are supported by those of other researchers [56-61], 
who found significant associations between lower risk of CRC and adherence to the 
Mediterranean dietary pattern. However, the HEISD was not associated with CRC risk, 
discrepancies in results obtained with the two dietary quality indices analysed are 
probably due to differences in their constructs and scoring criteria. The overall MDS was 
inversely associated with CRC risk, the total score in cases with the proximal location of 
cancer being higher than for those with the distal location. These last results contrast 
with previous findings, which showed that the protective effects of adherence to the MD 
were mainly for distal colon and rectal cancer and not for proximal colon cancer [13]. In 
the total sample, investigation of the separate score components showed that whole 
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grain score was lower for cases than for controls. This result is consistent with that 
obtained for the association between whole grain consumption and CRC risk. Therefore, 
we are able to confirm part of Hypothesis 3 put forward in this doctoral thesis with 
reference to the association between the MD pattern and decreasing risk for CRC, and 
to differences depending on tumour location.  
 
SNPs associated with susceptibility for the development of CRC in the case-control 
sample from the CRCSP of the Osakidetza/Basque Health Service 
The study of SNPs associated with susceptibility for the development of CRC showed 
that out of 48 analysed SNPs, only the rs6687758 was associated with the risk of CRC 
in this population. This is in agreement with previous GWAS that also reported a positive 
association between this SNP and CRC in the European population [62,63]. Some 
authors have also observed relationships between this SNP and colorectal polyp risk 
[64]; although this SNP is not associated significantly with adenoma risk and effects the 
malignant stage of colorectal tumorigenesis [65]. The frequency of the risk allele of 
rs6687758 (G) in the European population (22.2%) [66] is similar to that registered in the 
cases of the present study and higher than that of the controls. 
The SNP rs6687758 is in a regulatory region, flanking the promoter of dual specificity 
protein phosphatase 10 (DUSP10), also known as MAP kinase phosphatase 5 (MKP5), 
at ~250 kb from the start of the gene. Hence, it is likely to affect the expression of this 
gene. Polymorphisms in DUSP10 gene have previously been demonstrated to be 
associated with CRC risk [67,68]. DUSP10 is considered to be an inhibitor of 
inflammation [69] and was shown to negatively regulate the proliferation of intestinal 
epithelial cells and act as a suppressor for CRC [70]. It seems likely that DUSP10 inhibits 
the intestinal epithelial cell barrier function via inhibition of ERK1/2 activation and KLF5 
expression, which in turn reduces intestinal epithelial cell proliferation, necessary for 
wound healing [70]. In any case, the harmful effect will occur when, for example, the 
intestine is exposed to carcinogenic compounds leading to the development of cancer-
associated mutation.  
Target kinases of DUSPs are inactivated by dephosphorylation of both 
phosphoserine/threonine and phosphotyrosine residues [67,68]. They act at several 
levels, taking part in fine-tuning signalling cascades. DUSPs negatively regulate 
members of the mitogen-activated protein kinase (MAPK) superfamily [67,71], which are 
implicated in some activities that are often dysregulated in cancer, such as cell 
proliferation, survival, and migration [67]. The most important groups of MAPKs are the 
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p38, JNK1/2 and extracellular signal-regulated kinase (ERK1/2). MAPK signalling also 
plays a key role in determining the response of tumour cells to cancer therapies, since 
its abnormal signalling has important consequences for the development and 
progression of human cancer [71].  
Several studies have already shown the involvement of DUSPs as major modulators of 
critical signalling pathways dysregulated in different cancers [72], such as in the case of 
the overexpression of DUSP1/MKP-1 in the early phases of cancer and its decrease 
during tumour progression [68]. There is abundant evidence that DUSP10, in particular, 
may play an important role in tumorigenesis and could alter CRC risk [71,73]. It 
inactivates p38 and JNK in vitro [67,74], and its upregulation is very common in CRC 
[75]. The activation of the JNK protein is due to the protein kinase G 
(PKG)/MEKK1/SEK1/JNK cascade, and it is related to cell proliferation and apoptosis 
induction [67,70]. Moreover, p38 is involved in the promotion of cellular senescence as 
a means of eluding oncogene-induced transformation; it participates in cell cycle 
regulation, suppressing cell proliferation and tumorigenesis [67,70]. 
On the other hand, the results extracted from gene expression association analyses 
show a higher expression of the DUSP10 gene in CRC cases, but also that there is a 
higher expression of this gene in colon tissue of healthy controls when they have the GG 
genotype for rs6687758. Thus, a relationship is likely to be found between higher 
expression of the gene and the presence of allele G in rs6687758 in tumour tissue. 
Nonetheless, it would be interesting to further explore this aspect through future analyses 
to compare gene expression between individuals carrying the risk variant and control 
individuals. Previous studies have concurred to some extent that there is an overall 
increase in patients’ relapse-free survival when DUSP10 expression is upregulated, and 
that DUSP10 mRNA was increased in the tumour compared with normal tissue adjacent 
to the tumours [70,73,76]. 
In addition, we found an association between smoking status and the rs6687758 SNP 
for CRC risk in cases. Other authors have also observed this association [77]. 
Benzo[a]pyrene, one of the carcinogenic compounds included in cigarette smoke, up-
regulated COX-2 in mouse cells [78], which in turn could either activate or be dependent 
on the MAPK pathway, suggesting a possible gene-smoking interaction [79,80]. 
Regarding the association between physical activity, the rs6687758 SNP and CRC risk, 
as far as we know, there are no precedents in the literature. However, other studies have 
found interactions between polymorphisms associated with growth hormone (GH1) and 
insulin-like growth factor I (IGF-I) (rs647161, rs2665802), physical activity and CRC 
[79,80]. According to our results, rs6687758, medium-high physical activity level and 
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CRC would be associated. However, this outcome, contrary to what might be expected, 
could be related to lifestyle changes, including increased physical activity level, in cases 
following diagnosis [81]. 
The remaining 47 SNPs analysed in this doctoral thesis were not replicated in our 
population. This may be due to differences in the underlying linkage patterns given the 
ethnic differences in the populations studied. Twenty-one of the SNPs analysed have 
been replicated in Asian, American-Caucasian or African but not in European 
populations; and four were not replicated in any population studies; however, they were 
associated with susceptibility for development of CRC in GWAS. The effect sizes of 
some of these associations were small (OR <1.20, P<0.05, for rs1321311, rs12241008, 
and rs704017) [82-84]. Additionally, it may be that the distribution of environmental 
factors in our population differs from that of the populations in which these genetic 
variants were discovered. 
Finally, the unweighted and weighted GRS models showed that cases had more risk 
alleles than controls; this result was according to expectations considering the previous 
studies [85]. In the crude analysis, we observed that patients that had a higher number 
of risk alleles had a higher risk of CRC. Other authors observed similar results using an 
adjusted unweighted model [87]. However, some other authors did not find this 
association [88]. It should be noted that common allele variants generally have modest 
effect sizes [89], but the combination of multiple loci with modest effects in a global GRS 
might improve the identification of patients with genetic risk for common complex 
diseases, such cancer [90]. In this sense, Ortlepp et al. [91] concluded that more than 
200 polymorphisms might be necessary for “reasonable” genetic discrimination. 
Briefly, the results of this section of the thesis showed that most SNPs analysed were 
not associated with risk of CRC. Only one of the 48 SNPs analysed, rs6687758, was 
associated with a risk of CRC, in this population (on crude analysis). Moreover, there 
were significant associations between smoking status, physical activity, the 
rs6687758SNP and CRC risk. On the other hand, the results of the GRS showed that 
the risk alleles were more frequent in cases than in controls and this score was 
associated with this type of cancer in crude analysis.  
 
Strengths and limitations  
One of the strengths of this thesis comes from the originality of the pilot study, to the best 
of our knowledge, this nutritional study is the first one dedicated to nutritional adequacy 
and diet quality in CRC patients postsurgery. But the main strength is the fact that it 
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provides information based on a standardised protocol including not only dietary and 
genetic factors but also other possible determinants of CRC such as health determinants 
and weight status, among others. A further strength of the case-control study compared 
to others [56,92,93] is that colonoscopy was used as a diagnosis criterion to identify the 
cases in order to avoid false positives and negatives.  
However, there are a number of limitations that should be mentioned. First, the small 
sample size of the pilot study carried out in CRC patients postsurgery did not allow a 
more precise analysis of the dietary adequacy of this group. Second, recall bias inherent 
in a case-control study design cannot be ruled out. The primary concern of this study is 
the low participation rate, which may have limited the representativeness of study 
samples. The decision to participate or not may have been influenced by several factors, 
including social, educational and health conditions, which may again correlate with 
outcome risk factors. Third, self-reported data could be subject to measurement errors 
and the problem of food omissions due to memory failure and underreporting of 
unhealthy habits among disease subjects. Despite that, previous validation studies 
indicate that the self-reported dietary information is reported with sufficient accuracy for 
use in epidemiology analysis [94,95]; and it should be noted that dietary changes are 
usually modest after participating in the CRCSP due to a lack of information or 
personalized advice [96-98].  
Fourth, to avoid selection bias of controls we obtained controls from the same CRCSP 
and in the same period as cases, thus, it had been confirmed by colonoscopy that they 
did not suffer from CRC. Fifth, the lack of control of some possible confounders, such as 
comorbidities and other conditions that could affect food consumption and the capacity 
to absorb and to use nutrients, should be noted. Finally, sixth, the sample size of the 
case-control study makes it difficult to detect possible associations between 
polymorphisms and disease risk since some genotypes showed very low frequencies in 
our population. Another disadvantage of the small sample size is that it can produce 
false-positive results; in order to avoid this the Bonferroni correction was used.  
Despite these limitations and considering all the results obtained in this doctoral thesis, 
we can conclude that the diet of the studied CRC patients postsurgery is inadequate in 
many respects, including nutrients and food intakes, and that this inadequacy is 
associated with certain health determinants. Further studies are needed to confirm these 
determinants with the purpose of applying educational programs in target groups and 
individualized nutritional counselling sessions to improve life quality and reduce the risk 
of CRC mortality. On the other hand, we also conclude that there are direct associations 
between CRC risk and high-fat cheese, and inverse associations with fibre-containing 
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foods and fatty fish, as well as adherence to an MD pattern, in the case-control sample 
analysed. With respect to genetic factors, we have confirmed a CRC susceptibility locus 
and the existence of associations between modifiable factors and the rs6687758 SNP; 
moreover, the GRS was associated with CRC. However, further studies are needed to 
better understand the influence of the dietary habits on CRC prevention and to establish 
the role of the genetic factors, as well as the contribution of the gene-diet interactions to 
the risk of CRC in this population.   
 
Future perspectives 
The results obtained in this thesis will be confirmed in later studies with larger sample 
sizes. The population of the Basque Autonomous Community offers us a great 
opportunity due to the relatively high incidence of this type of cancer and the existence 
of a public health system that facilitates the obtaining of clinical histories, pathology 
reports and tissue samples needed for the study. Therefore, in the future, it is expected 
to be able to extend the project to other Osakidetza Hospitals in order to increase the 
sample size. It should be remembered that this doctoral thesis is part of a line of research 
on the impact of gene-diet interactions on the risk of CRC in the Basque Country. 
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On the basis of the results obtained in this doctoral thesis, the following conclusions were 
derived: 
1. The diet of the studied group of CRC patients postsurgery from the CRCSP of the 
Osakidetza/Basque Health Service is inadequate in many respects, including 
nutrients and food intakes. The inadequacy of some nutrients was associated with 
male gender, excess of weight, smoking and low educational level, and the low 
adherence to the MD was pronounced in those with a low educational level.  
2. The cases of the case-control study were more likely than controls to have 
overweight/obesity, a higher frequency of consumption of salt added for cooking, a 
lower intake of vitamin B2 and Ca/P ratio, and to have not adequate intakes of SFA 
and cholesterol. Thus, some environmental factors such as diet, and weight status 
could influence on the aetiology of CRC in this population group from the CRCSP. 
3. High consumption of high-fat cheeses was associated with CRC risk, whereas, a high 
intake of fibre-containing foods, especially whole grains, and fatty fish, and adherence 
to the MD pattern was associated with a lower risk for CRC, in the case-control sample 
from the CRCSP. In addition, according to tumour location, cases with the proximal 
location had higher adherence to MD pattern than those with the distal location.  
4. Most SNPs analysed in the case-control sample from the CRCSP were not associated 
with risk of CRC. Only one of the 48 SNPs analysed, rs6687758, was associated with 
risk of CRC, in this population (on crude analysis). Moreover, there were significant 
associations between smoking status, physical activity, the rs6687758SNP and CRC 
risk. On the other hand, the results of the GRS showed that the risk alleles were more 
frequent in cases than controls and this score was associated with this type of cancer 
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